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Microbubble agents are used to enhance image-contrast and therapy using ultrasound.
Current developments of these agents include the targeting of microbubbles to attach to
specific markers expressed on certain diseased cells. Inflamed areas of atherosclerosis
associated with unstable plaque in arteries have been shown to express specific inter-cell
adhesion molecules such as ICAM-1. In order to distinguish between areas of stable and
unstable plaque an ultrasonic contrast agent has been developed in-house for imaging with
high frequency intravascular ultrasound (IVUS). The contrast agent has been imaged with
IVUS at 40 MHz at different stages during development.
To assess in vivo applicability of the in-house agent it was necessary to image it attached to
surfaces and under flow conditions. To image microbubbles at surfaces, work was
undertaken on contrast agents at agar-based boundaries. Contrast agent was attached to agar-
based material using the avidin and biotin interaction. The attached microbubbles were
imaged with high frequency ultrasound, from 7-40 MHz. A flow chamber was developed
for use with IVUS. The attached microbubbles were imaged under flow conditions. The
microbubbles were found to remain echogenic and attached to the agar at a range of flow
rates from 75 - 480 ml min"1 through a flow area of 9 mm2. The peak negative acoustic
pressures for a selection of high frequency transducers were determined in order to define
the ultrasound imaging field.
Laser Doppler anemometry (LDA), a non-invasive high resolution technique for measuring
flow velocities in liquids and gases was used to determine the flow profile within the flow
chamber at the surface of the agar sample. The shear stress on the agar was calculated from
the profile. Attached contrast agent was found to remain attached to agar under wall shear
stresses of up to 3.4 Pa compared to a mean in-vivo arterial wall shear stress of 1.5 Pa. Free
flowing in-house agent was shown to attach to prepared agar under low flow rates.
In this thesis the in-house contrast agent has been shown: to be echogenic at high
frequencies, to be echogenic when attached to agar, to remain attached under physiological
wall shear stresses and to attach to avidin coated agar when subjected to flow. An LDA
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Microbubble contrast agents have successfully been used to enhance the backscatter
of ultrasound leading to new and developing methods for diagnosis and therapy
(Ophir and Parker 1989, Unger et al 2001a). A recent development of contrast agents
has been the tagging of them to target specific sites of interest within the body such
as areas of inflammation. Contrast microbubbles have the potential to be used to
highlight specific areas within the body. Targeting of microbubbles to a specific
marker expressed at certain areas could potentially be used for the enhancement of
images and drug or gene delivery (Unger et al 2002, Unger and Sweitzer 2003).
Contrast agents have been predominantly developed for use with ultrasound of
frequencies of 1-10 MHz. However, there is potential for the use of targeted contrast
agents at the higher intravascular frequencies of 20-40 MHz. In order to do this,
microbubbles specifically developed for use with frequencies greater than 10 MHz
need to be developed. Another reason for the need for development of new contrast
agents for targeting is the difficulty in modifying currently available contrast agents
due to commercial sensitivity regarding their composition. Modification of the
contrast agents is necessary to enable the shell to be adapted for targeting. To this
18
Chapter 1: Introduction
end, a microbubble is being developed in Edinburgh for use with high frequency
ultrasound which will have the potential to be targeted to markers expressed on areas
of atherosclerotic plaque (Moran et al 2003b, Moran et al 2004).
Areas of inflammation within the body are known to express certain molecules.
Inflammation and hence these markers are found at areas of vulnerable plaque.
Vulnerable plaque is a cause of myocardial infarction however; it does not always
cause major blockages within the artery. Currently, intravascular ultrasound can be
used along with angiography for the detection of plaque in arteries, however,
determining whether the plaque is stable or unstable (vulnerable) is not presently
possible. A contrast microbubble targeted to markers at areas of vulnerable arterial
plaque could potentially be used to distinguish between stable and unstable plaque,
leading to treatment prior to any episode of myocardial infarction.
1.2 Aims and Objectives
The title of this thesis is 'High frequency ultrasonic imaging of targeted microbubble
contrast agents under controlled shear stress'
The aims and objectives of this thesis are to:
o Aid in the development of a targeted ultrasonic contrast agent for use with
intravascular ultrasound,
o Use high frequency ultrasound to image contrast agents against surfaces and
attached to surfaces,
o Image attached ultrasonic contrast agents under flow conditions,
o Determine the wall shear stresses to which the attached contrast agents are
subjected.
o Investigate the wall shear stresses under which the contrast agents remain
attached and under which they form an attachment.
19
Chapter 1: Introduction
1.3 Overview of Work
To pursue these aims, an ultrasonic contrast agent was developed in-house which
could be imaged at intravascular frequencies. Initial optimisation of this agent was
undertaken along with imaging of microbubbles against surfaces. It can be difficult
to distinguish the backscattered signal from attached microbubbles from the signal
from the vessel wall. Initial work on imaging attached microbubbles was completed
against a surface of low echogenicity as this increased the ease of detection of the
microbubbles. The in-house microbubble could be attached to agar and was imaged
under flow conditions at increased flow rates. The shear rate to which the attached
microbubbles were subjected was determined and used to calculate the shear rate
under which the microbubbles remained attached.
1.4 Outline of thesis
This thesis follows the following format:
Chapter 1
Introduction to the thesis, motivation for the project and outline of thesis.
Chapter 2
Summary of the current literature on contrast agents and their applications. There is
also an introduction to cardiovascular disease, an application for targeted contrast
agents.
Chapter 3
Summary of work completed on imaging microbubbles against surfaces. Work on
the development of a new contrast agent and imaging it attached to agar based
samples with high frequency ultrasound. There is also work on imaging the attached




Summary of work completed on characterising high frequency ultrasound fields from
intravascular and transcutaneous transducers which have been used to image attached
microbubbles.
Chapter 5
Summary of methods for measuring flow velocities and flow profiles in the flow
chamber in order to calculate the wall shear stress experienced by the microbubbles
at increasing flow rates. Experimental work using laser Doppler anemometry to find
flow profiles within the flow chamber is described. Along with the determination of
the wall shear stresses to which the microbubbles were subjected.
Chapter 6
Summary of experimental work on imaging the microbubbles at increasing wall
shear stresses with high frequency intravascular ultrasound. Also experimental work
on imaging microbubbles with different shell constituents attached to agar.
Chapter 7
Summary of preliminary experimental work on attachment of the in-house agent in-
vitro under flow conditions.
Chapter 8






2.1.1 The Cardiovascular System
The major components of the cardiovascular system (CVS) are the heart, blood
vessels and blood, the principal function of this system is the transport of oxygen,
glucose, amino acids, other nutrients and drugs to and from tissues throughout the
body, as well as the transport of waste products. The CVS is also involved with the
control of hormones and the regulation of body temperature (Levick 2003, Seeley et
al 1996)
A diagram of the cardiovascular system is shown in Figure 2.1. The heart consists of
left and right ventricles which act as pumps. The right ventricle pumps deoxygenated
blood to the lungs while the left side of the heart receives the oxygenated blood from
the lungs and the left ventricle pumps it to the rest of the body via the aorta. The right
side of the heart receives the deoxygenated blood from the body via the inferior and




Figure 2.1: Basic diagram of the cardiovascular system.
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The coronary arteries supply oxygen rich blood to the tissues of the heart (Berne and
Levy 1997), typically the aorta splits into two coronary arteries, the right and left,
which form branches around the heart. Typically, the left coronary artery splits to
form the left anterior descending artery (LAD) usually 100-130 mm in length and the
left circumflex artery (LC) which is 60-80 mm in length. The right coronary artery is
120-140 mm long and gives rise to the posterior descending artery. Smaller arterial
branches extend from the left and right coronary arteries to surround the heart. The
aorta can be up to 25 mm in diameter and the coronary arteries approximately 4 mm
in diameter (Levick 2003). The anatomy of the coronary arteries is shown in Figure
2.3, they surround the heart supplying blood to the tissue. A diagram showing the
layers within a typical cross-section through a coronary artery is shown in Figure 2.4.
There are three layers which make up the vessel wall, the adventia on the outside,
followed by the medial and intima. Lining the inside of the vessel is the endothelium
which consists of thin flat endothelial cells. These cells form a smooth surface within






























Figure 2.4: Diagram of cross-section of a coronary artery.
2.1.2 Cardiovascular Disease
Atherosclerosis is the build up of deposits of fatty substances (lipids), calcium,
cholesterol or fibrous material in the lining of an artery. Arteries of the brain, heart,
kidneys and other vital organs can be affected. In the heart, narrowing of the
coronary arteries due to build up of plaque can lead to limited blood flow; thus
reducing the level of oxygen to the heart muscle during times of stress. This can
cause damage to the heart or cause the heart to malfunction. The first symptom of
coronary artery disease (CAD) is commonly chest pain, known as angina.
Atherosclerosis can cause damage by gradually or suddenly, during rupture, blocking
the arteries or weakening the walls of the arteries. A thrombosis may form at the
plaque which may lead to a myocardial infarction (heart attack).
2.1.3 Vulnerable Plaques
It is known that the plaques which cause unstable angina and myocardial infarction
do not always cause severe stenoses in the coronary arteries (Libby 2004). This can
make them difficult to detect by angiography as they are not seen as blockages in the
arteries. The components of a plaque can affect the likelihood of rupture. Hard
plaques with small amounts of lipids can be stable while soft plaques, with soft lipid
centres and thin fibrous caps, are unstable and vulnerable (Schroeder and Falk 1995).
These plaques can easily rupture leading to a myocardial infarction.
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Inflammation is an important process involved with the development of
atherosclerosis (Libby 1995). Animal models of atherosclerosis have shown that
inflammation and build up of lipid in the artery wall develop at the same time (Libby
et al 2002).
2.1.4 Statistics
Cardiovascular disease is the most common cause of death in the UK. Approximately
2.56 million people in the UK have CAD and nearly 50% of these have had a heart
attack. The cost of CAD to the UK healthcare system in 1999 was £1.7 billion with
the total annual cost to the UK economy being £7 billion after informal care and
productivity losses were included, this is greater than the cost of any other single
disease (NHS report 2003, Petersen et al 2004). About four in ten of all deaths are
due to cardiovascular disease. Approximately 50% of deaths from cardiovascular
disease are due to coronary heart disease. In Europe cardiovascular disease causes 4
million deaths each year. About 60% of all myocardial infarctions are caused by the
rupture of a vulnerable plaque (Casscells et al 2003).
2.1.5 Current Methods of Detection and Treatment
Coronary artery disease can often be controlled solely with drugs which can reduce
symptoms and risk factors associated with the disease. Drugs can be used to help
lower blood pressure, help reduce cholesterol levels and inhibit or prevent blood
clotting. However, if the blood vessels have become very narrowed or if drug
treatment alone is not controlling the symptoms, surgery can be necessary to open up
arteries or replace the blocked sections. Invasive treatments for coronary heart
disease include: coronary angioplasty and coronary bypass surgery.
Over 20,000 angioplasties are performed in the UK each year. This treatment
involves a catheter passing through a large artery in the groin or arm until it reaches
the blockage. A stent is placed between the blocked walls with a balloon inside the
stent being slowly inflated to expand the stent, flattening the blockage against the
artery wall. The balloon is then deflated and removed, leaving the stent helping to
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hold the vessel open. Coronary bypass surgery takes segments of blood vessels from
other parts of the body e.g. legs and arms, which are grafted between the aorta and
coronary arteries to bypass obstructions.
Prior to both treatments, the extent of narrowing within arteries needs to be assessed.
Angiograms are used to view arteries by injecting dye into the bloodstream through a
catheter. X-rays of the heart and coronary arteries are then taken, showing any
reduction in vessel diameter due to an obstruction. The best treatment is decided after
examination of the angiogram. There are however limitations to angiographies, some
studies suggest angiograms underestimate the amount of atherosclerosis present in an
artery (Nissen 2001, Nissen 2002). Also, vulnerable plaques can be invisible on
angiographies since they do not necessarily cause severe narrowing (stenosis).
An intravascular ultrasound (IVUS) catheter transducer is shown in Figure 2.5, IVUS
can be used to show the internal morphology of arteries (Figure 2.6) to complement
angiography. The image obtained using IVUS is a full, cross-sectional image,
whereas in angiography a planar, longitudinal image is seen. As well as imaging the
artery and plaque morphology, IVUS can be used to image the position and
expansion of stents which have previously been placed in arteries (Chong 1996).
Figure 2.7a shows an angiograph showing a 'normal' coronary artery while the
corresponding IVUS scan, Figure 2.7b, shows a substantial area of plaque within the
artery showing how angiography can lead to misleading diagnosis.
Analysis of the raw ultrasound data (RF data) obtained from IVUS can be used to
broadly determine the composition of plaque. 86% of plaques in excised coronary
arteries were correctly determined to be composed of mixed fibrous tissue, a lipid
pool or calcified plaque (Watson et al 2000). This work was subsequently performed
in-vivo where plaques in patients with stable coronary artery disease were studied.
Plaque composition in remodelled arterial segments was found to be mainly fibrous
(McLeod et al 2004).
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Unstable, vulnerable plaques cannot currently be routinely distinguished from stable
plaques and neither analysis of the radio frequency (RF) data nor study of IVUS
images give indication of biological markers expressed at areas of vulnerable plaque.
Effective methods of diagnosing vulnerable plaques are necessary to obtain early







Figure 2.5: IVUS catheter transducer for imaging the internal morphology of arteries.







Figure 2.7:a) angiograph showing 'normal' coronary artery b) corresponding IVUS image
showing area of plaque. Printed by permission ©Current Medicine LLC. & Current Science
Inc.
In addition to IVUS, other methods being researched for the detection of plaques
include, electron-beam computed tomography (EBCT), magnetic resonance imaging
(MRI) and optical coherence tomography (Nissen 2004, Regar et al 2003).
IVUS elastography is an alternative technique which is being developed for
identification of plaque where mechanical properties of plaque are determined by
deformation of the tissue. The strain values for fibrous and fatty plaques have been
found to be significantly different and could potentially be used to determine the
nature of a plaque (de Korte and van der Steen 2002).
2.2 Ultrasonic Contrast Agents
The application of contrast agents in ultrasound was first seen by Joyner and reported
by Gramiak and Shah in 1967. Initially injections of saline were used to identify the
aortic root (Gramiak 1997, Gramiak and Shah 1968). Later a study using saline,
indocyanine green, 5% dextrose and water and blood as contrast agents allowed the
identification of cardiac structures with ultrasound (Gramiak et al 1969). The
enhancement was attributed to microbubbles of air present in the solutions.
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Free gas microbubbles have a short lifetime (-few seconds) in the body as the gas
quickly dissolves or is filtered out by the lungs. To create more stable and long
lasting microbubbles, air was encapsulated by gelatin shells increasing the lifetime of
the bubbles (Carroll et al 1980). Further development led to encapsulated
microbubbles small enough to pass through the heart and pulmonary vasculature
which could provide enhancement of 1-10 minutes. Albumin was sonicated to form
small microbubbles which could be visualised in the left side of the heart (Feinstein
et al 1984). Since then ultrasonic contrast agents have developed to become a large
field of medical ultrasound which is constantly expanding (Dijkmans et al 2004,
Stride and Saffari 2003)
Ultrasonic contrast agents are gas-filled microbubbles approximately 6 pm or less in
diameter, making them comparable in size to a red blood cell. If a bubble is present
in a system the increased acoustic impedance mismatch between the gas and the
blood or tissue interface increases the intensity of the backscattered ultrasound
signal. The microbubbles can travel within the body to areas where the blood travels.
A larger proportion of the incident ultrasound is scattered from the blood-
microbubble interface than would be scattered from a blood cell, hence areas where
the blood travels can be highlighted by the contrast agent.
When a microbubble is subjected to an oscillating acoustic signal, the microbubble,
which is compressible, will oscillate. The resonant frequency, f0 of an encapsulated
gas bubble is given by (Forsberg 1997),
where, R is the bubble radius, y is the adiabatic ideal gas constant, Po and po are the





elasticity parameter which accounts for the effect of the bubble shell. The response
of an encapsulated microbubble to ultrasound is dependent on the shell properties.
2.2.1.1 Theoretical behaviour of contrast microbubbles
The resonant oscillations of a microbubble cause the increased backscatter of
ultrasound. The larger the amplitude of oscillation the larger the scattered signal.
Models describing the behaviour of free bubbles have previously been developed for
applications such as underwater acoustics. The first account of the theoretical
behaviour of bubbles when exposed to an external pressure was by Rayleigh
(Rayleigh 1917). Free bubble models have thus provided a basis for developing
models which describe the behaviour of encapsulated microbubble agents. A
comparison of three free gas bubble models was given by Vokurka (1986) in which,
the Rayleigh, Herring and Gilmore models were described (Vokurka 1986). The
Rayleigh model, developed to become the Rayleigh, Plesset, Noltingk, Neppiras and
Poritsky model (RPNNP) (Lauterborn 1976) describes the spherical oscillations of
the ideal gas bubble. The liquid surrounding the bubble is assumed to be
incompressible with the velocity of sound through the liquid infinite. The Herring
model assumes a compressible liquid with a constant velocity of sound, which
becomes the Rayleigh model for high sound velocities. The Gilmore model assumes
the velocity of sound varies with pressure in the liquid. Other models for free gas
bubbles exist, but are thought to behave in a similar way to the Herring model.
Gas bubble models have been further developed to describe encapsulated contrast
agents by including terms which account for the presence of the encapsulating shell.
The RPNNP equation was modified to account for factors associated with the
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where R is the bubble radius, Ro is the initial bubble radius, p is the fluid density, pgo
is the initial gas pressure within the bubble, pv and po are the vapour and ambient
pressure respectively, a is the surface tension, T is the polytropic exponent of the gas
which is equal to y (the ratio of specific heats Cp/Cv), 8t is a damping coefficient
which is the sum of damping due to re-radiation, viscosity of the surrounding liquid
and heat conduction and pac(t) is a time varying acoustic pressure. The damping
coefficients account for energy losses within the bubble shell due to re-radiation of
sound, thermal radiation and viscous losses.
The behaviour of an insonated microbubble is dependant upon the incident acoustic
pressure on the bubble. For low acoustic pressures (<50 kPa) the bubble oscillates
linearly, with the frequency of the scattered wave matching that of the incident one
(de Jong et al 2002, Deng and Lizzi 2002)'. As the incident acoustic pressure
increases (50 kPa-200 kPa) the bubble oscillations become more non-linear and can
contain harmonics allowing scattering due to the microbubble to be distinguished
from surrounding tissue. Finally, higher pressures (>200 kPa) can cause the bubble
to become disrupted. The increased non-linear oscillations can cause the bubble shell
to fragment releasing free gas into the blood-pool. The free gas bubbles in the blood-
pool provide an increased backscattered signal as there is no bubble shell which
dampens the bubble oscillations.
Studies have been completed predicting the response of a microbubble to medical
ultrasound (Chin and Burns 2000, Hilgenfeldt et al 1998) and also on observing the
response of contrast microbubbles to different acoustic pressures and comparing the
results to theoretical predictions (Sboros et al 2002). High speed cameras have been
used to observe microbubbles when insonated (Dayton et al 1997, Dayton et al
1999b, de Jong et al 2000). More recently, the behaviour of individual microbubbles
has been studied (Sboros et al 2003).
1
The majority of current literature describing the response of microbubbles to ultrasound considers
lower clinical frequencies (~3 MHz) where bubbles resonate and are currently used. When insonated
at the higher frequencies used with IVUS (40 MHz) different bubble behaviours maybe observed.
Morgan et al (1996) found that for 5 MHz insonation contrast agents were broken under low
intensities, but for 38 MHz insonation the contrast agents remained intact under pressures of up to 2
MPa (Morgan et al 1996).
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2.2.1.2 High Frequency Ultrasound and Contrast Agents
As the frequency of incident ultrasound on contrast microbubbles increases, the
radius of microbubble which will be at resonance decreases. Commercial
microbubbles are best detected by ultrasound at frequencies of 2-3 MHz. As the
resonant frequency of a free bubble increases and the bubble diameter decreases, the
damping coefficient due to viscosity increases (Miller 1998), (de Jong et al 2002).
Church (1995) compared the effect of the damping coefficients for encapsulated
bubbles to those for free bubbles previously obtained by Prosperetti et al (1988)
(Church 1995, Prosperetti et al 1988). The main difference between the two is that
for encapsulated bubbles viscous damping is due to the bubble shell as well as the
surrounding liquid. It has been shown that although shell viscosity is the dominating
damping mechanism at frequencies less than 10 MHz, as frequency increases
acoustic damping (energy losses due to re-radiation of sound) becomes more
important. Hoff et al (2000) have shown for a polymer shell microbubble acoustic
damping becomes the dominant damping mechanism for a 4 micron bubble at
frequencies greater than 40 MHz while viscous damping remains constant (Hoff et al
2000).
The resonant frequency of different microbubbles is shown in Table 2.1 (a more
detailed table of commercial contrast agents is given in Table 2.2). Compared to a
free gas air bubble the resonant frequencies of the encapsulated bubbles are greater.
The difference between the resonant frequencies of the encapsulated bubbles is due
to the shell properties, Quantison has a thick albumin shell making it a strong bubble,
this accounts for the increased resonant frequency compared to the lipid shelled
Sonovue and albumin shelled Albunex. As the microbubble diameter increases, the
effect of the shell on the resonant frequency decreases as shown by the reduction in




Diameter (pm) Air bubble
(MHz)
Sonovue (MHz) Albunex (MHz) Quantison
(MHz)
1 9.4 21 57 127
2 3.8 7.7 20 45
5 1.3 2.2 5.2 11
10 0.6 0.9 1.9 4.0
Table 2.1: Resonant frequency for different air bubbles and contrast agents of varying
diameters (de Jong et al 2002).
Intravascular ultrasound utilises frequencies of 20-40 MHz, which is higher than the
resonant frequency of soft microbubbles such as Sonovue. For optimum imaging of
microbubbles with high frequency ultrasound, bubbles with diameters less than 1pm
are required, currently little is known about the resonant behaviour of submicron
contrast microbubbles. There is little work published on the use of contrast
microbubbles and their behaviour with high frequency ultrasound.
Commercially available ultrasonic contrast agents have been demonstrated to be
echogenic at intravascular frequencies. Four intravenous contrast agents have been
characterised using IVUS at 30 MHz (Moran et al 2002). Non-linear imaging of
contrast agents at high frequencies of up to 30 MHz has been demonstrated (Goertz
et al 2005a). Later, in section 2.2.4.2 work using high frequency ultrasound to image
targeted contrast microbubbles is described.
2.2.2 Applications of contrast agents with ultrasound
Contrast Echocardiography was the first clinical application of ultrasonic contrast
agents. The agents were used to image structures within the heart (Roelandt 1982).
More recent developments of the use of contrast agents in echocardiography have
included stress echocardiography, myocardial perfusion and the determination of
valvular stenosis and regurgitation (Cheng et al 1998, Kaul 2001). Lesions within the
liver have been enhanced using contrast agent with pulse inversion imaging allowing
the detection of lesions less than a centimetre in width (Harvey et al 2000). The
detection of tumours by studying tumour vasculature is a further application which
34
Chapter 2: Background
can make use of ultrasonic contrast agents (Cosgrove and Blomley 1997, Schirner et
al 2004).
2.2.3 Available Contrast Agents
A list of ultrasonic contrast agents is shown in Table 2.2. Three of the agents listed
(Optison, Definity and Imagent) have approval in the USA and are commercially
available. Other agents also shown in Table 2.2 have approval in Europe and Canada
and there are more continually being developed (Frinking et al 2000, Miller and
Nanda 2004).
Agent Name Manufacturer Encapsulated
gas
Shell type Status
Levovist Schering Air Galactose/Palmic EU & Canada
acid approved
Optison Amersham Octafluropropane Albumin USA, EU &
Health Canada
approved
Definity Bristol-Myers Perfluropropane Lipid USA & Canada
Squib approved
Imagent IMCOR Perflurohexane/ Lipid USA approved
Pharmaceuticals nitrogen
INC
Sonovue Bracco Sulpher- Lipid EU approved
hexafluoride
CardioSphere Point Biomedical Nitrogen Albumin Development
PB127
AI-700 Acusphere Perflurocarbon Polymer Development
Sonazoid Nycomed Perflurobutane Lipid Submitted in
the USA
Table 2.2: Ultrasound contrast agents currently available and under development (Miller and
Nanda 2004).
2.2.4 Targeting of contrast agents
An alternative to using contrast agents as blood pool enhancers is to attach them to
specific sites enhancing the area of interest (Dayton and Ferrara 2002, Klibanov et al
1997, Lanza et al 2000). Microbubbles can be targeted to attach to specific cells
which are found at certain points within the body, for instance, areas of inflammation
or angiogenesis (Alessi et al 2004, Lanza and Wickline 2003). Expressed at these
areas are antigens specific to the disease or condition which can be targeted. The
relevant antibody can be attached to the shell of the microbubble. The antibody-
antigen reaction is a well known receptor-ligand bond with a dissociation constant
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ranging between 10"7 and 10" M, where M is Molar. The dissociation constant (Kd)
is used to describe the affinity between receptors and ligands. It is an equilibrium
constant for the dissociation of a molecule into its constituent components. The
smaller the dissociation constant, the stronger the binding.
Ideally contrast agents would be tagged to target areas of plaque within the coronary
arteries. It is hoped that vulnerable inflamed plaque which cause myocardial
infarctions can be distinguished from other plaques. This would improve the
understanding of the processes involved with inflamed plaques and lead to the
possibility of a quick, accurate and relatively easy diagnosis and so early treatment.
2.2.4.1 Avidin-Biotin
The avidin-biotin interaction is used throughout research for binding purposes in
areas such as immunology, histochemistry and affinity chromatography. Streptavidin
and avidin are proteins which will bind to biotin. The bond between the two is
known to be strong with a dissociation constant of 10"15 M, indicating a high affinity
and very stable binding.
The avidin-biotin interaction can be utilised with contrast agents for attaching the
microbubbles to surfaces. Biotin can be incorporated into the microbubble shell. An
avidin link can be used to bridge the gap between the microbubble and an antibody,
the antibody is specific to a certain antigen. The microbubbles can then be attached
to areas of interest which express the specific antigen. Targeting using avidin and








Figure 2.8: Use of avidin and biotin to attach an antibody to surface of microbubbles.
2.2.4.2 Targeted microbubbles for plaque
The targeting of ultrasonic contrast agents is an active field of research, which is
constantly developing. Targeting contrast agents for diagnosis of thrombus and
inflamed plaques is a technique which is possible due to endothelial cell adhesion
molecules present at areas of inflammation. These molecules are present in higher
concentrations at areas of plaque than at normal areas within blood vessels (O'Brian
et al 1996). Certain cell adhesion molecules have been connected to areas of
advanced atherosclerosis such as the intercellular adhesion molecule 1 (ICAM-1)
(Lindner 2002).
Albumin based contrast agents were shown to attach to activated endothelial cells in-
vitro(Villanueva et al 1997). Lipid shelled contrast agents have been modified to
allow targeting to activated sites of inflammation (Lindner et al 2000a, Lindner et al
2000b, Lindner et al 2000c). Ultrasonic imaging of inflammation with site-specific
targeted microbubbles has been shown to be a feasible technique (Klibanov et al
1997, Lanza et al 2000, Lanza 1996, Unger et al 1998, Villanueva et al 1998).
Targeting microbubbles to ICAM-1 was demonstrated when microbubbles targeted
with a monoclonal antibody were found to attach to endothelial cells which were
made to over-express ICAM-1 (Villanueva et al 1998). This work was further
developed with microbubbles containing different densities of surface antibodies
being exposed to normal and activated endothelial cells at different shear rates. It
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was concluded that the density of shell antibody and the wall shear rate were critical
bubble adhesion parameters (Weller et al 2002).
Contrast agents have been attached to porcine fibrin clots using the avidin-biotin
interaction (Lanza 1996). A biotinylated ligand was targeted to attach to the fibrous
tissue, avidin was then added which bound to the biotin. Finally the biotinylated
agent was introduced to the system, the biotin sites bound to the avidin on the clot,
attaching the contrast agent to the clot. Microbubbles, which have successfully been
attached in this way, have been imaged using ultrasound. The attached bubbles were
imaged at 7.5 MHz with a linear array transducer.
Microbubbles can be classified as liposomes when they are made from lipids and are
multi-lamellar. Liposomes are made of layers of phospholipids and have been
targeted to active endothelial cells at atherosclerosis in porcine carotid and femoral
arteries (Demos et al 1999). The targeted liposomes appeared to attach to the
activated areas within the arteries. The attached liposomes were imaged with 20
MHz IVUS and 7.5 and 3.5 MHz ultrasound. Enhancement in the ultrasound image
due to the liposomes was seen and the level of enhancement was determined using
grey scale levels (Hamilton et al 2002, Hamilton et al 2004).
2.2.4.3 Other Applications of Targeted Microbubbles
In addition to diagnostic applications for detection of inflammation at areas of
plaque, targeted contrast agents also have the potential to target areas of angiogenesis
and to be used to aid drug and gene delivery to specific sites (Alessi et al 2004,
Blomley et al 2001, Scheirner et al 2004, Linger et al 2002).
There are a number of markers specific to angiogenesis in tumours which are
currently being investigated and developed; a review of these is given in Alessi et al
(2004). One group of these markers, av-integrins, have been targeted with
microbubbles (Ellegala et al 2003, Leong-Poi et al 2003). The targeted microbubbles
were found to detect early angiogenesis in tumours which could potentially be used
with other biological factors such as changes in blood velocity and blood volume for
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studying angiogenesis and for diagnostic purposes. It has also been shown that
ultrasound contrast agents can be feasible for targeting active lymph nodes in mice
and dogs (Hauff et al 2004).
This diagnostic application of ultrasound microbubbles can be further developed for
therapeutic applications. If the microbubbles are made to contain a drug and targeted
to a region of interest, the microbubble shell can be disrupted and the drug delivered
directly to the site. Alternatively, the drug could be attached to the surface of the
microbubble or contained within the fluid surrounding the microbubbles (Klibanov
1999, Lindner and Kaul 2001, Unger et al 2001b, Unger et al 2004). Gene therapy is
also a feasible therapeutic application of targeted microbubbles (Unger et al 2001a).
Albumin microbubbles have been successfully used to delivery genetic material to
the myocardium in rats when insonated with ultrasound (Shohet et al 2000).
Targeted imaging and therapy with ultrasound and contrast agent microbubbles is an
advancing field with applications in many different areas of medicine. However,
development of these agents for targeting is difficult due to the lack of available
information regarding the manufacture and content of the microbubbles. In order to
study targeting of contrast agents in Edinburgh, we have found it necessary to
develop ultrasonic contrast agents which can be manipulated as required. Targeted
contrast agents capable of being imaged with high frequency ultrasound could
potentially be used with IVUS to aid the detection of vulnerable plaques (Lindner
2002). The avidin-biotin reaction has been used to target perfluorocarbon filled, lipid
shelled, microbubbles, to thrombus which can be imaged with high frequency
ultrasound (Lanza et al 1997). Work described in part 2.2.4.2 of this chapter has used
IVUS at 20 MHz to image liposomes conjugated to anti-ICAMl and other markers




2.3 Microbubbles and Flow
2.3.1 Introduction
While there is great potential for the use of targeted microbubbles in vivo, in order to
determine the feasibility of this application it is necessary to know the forces
attached microbubbles can withstand. It is essential to know that when subjected to
physiological wall shear stresses that the attached microbubble will remain in place.
It is also necessary to know that the agent can be attached under flow conditions to
ensure in vivo attachment is feasible. In larger blood vessels, attachment of targeted
microbubbles to the wall under flow conditions is reduced since the microbubbles are
distributed across the whole vessel, so only a proportion will come in to contact with
the wall (Rychak et al 2004). The flow rate through a vessel also affects the
attachment of microbubbles. At higher flow rates, the microbubbles are less likely to
make prolonged contact with the vessel wall, hence reducing the number which
attach. The following section of Chapter 2 describes wall shear stress in arteries and
work by others on imaging targeted microbubbles under controlled shear rates.
2.3.2 Wall shear stress in arteries
Wall shear stress is the effect of the force on a vessel wall due to the viscosity of the





where, t is the wall shear stress, p is the viscosity of the fluid, u is the velocity of the
fluid and x is the distance from the surface perpendicular to the flow, hence du/dx is
the shear rate at the wall (Figure 2.9). In arteries the level of low wall shear stress has
been associated with the development of atherosclerosis (Krams et al 1997, Malek et
al 1999). It was thought that areas of high wall shear stress caused damage to the
endothelial cell layer within vessels thus initiating areas of disease. More recently it
has been shown that areas of low wall shear stress can cause an increase in the risk of
arterial disease. At areas of low wall shear stresses the endothelial cells have a
random alignment in the flow. The low wall shear stress promotes the expression of
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molecules which aid in the development of atherosclerosis and also means there is an
increase in the time for uptake of atherogenic particles from the blood; increasing the
risk of disease development. Higher wall shear stresses have been shown to increase
production of nitric oxide and other factors which inhibit coagulation and help
protect against atherosclerosis (Shaaban and Duerinckx 2000).
Figure 2.9: Variables involved in wall shear stress calculations.
The determination of wall shear stress in vivo is highly dependent on the
measurement technique used. The main difficulty is in measuring the shear rate close
to the vessel wall. The calculated wall shear stress can vary depending on the line
fitting used with the profiles obtained. A linear fit to three data points closest to the
wall has been used to determine the shear rate in vitro where the velocity profiles
were found using pulsed Doppler ultrasound (Hughes and How 1993). Ultrasound
techniques have been developed for the measurement of shear rates in vivo by
determining the velocity profile (Brands et al 1995, Hoeks et al 1995). The wall
shear stress is the product of the fluid viscosity and the wall shear rate. Reported wall
shear stress in normal arteries ranges from 1-7 Pa (10 - 70 dynes cm"2), with a mean
arterial wall shear stress over the cardiac cycle of 1.5-2.0 Pa (15 - 20 dynes cm"2).
Atherosclerosis is predominant in areas of mean wall shear stress less than 0.5 Pa (5
dynes cm"2) (Malek et al 1999).
2.3.3 Attachment and Detachment of Microbubbles
Attached microbubbles have been imaged in-vitro under flow conditions (Klibanov
et al 1999). Recent attachment and detachment studies have been undertaken on
microbubbles targeted to P-selectin (Takalkar et al 2004). A parallel plate flow
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chamber was coated with P-selectin and the targeted microbubbles drawn through the
chamber. Attachment and detachment studies at increasing wall shear stresses were
completed. The maximum number of microbubbles was found to attach to the
chamber surface at wall shear stresses of 0.06 Pa (0.6 dynes cm"2) and 50% of the
bubbles had detached by the time the wall shear stress was increased to 3.4 Pa (34
dynes cm" ).
In larger blood vessels with high flow rates, the attachment rate of contrast agents
can be reduced due to the fact that fewer microbubbles make contact with the vessel
wall. The ultrasonic radiation force has been investigated as a method of increasing
the number of microbubbles which come into contact with the wall, hence increasing
the attachment rate (Dayton et al 1999a, Rychak et al 2004, Rychak et al 2005).
Dayton et al (1999a) confirmed that acoustic radiation forces were able to displace
contrast agents from the centre of a vessel. Rychak et al (2005) have investigated
contrast microbubble targeted to P-selectin in vitro. Enhanced attachment of contrast
agent was noted for acoustic pressures of up to 122 kPa.
2.3.4 Flow chambers
Parallel plate flow chambers are commercially available for observing cell
interactions under flow conditions, these flow chambers have been developed for
studying the attachment of microbubbles. In these chambers it is assumed that fully
developed flow has been achieved at the area of interest and that the wall shear stress
across the region of interest is approximately constant. For parallel plate flow
chambers the wall shear stress can be calculated using (van Kooten et al 1992),
6Qp
T = ——^ (2. 4)wh
where Q is the volume flow rate, p the fluid viscosity, and w and h the width and
height of the flow channel. However, it has been shown for parallel plate chambers
that the wall shear stress calculated using Equation 2.4 can vary by 80% across the
length of the area of interest, consequently the area of interest does not experience a
constant wall shear stress (Chung et al 2003). This potentially means that in studies
with parallel plate chambers where attached microbubbles are studied, the wall shear
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stress the attached microbubbles experience can be 80% less than calculated. This
can have implications for targeted contrast agents in-vivo. Attached contrast agents
have to be able to withstand physiological wall shear stresses to allow in vivo
imaging. For attachment of targeted contrast agents contact between the agent's shell
and the vessel wall is necessary. In wide vessels and at high flow rates it can be
difficult to ensure the microbubble and wall make contact; attachment of contrast
agents to the area of interest needs to be feasible under physiological wall shear
stresses.
2.4 Chapter 2 summary
Cardiovascular disease is the most common cause of death in the UK. Arterial plaque
has been found to have a variety of characteristics with some forms of plaque more
likely to cause myocardial infarctions. Vulnerable plaques have soft lipid cores with
a thin cap which are more likely to erupt. It is difficult to diagnose vulnerable plaque
in arteries as a severe arterial blockage is not always seen.
Contrast agents are gas filled microbubbles which enhance the backscatter of
ultrasound. They have been shown to be echogenic at intravascular ultrasound
frequencies. One development is the targeting of contrast agents to bind to markers
expressed at certain sites such as areas of inflammation where inter-cell adhesion
molecules (ICAM-1) are expressed. ICAM-1 molecules have been shown to be
expressed at areas of vulnerable plaque. Targeted contrast agents have the potential
to target these areas of inflammation to identify and hence aid in the diagnosis of
vulnerable plaque.
The following chapters describe the development of an ultrasonic contrast agent for
use with high frequency ultrasound and work completed on imaging attached
contrast agent under static and flow conditions.
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Chapter 3
Ultrasonic Imaging of Microbubbles against Surfaces
3.1 Introduction
Ultrasonic contrast agents are gas-filled microbubbles approximately 6 pm or less in
diameter, making them comparable in size to a red blood cell. If a bubble is present
in a system the increased acoustic impedance mismatch between the gas and the
blood or tissue interface increases the intensity of the backscattered ultrasound
signal. However, a problem can arise when the bubbles are next to surfaces. The
boundary of the surface can have a bright echo due the acoustic impedance mismatch
between the surface and the surrounding medium, making the bubbles difficult to
detect. The contrast microbubble is small compared to the size of the surface to
which it is attached. The returned signal from the microbubble can be difficult to
determine from the surface echo.
Ultrasound contrast agents are generally used at diagnostic frequencies of 1 - 10
MHz. As described in Chapter 2 microbubbles of the size normally manufactured are
known to resonate at these frequencies thus dramatically improving the contrast in
ultrasound images. Higher frequency ultrasound gives better spatial resolution in
images and frequencies up to 40 MHz can be used for intravascular imaging as
reduced penetration associated with high frequency is not generally detrimental to
the images obtained. Commercial agents which are used at lower frequencies have
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been found to be echogenic at intravascular frequencies (Moran et al 2002). A
potential use of microbubbles with high frequency intravascular ultrasound (IVUS)
as described in Chapter 2 is the targeting of microbubbles to attach to areas of
vulnerable plaque (Unger et al 2004). High frequency ultrasound is also used for
applications such as musculoskeletal imaging, carotid artery imaging and mouse
imaging (Foster et al 2002). Targeted contrast agents could potentially be used with
these applications for imaging near-surface internal structures.
With a view to being able to image microbubbles attached to surfaces with high
frequency ultrasound, initial work on imaging microbubbles at boundaries was
completed. This work is described in the following section.
3.2 Materials
3.2.1 Ultrasound Scanners
Ultrasound scanners available for imaging work included the Dynamic Imaging
Diasus scanner (Dynamic Imaging, Livingston, Scotland) with linear array probes of
5-10 MHz, 8-16 MHz, 10-22 MHz and 16-28 MHz. An intravascular ultrasound
scanner, the Boston Scientific ClearView Ultra scanner (Boston Scientific, Natick,
USA) was also available initially with 30 MHz Disco Ultra catheter transducers and
later with the 40 MHz Atlantis catheter transducer.
3.2.2 Contrast Agents
Contrast agents available for use within the department were Definity (Bristol-Myers
Squibb Medical Imaging Inc, N. Billerica, USA), Optison (Amersham Health,
Amersham Place, Bucks, UK) and Sonovue (Bracco International B.V, Amsterdam,
The Netherlands) which were described in Chapter 2. Definity and Sonovue
microbubbles are lipid shelled while the Optison shell is made from albumin.
Optison and Definity both contain fluorocarbon gases while Sonovue microbubbles
contain sulphur-hexafluoride.
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3.3 Initial Work
3.3.1 Transcutaneous transducer
Initial work was completed on imaging microbubbles against surfaces with high
frequency ultrasound. The bubbles were imaged as they floated up to and rested
against a boundary. The high frequency Dynamic Imaging Diasus scanner, with a 10-
22 MHz probe was used to image Definity microbubbles through agar based
samples. The initial experimental set up is shown in Figure 3.1.
Figure 3.1: Experimental set-up using Diasus scanner to image bubbles rising to an agar
surface.
Still images were saved as bitmaps on to the hard drive of the scanner and transferred
to a PC. The images obtained using this set-up are shown in Figure 3.2. The agar
used was based on a standard TMM recipe described in section 3.5 with a reduced
number of scatterers. Figure 3.2a shows the agar with no Definity in the water,
Figure 3.2b is 8 minutes after the Definity was added, echoes can be seen from the
interface between the agar and water, the bubbles can also be seen in water. Figure
3.2c is 16 minutes after the Definity had been added and after minor agitation to re-
suspend the bubbles which had settled against the surface of the agar. The
microbubbles were seen again, rising towards the boundary. However, while it was
possible to image the bubbles in the water and the agar-water boundary was
enhanced, it was difficult to determine the microbubble location on the agar surface
thus showing the difficulty in imaging microbubbles when against surfaces.
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Water
Figure 3.2: Agar containing aluminium scatterers, used as a boundary to rising bubbles, a) agar
water interface prior to addition of Definity, b) Definity microbubbles 8 minutes after being
added to the water. Some bubbles have risen to the interface enhancing the boundary between
the agar and the water, c) Definity microbubbles suspended in the water after agitation of the
whole solution.
3.3.2 Intravascular transducer
Imaging Definity against boundaries was repeated with IVUS. The Boston Scientific
ClearView Ultra IVUS scanner with a 30 MHz Disco Ultra catheter was used. The
experimental set-up is shown in Figure 3.3. The agar sample was cut to size and
placed on a plastic support.
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1VUS catheter 30 MHz
agent
Figure 3.3: Experimental set-up of microbubbles rising to an agar boundary, imaged using a 30
MHz IVUS catheter with the ClearView Ultra scanner.
Initially, agar with no scatterers was used in place of TMM as agar was both
optically and ultrasonicaily transparent. This significantly reduced the bright echo at
the water-sample interface; allowing the bubbles at the boundary to be clearly seen.
Images captured using this set-up are shown in Figure 3.4 and Figure 3.5. The




















Figure 3.4: a) IVUS image of agar supported in water with no contrast agent added, note the
echo from the agar-water interface b) The same agar-water interface after contrast agent was
added to the water and allowed to rise to the boundary.
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Figure 3.5: IVUS images of Definity bubbles rising up to an agar-water interface over
approximately one minute.
The images in Figure 3.5 a-d show bubbles as they rise to the surface of the agar and
show how the echo from the boundary changes over 55 seconds. Towards the right of
the interface in Figure 3.5d (arrowed), a row of echoes are seen, this is not present in
the previous three images. Echoes on the screen could be followed as they rose to the
agar boundary although this is not clear in the images obtained.
3.3.3 Discussion
When plain, transparent agar was used in place of the agar with scatterers, the
Definity bubbles could be clearly seen once they had reached the boundary. While
watching the screen on the scanner it was possible to visually track individual
bubbles and observe them come to rest at the interface. However, it was difficult to
follow the bubbles the whole way as they drifted in and out of the field of the
transducer. When agar with scatterers was used the stronger echo from the boundary
was not enhanced by the bubbles. It was difficult to observe if there were bubbles at
the boundary or not.
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This initial work showed that it was possible to image microbubbles at agar surfaces
using IVUS, provided the echo from the surface-water interface was minimised.
3.4 Development of new agent
Work funded by a British Heart Foundation (BHF) grant (Grant PG/03/061
Optimisation of a targeted antibody linked microbubble for ultrasonic imaging of
arterial plaque) has involved the in-house development of a new microbubble
temporarily named the in-house agent for the purpose of this work. The in-house
agent is currently being developed with a view to targeting markers expressed on
vulnerable plaques in coronary arteries. It is hoped that 'hot', vulnerable plaques,
which are likely to rupture and cause a heart attack can be identified. Although some
preliminary work was performed using commercial agents, the development of an in-
house microbubble was necessary due to the commercial sensitivity which surrounds
currently available ultrasonic contrast agents. The in-house microbubble was
manufactured within the Tissue Injury and Repair Group, University of Edinburgh,
who were collaborators on the BHF grant mentioned previously.
3.4.1 Manufacture of the in-house agent
The protocol for bubble manufacture was as follows. The lipid constituents of the
microbubbles, Phosphatidyl Choline (PC), Cholesterol, Phosphatidylethanolamine
(PE) and Phosphatidyl Glycerol (PG) (Sigma Aldrich Company Ltd, Dorset, UK)
were dissolved in chloroform. Nitrogen gas was fed into the mixture causing
evaporation which left a lipid residue on the sides and bottom of the container. The
residue was reconstituted with cyclohexane and placed in dry ice in preparation for
freezing. The mixture was left to freeze overnight and the remaining white powder
reconstituted in saline when needed (Moran et al 2004).
50
Chapter 3: Ultrasonic imaging of microbubbles against surfaces
3.4.2 Initial Work
The first stage in the development of the bubble was determining the optimal bubble
composition. Appendix 1 contains a review of the optimisation tests on the agent
described in this chapter, and also describes the various agent compositions tested in-
order to produce a contrast agent echogenic at 40 MHz. The shell constituents were
phospholipids which included cholesterol. Different concentrations of cholesterol in
the shell were tested. The different proportions were studied to identify the
concentration of cholesterol which gave the most echogenic microbubble. Solutions
of 2.5, 5 and 15 mg of liposomal powder per ml of saline were used to determine the
variation in echogenicity with concentration. Nitrogen (N2) and Helium (He) were
used during the preparation of the agent. N2 and He were bubbled through the agent
by placing the gas tube at the bottom of the container, allowing the gas to be bubbled
into the mixture. N2 and He were also incorporated by agitation of the agent with the
gas tube being placed at the surface of the mixture. Using this method the gas was
incorporated during the agitation of the agent. After ultrasonic imaging of the
bubbles containing different gases, it was determined that the N2 bubbled on top of
the solution gave the most echogenic microbubble so was used for future bubble
construction. More concentrated samples of 75 and 100 mg of liposomal powder per
1 ml saline were also tested. Examples of the IVUS images obtained from the agent
are shown in Figure 3.6. An image showing saline only (Figure 3.6a) and the
undiluted agent (Figure 3.6b) are shown along with an image for the agent in a 1:4
saline solution (Figure 3.6c).
In order to obtain quantitative information about the echogenicity of the agent, a data
capture card was added to the PC. This allowed the radio-frequency (RF) signals to
be captured and digitised and values for the mean backscatter power to be obtained.
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Figure 3.6: Images printed from the scanner, a) saline with no agent, b) the in-house agent of 75
ml of liposomal powder per ml saline, c) the in-house agent diluted to a 1:4 concentration with
saline.
3.4.3 Data Capture
The digitising card (Gage Applied CS8500, Gage Applied Technologies, Lachine,
Canada) was used to collect RF data for each experiment with the in-house contrast
agent. The RF data was used in conjunction with the IVUS images to determine the
variation in echogenicity of the in house microbubble during the various stages of
characterisation. The data capture card which could digitise up to 500 Msamples per
second was used to digitise the data to 8 bits at 250 Msamples per second. Programs
had been previously written in DDL by Dr Robin Watson, Medical Physics,
University of Edinburgh, for the analysis of contrast data, these were used in analysis
of the captured data. A region of interest was chosen at the same point in each
sample. Each region of interest contained 9 ultrasound lines of data with 128 points
per line. The chosen region was centred about line 90 at a distance of 660, where 660
corresponded to 2mm from the centre of the transducer. Figure 3.7 shows a selected
region of interest showing the area containing the 9 lines of data.
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Figure 3.7: Reconstructed IVUS image from RF data showing the position ofline 0 and line 90
at a distance corresponding to 660.
The perfect reflector data was determined using an air-water interface. The echo was
maximised at a distance of 2 mm from the catheter and the RF data captured. The
mean backscatter power over the region of interest was then calculated and plotted
for each concentration. Data was also collected for the undiluted agent and the
dilutant.
3.4.4 Comparison to different agents
The data capture card was used in experimental work to compare the in-house agent
to present commercial contrast agents at high frequencies. The variation in mean
backscatter power for each commercial agent is shown in Figure 3.8. The point
representing the in-house agent was at the same concentration as the commercial
agents and compares well.
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Figure 3.8: Graph showing the mean backscatter power with concentration for four contrast
agents. These are compared to the mean backscatter power for the in-house contrast agent.
(Courtesy of Dr C.M. Moran)
3.4.5 Frequency tests
During the experimental work the ClearView Ultra scanner was upgraded to run at
40 MHz for use with the Atlantis 40 MHz catheter (Boston Scientific, Natick, USA).
Previously a 30 MHz Disco Ultra catheter transducer had been used, after the
upgrade of the scanner Atlantis 40 MHz transducers were used. Comparisons were
made between the Atlantis catheter and the Disco Ultra catheter to see how the
power spectrum for each transducer varied. Examples of the power spectra from a
perfect reflector at each frequency are shown in Figure 3.9. An air-water interface
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Figure 3.9: Power spectra from a perfect reflector a) 30 MHz Disco Ultra Transducer, b) 40
MHz Atlantis Transducer.
The bandwidths at -6 dB for each frequency are shown in Table 3.1~. The centre
frequency for each transducer is also given. For 40 MHz, the centre is 35 MHz and
for 30 MHz it is 27 MHz. The increase in centre frequency was 8 MHz.
40 MHz 30 MHz






Table 3.1: -6 dB bandwidth and centre frequency, determined using a perfect reflector, for the
30 MHz and 40 MHz IVUS transducers used with the ClcarView Ultra scanner.
3.4.6 Timed and Gas Tests
To investigate the change in echogenicity with time, images of an undiluted sample
were captured every 30 minutes. The sample was then imaged after 24 and 47 hours
with images and RF data being captured. Before imaging, the sample was gently
inverted to re-suspend the microbubbles in the saline. Figure 3.10 shows that the
bubbles remained significantly echogenic with time. The mean backscatter power is
given in Table 3.2. The error shown is the standard deviation in three measurements.
There was no significant variation in the mean backscatter power over the three days
for which the sample was tested.
2 The -6 dB bandwidth was taken instead of the -3 dB bandwidth as the IVUS transducers were both
transmitter and receiver.
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RF data was also captured for microbubbles made using Nitrogen and Helium, the
mean backscatter powers are given in Table 3.3. There was no significant difference
between the mean backscatter for the two types, although there was a larger standard
deviation associated with the microbubbles containing helium. It was thought that air
may be incorporated into the microbubble during manufacture, the sample made with
no extra gas confirms this as the mean backscatter power was not significantly
different from that of the sample containing helium and nitrogen.
Figure 3.10: a) in-house agent at time =11.00, b) in-house agent day 2 at time= 11.00, c) in-house
agent day 3 at time= 10.00. The samples were inverted prior to imaging each time to ensure the
microbubbles were suspended in the saline.







Table 3.2: Mean backscatter power from in-house agent over three days.
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Gas used in microbubble manufacture Mean backscatter power (dB)
No gas (air) -30.9 ±0.4
Nitrogen -31.5 ±0.8
Helium -31 + 4
Table 3.3: Mean backscatter power from-house microbubble made using no gas, nitrogen and
helium.
3.4.7 Targeting in-house agent
Since the motivation for developing the microbubble was to target it to bind to
specific sites, work was completed on incorporating biotin into the bubble shell.
Biotin could be used with avidin for attachment of the in-house microbubble as
described in section 2.2.4.1. Biotin was added as 1% of the mixture at the initial lipid
mixing stage of the manufacture process described in part 3.4.1 of this chapter.
Prior to the attachment of the microbubbles, the echogenicity of the biotinylated
microbubbles was investigated. IVUS was used to image microbubbles with biotin
incorporated into the shell. The backscattered power was determined as described
previously. The addition of biotin to the shell was found not to affect the
echogenicity of the microbubbles. For in-vivo use streptavidin could be used to bind
the biotin in the microbubble shell to a biotinylated antibody which, in turn could
bind to an antigen.
3.4.8 Size distribution of the in-house contrast agent
In order to determine the size distribution of the in-house contrast agent a Malvern
Mastersizer 2000 (Malvern Instruments Ltd, Enigma Business Park, Malvern, UK)
was used. The Mastersizer was used during the development of the in-house contrast
agent to assess the change in size distribution of the agent when subjected to
different manufacture techniques and when made with variations in the proportion of
constituent ingredients. This is discussed further in Chapter 6. Figure 3.11 shows the
size distribution of the in-house contrast agent when made containing biotin, the
d(0.5) (diameter for which 50% of the particles measured are less than) is 1.229 pm.
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Figure 3.11: Size distribution of in-house contrast agent containing 1% biotin. Measured using a
Malvern Mastersizer 2000.
3.4.9 Summary
The microbubble being developed was tested and was shown to be long-lasting,
echogenic for up to 47 hours and echogenic at intravascular frequencies of 30 and 40
MHz.
The microbubble was adapted for targeting. Biotin was incorporated into the shell;
the echogenicity of the bubble was unaffected. Since the bubble could potentially be
targeted to bind to specific sites, work commenced on developing surfaces to which
microbubbles could be attached, and which would be suitable for ultrasonic imaging.
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3.5 Tissue Mimicking Material
3.5.1 Tissue mimicking materials
Previous work in this chapter has shown that it was easier to image microbubbles at
boundaries when the material forming the boundary was not echogenic or had low
echogenicity. Agar based tissue mimicking material (TMM) contains aluminium
oxide (AI2O3) (size: 0.3 pm and 3 pm) and silicon carbide (SiC) (400 grain). These
particles act as scatterers and the combination of all of the scatterers, the agar and
glycerol produces a material which has the acoustic properties of soft tissue
(Teirlinck et al 1998). It was thought that making the TMM recipe with less
aluminium oxide scatterers would reduce the echogenicity of the sample and hence
make microbubbles at the interface easier to image with ultrasound. This was
confirmed when using the plain agar with IVUS shown in Figure 3.4 and Figure 3.5.
The bubbles could be clearly seen against the agar-water interface. The acoustic
properties of plain agar however are not ultrasonically the same as tissue, as the
speed of sound is not the same due to the lack of glycerol in the recipe and the
echogenicity is reduced due to the lack of scatterers.
In order to find an agar based sample which would be practical for ultrasonic
imaging of attached microbubbles, agar samples based on a standard tissue mimic
recipe, with different concentrations of scatterers were made. The acoustic
impedance of each one was calculated for comparison with physiological values.
3.5.2 Recipes and Methods
The standard TMM recipe was followed but the concentration of particles was
reduced. Agar samples containing 0%, 10%, 30%, 50% and 100% of particles of
AI2O3 and SiC required for TMM were made using the following recipe.
3.5.2.1 TMM ingredients and recipe
The ingredients for standard TMM by percent of total mass are given in Table 3.4.
To obtain the different agar samples of 0%, 10%, 30% and 50% scatterer
concentration, the ingredients as in Table 3.4 were used but the percentage of SiC
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and AUO3 were varied according to the sample required (i.e. 0% contained no
scatterers, 10% contained 10% of the mass of SiC and AI2O3 (the scatterers) shown
in Table 3.4 and 100% contained 100% of the mass of the scatterers.)
Ingredient % mass (%)
Water 79.04
Glycerol (99% solution) 11.32
Rodalon Benzalkoniumchloride (10% solution) 4.6
Silicon Carbide powder (SiC) (400 grain) 0.56
Aluminium oxide powder (Al203) (0.3 pm) 1.00
Aluminium oxide powder (Al203) (3 pm) 0.93
Agar 3.18
Table 3.4: Ingredients for tissue mimicking material.
3.5.2.2 Method
The dry and wet ingredients were weighed and mixed together separately. The water,
glycerol and Rodalon were placed in a large heatproof beaker and secured in a
temperature controlled water bath. A stirrer was placed in the solution and set to
rotate to approximately 2.5 revolutions per second. The dry ingredients were slowly
added to the solution ensuring that none remained on the inside of the beaker or the
stirrer. This ensured that the particles were well mixed into the tissue mimic. A lid
was kept on the beaker in the waterbath at all times during heating and cooling to
minimise evaporation of water from the mixture.
The solution was heated to 96 °C using the water bath and left at this temperature for
one hour. The mixture was continuously stirred during this time. After an hour, the
mixture was cooled to 42 °C. Stirring was continued during this time to keep the
particles homogenously distributed in the mixture. The TMM was poured into
moulds once it had reached 42 °C since at this temperature the particles would not
settle in the mixture as it set.
When the TMM was not in use, it was stored in a solution of 10% water-glycerol in
an airtight container. This kept the concentration of glycerol in the samples constant.
When stored in water, the glycerol eventually diffuses out; changing the acoustic
properties of the samples (Hall et al 1997).
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3.5.3 Acoustic Impedance
Since the number of scatterers in the agar based samples was reduced, the acoustic
properties would be different to that of TMM. The attenuation and backscatter of the
sample is dependent on the concentration of scatterers within the agar. The speed of
sound is dependant on the concentration of glycerol which was not changed in the
different samples hence the speed of sound in each sample should have remained the
same.
Acoustic impedance is calculated using,
Z = pc (2.1)
Where Z is the acoustic impedance (kg m~2 s"1 or MRayl), p is the density of the
3 1material (kg m" ) and c is the velocity of the sound (m s" ). The size of the echo from
a surface depends on the difference in acoustic impedances of the materials making
up the interface.
To confirm that the speed of sound in the samples did not vary with different
amounts of scatterers, and to allow the calculation of the acoustic impedance of each
sample, the scanning acoustic macroscope (SAM) (Ultrasonic Sciences, Aldershot,
Hants, UK) was used.
3.5.4 Materials and Methods
3.5.4.1 Scanning Acoustic Macroscope
A diagram of the scanning acoustic macroscope is shown in Figure 3.12. The SAM is
formed by a single element focused transducer which operates in pulse echo mode.
The measurements were made in a water bath which was kept at a constant
temperature. The transducer was focused on the surface of a reflector and a reference
dataset was collected. The transducer was then raster scanned over the sample
surface. At each point the pulse from the transducer travels through the sample and a
proportion of the incident signal is reflected back to the receiver. The received echo
is digitised. Programs have been previously written in MATLAB (Version 6.5.0.1,
The Mathworks Ltd, Cowley Park, Cambridge, UK) for the analysis of SAM data
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(Inglis 1999, Ramnarine and Browne 1999). The speed of sound through the sample
and the attenuation of the sample can be calculated. The difference between the
peaks of the reference and sample data is used to calculate the speed of sound in the
sample. For each set of data analysed the thickness of the sample and the reference








Plane reflector Agar based sample
Figure 3.12: Diagram of scanning acoustic macroscope for determining the speed of sound
through the agar based samples.
The agar samples, with different concentrations of particles, were cut to disks of 25
mm diameter and 5 mm depth. A water bath was fdled prior to experiments and left
to degas for a minimum of 24 hours.
A steel block acting as a plane reflector was placed in the base of the water bath. The
temperature of the water was constantly monitored, the temperature of the water
ranged from 20.0 to 20.8 °C. The reference speed of sound used in the analysis was
1482 m s" , which is the speed of sound in water at 20 °C. The SAM system running
at 7 MHz was aligned over the steel reflector. The focal point for the transducer was
54 mm and the frequency range was 5.5 - 10.5 MHz. The signal was maximised and
the transducer focused onto the reflector. The transducer was raster scanned over the
surface, covering an area of 16 mm x 16 mm. Reference measurements were made at
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the surface of the reflector. The transducer was then aligned over the sample and
measurements of attenuation and speed of sound through it were made.
Two separate samples for each concentration of scatterers were measured. For
analysis purposes the thickness of each sample was measured using a digital
micrometer.
Each sample was then weighed and the volume calculated using the cross-sectional
area and sample height. These values were used to calculate the density of the
samples, which was in turn used in the calculation of acoustic impedance.
The SAM data was analysed using the pre-written in-house software. A map of
attenuation across the sample was displayed during analysis. This enabled selection
of data from a region of interest (ROI). Areas where the SAM scanned off the
surface of the sample on to the reflector could be removed. The mean speed of sound
and attenuation through each sample were then determined from the ROI.
3.5.5 Results
The speed of sound, attenuation and calculated acoustic impedance for each of the
samples are shown in Table 3.5. The speed of sound values are the mean values of
the speed of sound through the regions of interest in two different samples. The error
associated with each value is the mean standard deviation for the ROIs. The variation
of acoustic impedance with each sample is shown in Figure 3.13.








0 0.20 + 0.01 1539 ±2 1.570 ±0.003
10 0.21 ±0.01 1538 ±4 1.629 ±0.004
30 0.23 ± 0.08 1543 ± 4 1.666 ±0.004
50 0.44 ± 0.09 1544 ± 4 1.675 ±0.004
100 0.52 ± 0.01 1542 ± 4 1.680 ±0.004
Table 3.5: Attenuation, speed of sound and acoustic impedance values for the TMM samples.
The errors in the speed of sound values are one standard deviation of the mean speed of sound.
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Figure 3.13: Acoustic impedance calculated for each agar sample where 0% contains no
scatterers and 100% contains 100% of the scatterers needed for tissue mimicking material.
3.5.6 Discussion
The values of acoustic impedance for the different samples were compared to
published values for the aortic wall and the aortic wall with different types of lesion
(Goss et al 1978). The comparisons are shown in Table 3.6. The measured values are
not the same as the aortic values but there were similarities and the recipes for the
agar samples could potentially be modified to better mimic the acoustic impedance
of different lesions if required.
64

























Water at 20°C 1.48 Blood 1.67
Table 3.6: Measured acoustic impedance in agar samples with difference concentrations of
scatterers compared to published values of acoustic impedance of different lesion types (Goss et
al 1978).
3.6 Imaging bubbles attached to TMM
Once the microbubbles had been adapted for targeting and binding they were
attached to the agar samples.
3.6.1 Methods
The agar containing 0% scatterers was used as this had the lowest impedance
mismatch with water and so the echo from the agar surface was less echogenic than
the other samples. The lipid-based, biotinylated bubbles were made and attached to
0% scatterer agar in-house. To attach the microbubbles, agar samples were coated
with 1 ml of streptavidin (a form of avidin) in a coating buffer (0.5 ml streptavidin
per 6 ml buffer) and left for 20-24 hours. They were then washed with saline and 1
ml of blocking buffer (saline and 1% BSA) was added and left for 2 hours. The
samples were washed again with saline, and 200 pi of the in-house microbubble was
added, at a concentration of 30 mg per 2 ml saline, and left for a further 2 hours.
Finally the samples were washed with saline again to remove any excess unattached
microbubbles.
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To investigate how the speed of sound through the samples was affected by the use
of strcptavidin, agar samples with and without streptavidin were tested in the SAM
system using the methods described previously. Samples with 0% and 100%
scatterers were tested. Two different samples of each were used.
The samples with microbubbles attached were then imaged with IVUS at 40 MHz.
Initially an agar sample before and after the addition of strcptavidin was imaged.
This was to determine if there were any changes in the ultrasound image due to the
streptavidin.
3.6.1.1 IVUS imaging of attached contrast agent
Following this a block of TMM with a wedge cut-out as shown in Figure 3.14 was
used as a support for the samples to sit on. The block and sample were submerged in
water. The IVUS transducer was placed underneath the sample in the wedge and the
attached microbubbles were imaged through the sample. The sample was then
inverted and imaged again. Images were printed from the IVUS scanner and also
saved to PC using image capture software (Matrox Intel beam software, Matrox




Figure 3.14: TMM block with wedge area cut-out to allow IVUS imaging of microbubbles
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3.6.1.2 Imaging attached contrast agent with transcutaneous
transducers
A similar set-up as previously described was used with the transcutaneous
transducers. Microbubbles were attached to the agar samples using streptavidin and
biotin. The block of TMM with the wedge shape cut out was used to hold the agar
samples. The samples were then imaged at a low middle and high power. Initially a
sample without microbubbles attached was imaged. The images were saved on the
scanner as bitmap files. The characterisation of these transducers is described in
Chapter 4 where the peak negative acoustic pressures were determined.
3.6.2 Results
Figure 3.15: IVUS images of 0% scatterer samples, a) sample with nothing on, b) sample coated
with streptavidin.
3.6.2.1 IVUS
IVUS images of the unaltered samples and samples coated in streptavidin are shown
in Figure 3.15. There is little visual difference between the two images. The speed of
sound through samples with 0% and 100% scatterers is shown in Table 3.7. The
errors are one standard deviation of the mean.
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Table 3.7: Speed of sound values from SAM data for agar samples with 0% and 100%
scatterers, with and without streptavidin. The errors in the speed of sound are one standard
deviation of the mean.
Figure 3.16 shows 0% scatterer samples with no microbubbles attached (a) and 0%
samples with microbubbles attached (b). The edge of the sample with bubbles
attached is enhanced by the microbubbles. On inversion of the sample the line of
bubbles can be seen again in (c). Before imaging, the samples were submerged in
water to remove any bubbles which were not attached to the sample.
Figure 3.16: Agar based, 0% scatter samples: a) no bubbles attached, b) bubbles attached, c)
sample with bubbles attached - inverted (edge with bubbles attached closest to transducer).
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The bubbles attached to the agar samples containing 10% scatterers were more
difficult to see in the IVUS images. Images of agar samples containing 10%
scatterers with and without bubbles attached are shown in Figure 3.17. It is difficult
to see any notable difference between the two samples meaning that if the
microbubbles are targeted to tissue with an acoustic impedance of that of the agar
with 10% scatterers, B-mode imaging of the microbubbles may not be possible.
Other detection techniques may need to be employed.
Agar sample with 10% scatterers
Figure 3.17: Agar samples containing 10% scatterers, a) no bubbles attached, b) bubbles
attached.
3.6.2.2 Transcutaneous Transducers
An image of the 0% scatterer agar with no microbubbles attached is shown in Figure
3.18. The probe used was the L5-10 MHz. The sample with microbubbles attached is
shown in Figure 3.19. Both images are taken for the same scanner settings and a low
transmit power (11%).
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Figure 3.18: Agar sample containing 0% scatterers, with no microbubbles attached imaged with
a L5-10 MHz transducer.
















Figure 3.19: 0% scatterer agar samples with in-house microbubbles attached. Imaged with 5-10
MHz linear array transducer.
There was a slight difference in the images obtained with and without contrast agent
attached as shown in Figure 3.18 and Figure 3.19, it was difficult to determine where
the contrast agent was attached in Figure 3.19. On increasing the transmit power, the
echo from the sample surface increased, but there was no obvious surface
enhancement due to the attached contrast agent.
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Imaging of the contrast agent attached to 0% scatterer agar was repeated with the
LI6-28 MHz transducer. Images obtained using this transducer are shown in Figure
3.20. Again the transmit power and the gain were the same in each image, the
transmit power was at 10%. The microbubbles attached to agar in Figure 3.20c
contained a higher percentage of PE (a phospholipid in the agent shell) than the
original recipe. This is explained further in Chapter 7. In brief, during optimisation of
the in-house microbubbles it was found that increasing the concentration of PE in the
microbubble shell increased the backscatter power from the microbubble. In the
images shown in Figure 3.20 the surface of the agar samples was enhanced when the
microbubbles were attached. The enhancement was greater in the sample with
increased levels of PE. On increasing the transmit power there were no observable
effects on the microbubbles.
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Figure 3.20: Transducer L16-28 MHz a) agar sample with no bubbles attached b) original
microbubbles attached to agar, c) microbubbles, with an increased amount of PE in the shell,
attached to agar.
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3.6.3 Discussion
Agar based tissue mimicking materials have been made containing different
concentrations of scatterers. This was in order to find a sample to which
microbubbles could be attached and imaged effectively. The SAM system was used
to measure the speed of sound through the samples and this was used to find the
acoustic impedance of the different samples. The impedances for the samples tested
compared well to measured values of acoustic impedance for different lesions on the
aortic wall.
The 0% scatterer agar based samples were used as a surface to which the in-house
bubbles could be attached. The bubbles were attached to the samples and imaged
with IVUS. The microbubbles were also attached to the 10% scatterer agar samples
but detection of the microbubbles proved more difficult. The next stage was to image
the microbubbles under flow conditions.
When agar samples with microbubbles were imaged with the transcutaneous
transducers the agar water boundary was enhanced when the higher frequency probe
was utilised. This could have been due to the variation in bubble response with
different incident peak negative pressures. The peak acoustic pressures to which the
microbubbles were being subjected from the transducers were not known so the
differences between the probes was unknown. It would be useful to know the peak
pressures from the transducers when imaging microbubbles this would allow some
control over the response of the bubbles to the ultrasound. As described in Chapter 7,
during the optimisation of the in-house microbubble, increasing the amount of PE in
the bubble shell was found to increase the mean backscatter power. When imaged
with the LI6-28 MHz transducer, the attached contrast agent, made with an increased
amount of PE, was shown to increase the echo from the agar boundary as shown in
Figure 3.20.
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3.7 Imaging bubbles under flow
Once the process of attaching microbubbles to the agar based samples was
reproducible and consistent, the attached bubbles were imaged under flow
conditions. It was possible to repeatedly attach microbubbles to 0% scatterer agar
based samples using streptavidin and biotin and to image the attached bubbles with
high frequency ultrasound. A flow chamber had been previously designed in-house
based on the work of Rainger et al (Rainger et al 2001) for the purpose of imaging
microbubbles attached to agar. Rainger et al had designed a flow chamber which
allowed the perfusion of leukocytes over endothelial cells in an effort to determine if
stromal cells influenced the adhesion of leukocytes to endothelial cells. Their flow
chamber allowed a coculture of endothelial and stromal cells allowing the adhesion
of flowing leukocytes to be studied. The initial flow chamber for the study described
here was designed by Mr Tom Anderson, Medical Physics, Edinburgh. The flow
chamber was used and further developed as described throughout this thesis.
3.7.1 Materials and Methods
3.7.1.1 Flow Chamber
The flow chamber which had been designed and constructed was made of Perspex. A
schematic diagram is shown in Figure 3.21 and a photograph of the flow chamber is
shown in Figure 3.22. The overall dimensions of the flow chamber were 120 x 40 x
15 mm. In the centre of the chamber were two circular sample wells, 1 mm deep and
10 mm diameter. Below the sample wells was a channel for an IVUS catheter, 95 x
1.5 x 2 mm, above the samples was a flow channel. The flow channel was 1.5 mm
high and had tapered ends. The main flow area over the samples was 6 mm wide and
55 mm long. Leur fittings were attached to the ends of the chamber to allow tubing to
be secured for flow inlets and outlets. The chamber was in two main layers, the
sample wells and IVUS channel within the base layer and the flow channel in the top
layer. There were also 12 nuts recessed into the base and glued in place. Between the
layers was a rubber lining which acted as a gasket. A small amount of silicon grease
was applied to this and 12 screws were used to keep the layers together.
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Figure 3.22: Picture of original flow chamber.
3.7.1.2 Methods
The agar samples were cut to the depth of the wells in the flow chamber. A
microtome with blade was used to cut the agar to the correct depth for the sample
holder. The microbubbles were attached using streptavidin as described earlier with
the microbubbles containing 1% biotin. A circular cutter, made from Perspex, with
internal diameter the same as the wells was used to cut the sample to the correct
diameter for the wells. Agar samples with and without bubbles attached were placed
in the chamber. Initially an IV-bag filled with degassed water was used to administer
flow. Different flow rates were obtained by varying the height of the bag. The
variation of flow rate with height of bag is shown in Figure 3.23. Each point is the
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Figure 3.23: Variation of volume flow rate with height of IV-bag. Each point is the mean of
three flow rates and the error bars are one standard deviation.
To ensure the microbubbles could be imaged before the chamber was sealed the
samples were placed in the chamber, covered with water and imaged using IVUS.
After being sealed watertight, flow was started and the microbubbles imaged. The
flow rate was initially set to 100 ml min"1.
Once it was established that the bubbles could be imaged in the flow chamber, a
range of flow rates were investigated. The IV-bag was tested to ensure that a constant
flow rate was delivered. The flow rate through the chamber at different bag heights
was then determined. Ideally a pump system would have been used for this work but
at the time the IV-bag was most suitable, when increased flow rates were required a
pump system was used as described in Chapters 5 and 6.
Microbubbles were attached to 0% scatter agar samples as previously described in
section 3.6.1. Samples with and without bubbles were then placed in the flow
chamber. A picture of the set up is shown in Figure 3.24. The initial flow was 80 ml
min images were saved after 2 and 4 minutes. The flow rate was then increased to
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100 ml min"1 and images saved after 4 and 6 minutes, finally the flow rate was








Figure 3.24: Picture of experimental set-up for IVUS imaging attached contrast agent under
flow conditions.
3.7.1.3 Results
Figure 3.25 shows samples with and without microbubbles attached under no flow.
The line of attached bubbles can be seen in Figure 3.25b. Figure 3.26 shows attached
microbubbles when subjected to flow of 100 ml min"1.
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Top of sample IVUS catheter
Back of chamber
Flow channel
Line of attached bubbles
Figure 3.25: a) agar with 0% scatterers with no microbubbles attached b) 0% scatterer agar
with in-house microbubbles attached. No flow is present in either situation.
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Figure 3.26: 0% scatterer agar sample with bubbles attached in flow chamber. Attached
bubbles were subject to flow at 100 ml min"1.
Figure 3.27 shows the attached microbubbles subjected to increasing flow rates.
From observing the images, there was no difference in the image as the flow
increased, suggesting that the microbubbles remained attached at these flow rates.
The flow rate in the left anterior descending coronary artery is 80 - 130 ml min"1, the
in-house contrast agent remained attached to the agar under flow rates up to 135 ml
min"'.
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Figure 3.27: Microbubbles attached under different flow rates, a) sample with no bubbles, b) 80
ml min ', c) 80 ml min"1 after 4 minutes of flow, d) 100 ml min"1, e) 100 ml min"1 after 4 minutes
of flow, f) 135 ml min"1, g) 135 ml min"1 after 8 minutes of flow.
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3.7.2 Discussion
The microbubbles were attached to agar samples and imaged with IVUS at 40 MHz.
A flow chamber was employed to hold the samples for imaging of the attached
bubbles when subjected to flow rates of up to 135 ml min" . From observing the
IVUS images the microbubbles remained attached to the agar samples at flow rates
up to 135 ml min"1.
As well as increased flow rates, the microbubbles were found to remain attached
with time. The microbubbles could be seen in the IVUS images to remain attached to
the 0% scatterer agar after being subjected to flow at 135 ml min"1 for at least 8
minutes.
The section of the agar to be placed in the flow chamber was taken from the edge of
the sample, when attached contrast agent was imaged with IVUS under no flow
conditions (as in Figure 3.16) the attached contrast agent was found at the edges of
sample. While the IV bag provided a steady flow it had to be refilled regularly, also
ensuring the correct height was sometimes difficult. The maximum flow rate through
the chamber was limited by the height of the bag. Future work would be enhanced by
the use of a pump system which would allow increased volume flow rates.
The bubbles remaining attached at increasing flow rates suggested that they would
remain attached when attached in-vivo. Further work needed completion on
determining the stresses to which the attached microbubbles were subjected in order
to determine the feasibility of targeted agents for in-vivo use.
Imaging microbubbles through the lid of the flow chamber with the transcutaneous
transducers was attempted. It was possible to distinguish the sample wells but not
possible to see the microbubbles on the sample surfaces.
While the microbubbles could be imaged when subjected to increasing flow rates, the
forces the attached bubbles were subjected to were unknown. It would be beneficial
80
Chapter 3: Ultrasonic imaging of microbubbles against surfaces
to know the wall shear stresses the attached microbubbles could withstand to
determine if they would remain attached at physiological wall shear stresses if used
in-vivo.
3.8 Chapter 3 summary
The initial work described here shows how it was possible to ultrasonically image
microbubbles which were against agar surfaces. The in-house contrast agent could be
imaged with both IVUS and transcutaneous transducers at frequencies ranging from
10 to 40 MHz. When the echo from the water-sample interface was minimised the
microbubbles were easier to distinguish from the boundary.
Agar samples based on a standard TMM recipe were made with different
concentrations of scatterers and absorbers. The acoustic impedance of each of the
agar based samples was calculated using speed of sound data acquired using a SAM
and the density of the samples. These values were compared to published data of
acoustic impedance of different types of aortic lesions.
The in-house bubble which was developed as part of a BHF grant was found to be
long-lasting and echogenic. It could also be adapted to target specific sites. The
microbubble could be attached to the agar based samples using biotin and
streptavidin. When attached to the agar samples containing no scatterers (0%
scatterer agar), which has an acoustic impedance comparable to that of the aortic
wall) the microbubbles could be imaged with intravascular frequencies. The
microbubbles could also be imaged with the linear array LI6-28 transducer.
Samples with the bubbles attached were then placed in a flow chamber and imaged
with IVUS under flow rates up to 135 ml min"1 through a flow area of 9 mm2. The
microbubbles were found to remain attached and echogenic with time.
While it was known that the microbubbles remained attached and echogenic with
time, the flow velocities and wall shear stresses to which the microbubbles were
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subjected were not. To assess the feasibility of using the agent in-vivo, it was
necessary to ascertain the wall shear stresses attached contrast agent could withstand.
Methods of measuring shear stresses are discussed further in Chapter 5. It is also
helpful to know the acoustic pressures the microbubbles are subjected to when
insonated. To do this, the transducers used for imaging needed to be characterised.
Work detailing this is described in Chapter 4.
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Chapter 4
Characterisation of High Frequency Transducers
4.1 Introduction
Contrast microbubbles expand and contract when insonated. The extent to which the
bubble expands depends on the characteristics of the shell and also on the insonating
peak negative pressure. As described in Chapter 2, increasing incident acoustic
pressure affects the response of the microbubbles to ultrasound. It is essential to have
knowledge of the pressures from the transducers used in experimental work so that
the pressures to which the bubbles are subjected are known. This can aid in
optimising the signal obtained when imaging the microbubbles and can be beneficial
depending on the required bubble response e.g. bubble disruption.
Scanners used for the experimental work described in this chapter were the Diasus
scanner and ClearView Ultra IVUS scanner which were introduced in Chapter 3.
Diasus scanners are designed and built for musculoskeletal imaging, veterinary work
and mouse imaging. The probes are wideband linear arrays and have frequency
ranges of 5-10 MHz, 8-16 MHz, 10-22 MHz and 16-28 MHz. The IVUS scanner is
used clinically for invasive imaging of arteries. A rotating 40 MHz transducer
(Atlantis 40) was used with this scanner.
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Currently the pressures produced by these transducers are not known for a range of
distances from the transducer and for different scanner settings. Knowledge of the
peak negative and peak positive pressures of the beam at different depths, transmit
powers and focal points are needed for optimum imaging of ultrasonic contrast
agents.
4.2 Materials and Methods
To characterise the transducers a hydrophone was set up to detect the output acoustic
signal from the transducer and the peak pressures were then calculated. A Precision
Acoustics, membrane hydrophone with active element of diameter 0.2 mm (Precision
Acoustics Ltd, Dorchester, Dorset, UK) was used. The hydrophone calibration
certificate containing values of sensitivity which were used in the pressure
calculations was available. The hydrophone was calibrated at NPL (National
Physical Laboratory, Teddington, Middlesex, UK) for 1 to 40 MHz (Date of
calibration: February 2002). This assured that the hydrophone was sensitive enough
for characterisation of the high frequency transducers. A plot of the hydrophone
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Figure 4.1: Sensitivity of the membrane hydrophone. (Data from calibration certificate).
84
Chapter 4: Characterisation of high frequency transducers
Since the transducers for the Diasus scanner were wideband linear arrays, it was
necessary to isolate the signal from the centre line so a single output signal could be
detected. Circuitry was previously built in-house which allowed a line pulse from the
64th line to be detected. A picture of the line pulse decimator is shown in Figure 4.2.
There were two sets of switches incorporated into the circuitry. One set of switches
allowed the line pulse to be selected and the second set allowed the number of lines
of data to be selected. For the experimental work described here, one line of data at
the 64th line pulse was selected.
Figure 4.2: Picture of circuitry used to selected 64th line pulse.
A rig as shown in Figure 4.3 was available which could hold and move a hydrophone
in a vertical direction and rotate it in the vertical plane. A device to attach the
hydrophone to the holder was designed, made and secured into the holder. A
transducer holder was incorporated into the rig, this held the transducer face
perpendicular to the hydrophone.
85
Chapter 4: Characterisation of high frequency transducers
Transducer holder, movement of
transducer in x and y direction
Figure 4.3: A schematic diagram of the rig and water tank for holding hydrophone and
transducer in place.
A photograph of the actual rig used is shown in Figure 4.4. A micromanipulator with
vernier scale was mounted on top and connected to the transducer holder which
allowed fine movement of the transducer in both the x and y directions (see also
Figure 4.6).
Figure 4.4: Picture of rig to hold hydrophone and transducer.
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A KIKUSUS 100 MHz digital oscilloscope and Tektronix 2445b 150 MHz
oscilloscope were used to view the signal detected by the hydrophone. The signal
was captured using the data capture card described in Chapter 3. The data was saved
at 500 megasamples per second in binary files. MATLAB was used to read in the
binary data, find the peak positive and peak negative voltages and then calculate the
peak positive and negative pressures. The captured voltages were converted to
pressures using (Preston 1991),
P = V/M (4.1)
where P is the acoustic pressure (Pa),V is the measured voltage (V) and M is the
sensitivity of the system (pV Pa"1). The calibration certificate provided with the
hydrophone was used to obtain the sensitivity of the system for different frequencies.
4.3 Experimental procedure
4.3.1 Transcutaneous transducer characterisation
A 21 litre cylindrical tank was fdled with deionised water and left to degas for at
least 24 hours before any experiments commenced. The hydrophone holder was
secured to the rig and the whole set up was placed in the tank. The hydrophone was
carefully placed in the holder ensuring no air bubbles were trapped underneath. A
spirit level was used to ensure the hydrophone was flat. This was left to sit for at
least 30 minutes to allow air bubbles to collect on the hydrophone. These were
removed by gently flushing a syringe near the surface of the membrane. The
hydrophone was connected to the oscilloscope with a 50 O terminator. The 50 Q
terminator was necessary for the calibration data to apply. A picture of the set-up is
shown in Figure 4.5.
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Oscilloscope
Figure 4.5: Picture of the set-up for characterising transcutaneous transducers.
The peak positive and negative voltages associated with the signals could be
measured on the oscilloscope. The signal from the hydrophone was delayed using the
oscilloscope so the pulse could be seen and measured easily. The output from the
oscilloscope was saved as a binary file using the data capture card. This file was later
used to calculate the peak positive and negative pressures for each dataset. This was
a substitute to reading each measurement off the scope as it was less time consuming
and gave an automatic electronic copy of the data collected. Intermittent data points
were taken from the oscilloscope during each experiment to compare to the captured
data to ensure the captured data was reliable.
The transducer was placed in the holder above and with its face perpendicular to the
hydrophone. It was moved in the x and y planes until the hydrophone signal was
detected on the scope, the micromanipulator was then secured to the transducer
holder. The orientation of the transducer with respect to x and y is shown in Figure
4.6. The micromanipulator allowed fine movement of the transducer so the
maximum signal could be identified. The image displayed on the scanner was used to
ensure the transducer face was parallel to the hydrophone.
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Figure 4.6: Diagram showing orientation of x and y planes with respect to the transducer. The
beam profiles in the x-plane were along the width of the line and the beam profiles in the y-
plane were along the length of the line.
4.3.1.1 Beam profile measurements
Beam profile measurements were collected for each of the transducers. The
transducer was placed in the holder and the centre positioned over the sensitive
element of the hydrophone. The peak signal was found and the transducer moved
across the element to determine the boundary positions of the profile. The transmit
power on the scanner was set to 50% of the maximum power and signals were
captured as previously described. The transducer was moved in increments of O.l
mm from the edge of the profile, through the peak and to the other edge. The focal
point on the scanner was set to the 7th point. The depths corresponding to focal points
1 and 7 for each transducer are shown in Table 4.1. The hydrophone was positioned
as close as possible to the focal point on the scanner. The position was determined
using the image displayed on the scanner.
4.3.1.2 Variation with power and depth
Signals were also captured at different transmit powers for different depths of
hydrophone. Again the 7th focal point was chosen. To obtain values for pressures at a
focal point close to the transducer for two of the transducers, pressure data at
increasing transmit powers were obtained for focal point 1.
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Transducer Depth of focal point 1 (mm) Depth of focal point 7 (mm)
L 5-10 MHz 2.0 30
L 8-16 MHz 1.5 12
L 10-22 MHz 1.5 12
L 16-28 MHz 1.5 12
Table 4.1: Depths of focal points 1 and 7 for each transducer.
The transducer was placed in the holder, centred over the hydrophone and the signal
maximised. Signals were captured for power settings in increments of 10, where 0 is
0% transmit power and 50 is 50% transmit power. The mechanical index (MI) of a
scanner is given by,
MI = (4.2)
Vf
where pneg is the peak negative pressure of the acoustic field and f is the frequency.
The MI is a safety index and is present on clinical scanners. The maximum available
power from the scanner for the available probes was 96 - 98%; 100% output power
was never achieved with the scanner used. The MI corresponding to increasing
transmit power for each probe is given in Table 4.2. The values were calculated by
the scanner and are relevant for tissue. While the experimental work described in this
chapter was undertaken in water, the MI values were noted so the MI corresponding
to each power setting was known .
Transmit Power Ml Ml Ml Ml
(%) L 5-10 MHz L 8-16 MHz L 10-22 MHz L 16-28 MHz
10 0.01 0.01 0.00 0.00
20 0.05 0.03 0.01 0.01
30 0.10 0.06 0.02 0.02
40 0.18 0.11 0.03 0.03
50 0.26 0.16 0.05 0.05
60 0.37 0.23 0.07 0.07
70 0.50 0.30 0.10 0.10
80 0.65 0.39 0.12 0.12
90 0.82 0.50 0.16 0.16
Maximum 0.96 0.58 0.19 0.19
(actual power) (96%) (98%) (96%) (96%)
Table 4.2: MI for each probe of the Diasus Scanner with increasing transmit power.
The depth of the hydrophone was altered and data captured for increasing transmit
power was repeated. The hydrophone was moved from above the chosen focal point,
through the focal point and past the focal point. The depth of the hydrophone was
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dependent on the focal point chosen. The placement of the transducer was kept
constant. To ensure the maximum signal was always captured the signal was
maximised after the depth of the hydrophone was changed. This corrected any
misalignment in the positioning of the transducer. The depth of the hydrophone was
determined using the measurement callipers available on the scanner. Signals were
captured at each point and the peak positive and negative pressures calculated.
4.3.1.3 Acoustic pressure through the flow chamber
To assess the change in acoustic peak pressure when imaging microbubbles through
the flow chamber, the lid of the flow chamber was positioned between the transducer
and the hydrophone. Peak voltages for the same scanner settings with and without
the placement of the flow chamber lid were captured as described previously in part
4.3.1. The hydrophone was positioned 2 cm from the transducer. The flow chamber
lid was secured at the face of the transducer. The transmit power was set to 40% (MI
= 0.03). Signals were recorded at three different flow chamber positions: close to the
transducer, close to the hydrophone and between the two. The LI0-22 MHz
transducer was used for this.
4.3.2 IVUS transducer characterisation
The tank of deionised water was prepared as described in section 4.3.1 and the
hydrophone was held in the same holder set-up. A holder for the IVUS catheter was
designed to be clamped to a micromanipulator thus allowing fine movement of the
catheter in x, y and z planes. The experimental set-up is shown in Figure 4.7. The
angle of the catheter could also be finely adjusted. The hydrophone was connected to
the Tektronix oscilloscope. The signal was detected in a delayed mode and
maximised. The peak positive and negative voltages were then measured from the
scope. Measurements were taken at 1 mm intervals from 1 to 5 mm from the
hydrophone. These depths were chosen as when working with IVUS on the
optimisation of the in-house microbubble, RF data was collected at 2 mm from the
centre of the catheter.
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Micromanipulator
Figure 4.7: Pictures of set-up for IVUS catheter characterisation.
4.4 Results and Discussion
4.4.1 Transcutaneous transducers
4.4.1.1 Beam profiles
The beam profiles for each of the transcutaneous transducers are shown in Figure
4.8. The hydrophone was positioned as close as possible to the focal point. Figure 4.8
shows profiles in the x and y directions across the transducer face. As expected, as
the frequency of the transducer increased the peak became narrower and smaller. The
difference between the peak positive and peak negative values decreased from 3 MPa
to 0.7 MPa as the frequency increased.
The resolution of the measurements was 0.1 mm and the maximum peak was initially
found before any measurements were made. The end points of the profiles were then
decided. This was to determine the end points of the measurements. As the end
points for the profile were being determined, the signal was checked to ensure that
the maximum signal was always being obtained. The signal was not maximised in
the vertical direction. This would have ensured that the profile obtained was the
maximum potential one and would have been a preferable method of choosing a
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hydrophone depth. However, the hydrophone was placed as close as possible to the
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Figure 4.8: Beam profiles for each transducer, a, c, e, g are profiles in the x direction across the
transducer face and b, d, f, h are in the y direction across the transducer face.
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An example of how the signal changed for the beam profile shown in Figure 4.8c as
the transducer was scanned across the sensitive element of the hydrophone is shown
in Figure 4.9. The signal could be clearly seen to increase and decrease as the
transducer moved across the sensitive element of the hydrophone. The plots
numbered 1-20 show order of the signals in Figure 4.9. The y-axis was the measured
voltage in mV for each position of the transducer. The y-axis scales on each plot vary
as the peak voltages increase.
(MS)
Figure 4.9: Example set of signals obtained for one beam profile at 0.1 mm intervals as the L8-
16 MHz transducer moves across the sensitive element of the hydrophone. The corresponding
beam profile is shown in Figure 4.8c. The y-axis on each plot is the measured voltage in mV and
x-axis is time in ps.
4.4.1.2 Variation of pressure with depth
The peak negative pressures for each transducer with the hydrophone at a range of
depths are shown in Figure 4.10. Pressures were calculated for increasing transmit
power. The associated peak positive pressures were also calculated but for brevity
and clarity are not shown here. In each of the plots, as the hydrophone passes through
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the focal point of the transducer, the peak pressure recorded increased, peaked and
then decreased. Again the signal was not maximised in the vertical plane which
would have been preferable in order to find the maximum signal around the focal
point. Although, for the 8-16 MHz and 16-28 MHz transducers, the hydrophone was
moved in finer increments around the focal point.
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Figure 4.10: Peak negative acoustic pressures with distance between transducer and
hydrophone at increasing transmit powers for four frequencies.
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Peak negative acoustic pressures calculated for the LI0-22 MHz and L8-16 MHz
transducers, with the focal point set to 1, for increasing peak transmit powers are
shown in Figure 4.11. This was not repeated for the other transducers as the
maximum pressures for this focal point were very close to the transducer and it was
difficult to manoeuvre the hydrophone in small increments to bring it close enough to
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Figure 4.11: Peak negative pressures for increasing transmit power. Focal point on scanner set
to number 1. Transducers: L10-22 MHz and L 8-16 MHz.
For the data shown in Figure 4.10 and Figure 4.11, repeat measurements were made.
The data shown is typical of the captured data which was found to be consistently
repeatable. An example of the change in signal with increasing power and change of
depth is shown in Figure 4.12. There is a set of signals for 10 - 96% of the maximum
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distances between transducer and hydrophone are 0.5, 1, 1.5, 2 and 2.5 cm. The focal
point was at 1.2 cm. The peak for each set increases as the hydrophone approaches
the focal point and reduces after the focal point has been passed.
Time (ps)
Figure 4.12: Signal with increasing transmit power (10% - 96%) for the 8-16 MHz transducer at
increasing hydrophone depths. For a depth of 0.5 cm the plots corresponding to each power
output are labelled, this labelling also applies to the other plots in the figure. The y-axis on each
plot is the measured voltage and the x-axis on each is time. The depth each data set was
recorded at is indicated on the left-hand side of the figure.
It is necessary to know the values of the pressures to which the microbubbles are
subjected during contrast agent characterisation. Knowledge of microbubble
behaviours at different acoustic pressures allows imaging techniques to be optimised
depending on the application required. A summary of the peak negative pressure
values calculated for each transducer at different transmit powers is given in Table
4.3.
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Table 4.3:Peak negative pressures (MPa) measured for each transducer where fp is the focal-
point number for which the data was captured and the depth corresponds to the distance
between the transducer and the hydrophone.
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Microbubbles attached to agar have been imaged with two transcutaneous
transducers (L5-10 MHz and L16-28 MHz) at 10%, 50% and 96% transmit powers.
Selected images of these were shown in Chapter 3. These images were taken with the
focal point at number 7. Table 4.3 can be used to find an approximate value for the
peak negative pressures to which the attached microbubbles were subjected
depending on the depth of the sample. From the images in Chapter 3, the surface of
the agar sample was at approximately 1.8 cm. From Table 4.3 the peak negative
pressures at 10% transmit power at the surface of the agar for each transducer was
0.44 MPa for the L5-10 MHz probe (taking the value for a depth of 2.0 cm) and 0.2
MPa for the LI6-28 MHz probe. At the maximum transmit power, these values
increased to 2.76 and 0.80 MPa respectively.
4.4.1.3 Acoustic pressure through the flow chamber wall
The acoustic signal with and without the flow chamber lid between the transducer
and the hydrophone is shown in Figure 4.13. This was to investigate how the signal
would be affected if the attached bubbles were imaged with the transcutaneous
transducers through the flow chamber. The hydrophone was 2 cm from the
transducer. As expected, there was no difference in the signals when the flow
chamber lid was placed at different positions between the transducer and the
hydrophone. On removal of the lid from between the hydrophone and transducer the
peak value of the detected signal increased. The peak positive signal was three times
higher when the flow chamber was not in place (32.57 mV reduced to 10.83 mV).
The peak negative signal was 2.5 times larger when there was no flow chamber
present (-16.65 mV reduced to -6.66 mV).
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Figure 4.13: Signals with and without the flow chamber lid between the transducer and the
hydrophone. L10-22 MHz transducer.
This experiment was only performed for one transducer since the flow chamber lid
was very close to the membrane hydrophone so the total time performing the
experiment was minimised to reduce the risk of accidental damage. Ideally, the
decrease in signal for each transducer would have been determined. But the above
data provided a guide on how the signal decreased. Since it was found that imaging
the agar with these transducers through the flow chamber was difficult to perform, it
was not deemed necessary to repeat for the remaining transducers.
4.4.1.4 Errors associated with placement of transducer in holder
The placement of the transducer was crucial to the size of the signal obtained. For
maximum signal the transducer had to be perpendicular to the hydrophone. Images
from the Diasus scanner are shown in Figure 4.14. Figure 4.14a shows the transducer
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perpendicular to the hydrophone, the peak positive voltage measured from the
oscilloscope was measured to be 139 mV and the peak negative voltage was




Figure 4.14: Images from Diasus scanner of hydrophone, a) Transducer is at 90° to the
hydrophone, b) Transducer is at 93° to the hydrophone.
The peak voltages were measured to be 18.6 mV and -11.8 mV. This is a 120 mV
difference in the peak positive voltages. There is a difference of 28 mV in the peak
negative voltage.
To ensure that the transducer was perpendicular to the hydrophone during
measurements, the distance from the hydrophone to transducer face was measured at
each end of the transducer using the callipers on the ultrasound scanner. This was
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completed each time experiments were started to ensure maximum signal was
recorded. Figure 4.15 shows an example of an image with the scanner calliper
measurements displayed.
Hospital: Clinician: 18 :5/■■■II
Patient: ID: "9 An g 2003
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Figure 4.15: Image from Diasus scanner, measurements on screen showing distance of
transducer from hydrophone.
IVUS transducer Figure 4.16 shows how the maximum peak acoustic pressure from
the IVUS transducer varied with depth. The peak negative pressure ranged from 1.4
MPa at 1 mm to 0.55 MPa at 5 mm. At the working distance of 2 mm the peak
negative pressure was 1.2 MPa. The transducer had the plastic catheter surrounding it
which was also the case when using IVUS for imaging. When the IVUS transducer
was used with the flow chamber, the attached microbubbles were imaged through the
agar samples. It would have been useful to know the peak negative pressure through
the agar samples but this would have been difficult to obtain due to the delicate
nature of the work. It would have been difficult to mount the agar samples between
the IVUS transducer and the hydrophone. An example signal detected by the
hydrophone from the 40 MHz IVUS transducer is shown in Figure 4.17. The
calibration of the hydrophone as shown in Figure 4.1 was only performed for
frequencies of up to 40 MHz hence the IVUS was at the limit of this calibration.
From Figure 3.9 the centre frequency for the 40 MHz Atlantis transducer was around
35 MHz. This is less than anticipated and will reduce the expected resolution of the
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images obtained. There are difficulties in constructing transducers which work at
high frequencies of 30 - 40 MHz, the transducers used in this thesis were the only
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Figure 4.16: Variation of peak acoustic pressure with depth for a sheathed IVUS transducer
running at 40 MHz.
Figure 4.17: Example signal detected by hydrophone from 40 MHz IVUS transducer. The
distance between transducer and hydrophone was 2 mm. Y-axis: 4 mV per division, x-axis: 41.3
ns per division.
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4.5 Chapter 4 summary
The peak acoustic pressures for 4 different transcutaneous transducers were
calculated for varying transmit powers and depths. Beam profiles for each transducer
were also measured. When attached microbubbles are imaged with these transducers,
the peak negative acoustic pressures which they are being subjected to will be known
which may be useful for imaging. The peak acoustic pressures from the sheathed
IVUS transducer were also measured at different depths. Transducer information will
be useful to have during future characterisation and optimisation of the in-house
microbubble and other contrast agents.
It is useful to have knowledge of the acoustic pressures the microbubbles may be
subjected to depending on the response required from the microbubble. If bubble
destruction is required, the pressure at which the bubble is destroyed needs to be
known, if non-linear imaging is required, knowledge of the bubble response at
different pressures is required.
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Chapter 5
Measuring flow velocities in a chamber
5.1 Introduction
Chapter 3 showed IVUS images of microbubbles attached to agar subjected to flow.
The microbubbles remained attached, with time, at flow rates of up to 480 ml min"'.
However, the flow velocities and wall shear stresses to which the microbubbles were
subjected were unknown. To assess the feasibility of using the microbubbles in-vivo,
it is necessary to determine the wall shear stresses to which they are subjected and to
identify the wall shear stresses the attached microbubbles can withstand. It is also
necessary to know how the attached microbubbles respond to ultrasound when
subjected to increasing flow rates.
Wall shear stress was described in Chapter 2. It is calculated from Equation 2.3. To
calculate the wall shear stress to which the in-house microbubbles were subjected, a
detailed profile of the flow in the chamber was needed, more importantly, a well
defined profile perpendicular to the surface of the agar sample.
5.2 Velocity measurement techniques
5.2.1 Doppler wire
There are various methods for obtaining flow velocities in vessels. Doppler catheter
devices known as Doppler wires can be used to find the velocity of fluid flow.
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However, it has been shown that the introduction of the Doppler wire into the flow
can alter the flow profile, the extent to which depends on the measurement site, flow
rate, degree of stenosis and dimension of the wire (Porenta et al 1999). The Doppler
wire cannot be used to determine a detailed profile of flow, only a peak velocity. It
has been shown computationally that peak velocities determined using Doppler wires
can be subject to errors of up to 50% (Moraes and Evans 1995).
5.2.2 Particle image velocimetry
A method of measuring wall shear stresses in-vitro is the use of particle image
velocimetry (PIV) to determine the velocity profile within the vessel. PIV is a non¬
invasive method of measuring the velocity of micron sized particles which are used
to seed the flow. A sheet laser beam illuminates the seeding particles in the flow and
a camera is used to record the positions of the particles with time. A velocity vector
map across a section of the flow can be determined and hence the velocity profile
within the model being studied (Prasad 2000). Flow patterns through carotid
bifurcation models have been studied using PIV (Bale-Glickman et al 2003). The
suitability of PIV for use with the flow chamber is discussed further in section 5.2.4.
5.2.3 Laser Doppler anemometry
Laser Doppler anemometry (LDA) provides an alternative method of measuring flow
velocities and has been used to determine wall shear stress in-vitro. It is a well
established, non-invasive technique of high resolution which measures point
velocities in the flow. Velocities in 1, 2 and 3 dimensions can be determined. The
flow is seeded with micron sized particles as with PIV. A laser pair is needed for
each velocity component to be measured. The seeding particles in the flow scatter the
laser light; there is a Doppler shift in the frequency of the scattered light due to the
movement of the particles. The velocity of the particles can be determined from the
Doppler frequency. LDA is described further in part 5.3. LDA has been used for the
calculation of shear rate near walls under flow conditions (Fatemi and Rittgers 1994)
and to validate numerically predicted results (Walsh et al 2003).
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5.2.4 Which technique to use
A Doppler flow wire was used to determine flow velocities in the flow channel.
However, it was difficult to obtain repeatable measurements of the flow rate and it
was difficult to position the flow wire in the flow channel. Using the Doppler wire
also meant it was not possible to obtain a detailed profde of the flow, only
measurements at certain positions in the chamber. It was difficult to obtain repeat
measurements at specific positions in the chamber. There were complications in
positioning the wire in the centre of the flow, consequently it was not known if the
peak velocity in the chamber was being measured. It was also often difficult to detect
a signal from the wire due to difficulty orientating the wire correctly in the flow. In
clinical practise it can be difficult to manipulate the wire to obtain the optimal signal
(Gatzoulis et al 2003). Due to the size of the flow channel, the flow wire was often in
contact with the edges of the channel making it difficult to position in the flow.
It was quickly determined that measurement of flow velocities using the Doppler
wire would not provide data which could be used to calculate the shear stress on the
surface of the samples.
In order to calculate the wall shear stress in the channel, PIV and LDA were
investigated as methods of determining the flow profile. Practically, the size and
design of the flow chamber described in Chapter 3 meant it was not ideal for PIV
measurements. The area of the flow channel accessible for PIV was from the top,
which would have allowed profdes across the width of the flow channel to be
determined, however, profiles from the surface of the sample were required.
LDA was deemed to be more suitable than PIV since the probe volume could be
moved through the flow channel, from the sample surface to the top of the flow
channel, measuring the flow velocity at each increment. It was known there was
potential for high resolution measurements of 45 pm and the current flow chamber
design was thought to be suitable for use with the technique.
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5.3 Laser Doppler Anemometry as a method for determining
flow profiles in the flow channel
LDA is a well established technique allowing non-invasive, high resolution
measurements of the velocities of liquids and gases. The first velocity measurements
using LDA were made in 1964 (Yeh and Cummins 1964). This first set-up used an
optical set-up referred to as a 'reference beam system' which is shown in Figure 5.1.
A helium-neon laser whose output was split using a mirror was used with a
polystyrene sphere-seeded flow. One beam was aligned along the flow tube through
the flow, the light scattered by the spheres was collected through a port in the flow
tube. The second laser beam, the reference beam, was frequency shifted, this beam
corresponded to zero flow velocity. The scattered beam and reference beams were
then compared and the flow velocity determined from the frequency of the scattered
light. The LDA setup used for the work described in this thesis was a dual beam
system described fuller in section 5.3.1. It was thought that LDA would be a feasible













Figure 5.1: Diagram of the first LDA experimental set-up (reference beam system).
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5.3.1 Dual Beam LDA
For dual beam LDA the original laser beam is split into pairs of parallel laser beams
of different wavelengths (up to three pairs for 3D measurements). Figure 5.2 shows a
diagram of a dual beam LDA set up for measurement of velocities in one direction.
A laser beam pair is needed for each velocity component measured. Each pair of
lasers is focused with lenses and the volume where the two intersect is known as the
probe volume. The probe volume is positioned in the flow which contains micron-
sized seeding particles. The seeding particles are assumed to move at the same
velocity as the fluid, as they pass through the probe volume, they act as moving
reflectors. There is a Doppler shift in the frequency of the scattered light due to the
movement of the particles. The scattered light is received by a photodetector, the
Doppler shift in the frequency of the scattered light is proportional to the velocity of
the particle passing through the probe volume so the particle velocity and hence fluid
velocity can be calculated using Equation 5.2.
Figure 5.2: Schematic diagram of LDA set up for measurement of velocity in one dimension. For
2D LDA another laser pair is added in the plane perpendicular to the first pair.
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5.3.1.1 The fringe model
The fringe model is often used to describe LDA (Watrasiewicz and Rudd 1976). At
the intersection of the two coherent beams interference will occur producing parallel
fringes of light. The distance between the fringes, 8f, is:
where X is the wavelength of the laser light and 0 is the angle between the incident
beams. The fringes are orientated perpendicular to the flow direction hence the
scattered light from the particles moving through the fringes varies at a frequency
proportional to the velocity of the particle. Thus the velocity of the particles can be
calculated using:
where fo is the Doppler frequency and u is the particle velocity.
5.3.2 Materials
A Dantec (Dantec Dynamics A/S, Skovlunde, Denmark) Dual Beam LDA system
was available for use in the Mechanical Engineering Department of the University of
Edinburgh. The system comprised of an Argon-ion, 5 W laser with a wavelength of
488 nm. There was a traverse system with two probes attached to it. The traverse
system allowed movement of the probes in three perpendicular planes. Two pairs of
laser beams (blue and green) were housed in one probe and a third pair was housed
in the second probe. To focus the laser beams a 160 mm lens was purchased with
funding from the British Medical Ultrasound society (BMUS) and The Moray
Endowment Fund. This lens gave a probe volume of 45 x 45 x 200 pm, which
allowed detailed profiles to be obtained. As only one 160 mm lens was available, this
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5.3.2.1 Flow chamber design
The flow chamber described in Chapter 3 needed slight modification to enable use
with LDA. A new chamber with the same flow area as the previous one was made.
The main difference between the two chambers was that a microscope slide was
incorporated into the lid of the chamber to allow a clear, scratch free window for the
laser work. The microscope slide was added as the previous lid was made from
Perspex which was easily scratched. The scratches would have caused the laser light
to be diffracted and would have prevented reliable measurements from being made.
5.3.3 Experimental Procedure
The flow chamber was mounted on a tripod. A small spirit level was used to ensure
the chamber and traverse system were parallel. The probe volume was positioned on
the surface of the bottom left corner of the flow chamber. This was set to coordinates
(0,0,0) and the probe was then moved relative to this position. The probe volume was
scanned along the edge of the chamber to ensure the set-up was aligned correctly.
Figure 5.3: Photographs of the LDA experimental set-up. a) The traverse system with probe
holders and mounted flow chamber, b) Mounted flow chamber with the laser probe volume
positioned at the front left corner of the flow chamber, this point was taken as (0,0,0) and used
as a reference point when positioning the probe volume in the flow area.
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5.3.3.1 Optimisation of LDA technique
Flow was provided using an IV-bag filled with water. As in Chapter 3 the height of
the bag was varied to give different flow rates.
Due to the design of the How chamber, the orientation of the probe volume in the
flow was as shown in Figure 5.4. The probe volume was incremented towards the
agar sample in 200 pm intervals with the flow direction being parallel to the sample
surface. This meant that the resolution of the profiles initially obtained during
optimisation of the technique with the flow chamber were 200 pm and not the
optimum resolution possible with the available lens of 45 pm.
5.3.3.1.11nitial Measurements
Agar samples, as described in Chapter 3 were placed in the sample wells in the
chamber. The chamber was mounted in the LDA system. Water was used initially as
it is known to often contain enough impurities to act as scatterers. The laser was run
at 0.2 W. The probe volume was then moved to the middle of the flow chamber over
the centre of one of the agar samples. The probe volume was incremented through
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the flow channel towards the sample as shown in Figure 5.4. Point velocities of flow
at 200 pm intervals were made. At each point, 10,000 measurements were made. The
mean of these measurements was then recorded as the velocity at each point. After
each increment of the traverse system, data collection was paused for 8 seconds
allowing vibrations in the traverse system to disperse before making the next set of
measurements.
5.3.3.1.2 Variation in laser power and seeding particle
The initial profiles obtained were not well defined, there was no distinct areas in the
profiles which could be associated with the edges of the flow channel. To optimise
the technique for use with the flow channel and to improve the definition of the
profiles obtained, a series of runs were repeated with different experimental set-ups.
Laser powers of 0.2, 0.5 and 1 W were used, as the power was increased, the profiles
became more identifiable, but were still not what was predicted for the chamber.
Milk was added to the water to act as seeding particles in the flow. This was an easy,
inexpensive method of testing and further developing the system. The concentration
of milk was varied to see if the poor profile was due to insufficient scatterers. As
with the laser power, as the concentration of milk was increased, the profile was
easier to identify but it was not as predicted for the flow in the chamber. The peak
velocity was much lower than predicted and the profile shape was not a clear
parabola as expected.
5.3.3.2 Further Development
5.3.3.2.1 Variation in flow chamber set-up
Reasons for the low measured flow velocity and undefined profile were thought to be
backscatter from the agar sample and the IVUS channel. The chamber used was the
same design as the first chamber described in Chapter 3 with the addition of a glass
microscope slide. A consequence of this was that the IVUS channel was underneath
the samples. The agar samples were not transparent which meant a large portion of
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the laser light was backscattered to the receiver. The IVUS channel behind the
samples could have also been affecting the amount of backscattered laser light.
To investigate the effect of the IVUS channel and the agar samples on the profiles
obtained with LDA, a new chamber base of plain Perspex without the IVUS channel
was made and the agar sample holder was removed. The lid was secured to the base
and LDA measurements were made with no agar samples in the flow chamber.
The resulting profile was more defined and easier to identify as a flow profile. It also
had a peak velocity which could be expected in the chamber. However, the areas of
the profile at the surface of the sample and at the edge of the chamber were not well
defined. It was difficult to identify points which could be used to calculate the shear
rate at the sample surface.
The sample holder was then replaced and samples made from gelatin were used. The
gelatin samples were made to a recipe for a tissue mimic (Hall et al 1997) but again
without the addition of the scatterers. The gelatin samples were transparent whereas
the agar samples, although they contained no scatterers, were not transparent. It was
thought that if the profiles obtained with LDA were affected by the backscatter of
laser light from the agar sample that a transparent sample may prevent this problem.
The experimental set-up was then altered slightly with the addition of a pump. This
allowed increased flow rates and since the system would be re-circulating, an
alternative seeding particle could be considered since there would be less wastage.
The pump was controlled by a power supply. The flow rate through the flow
chamber was measured for different pump speeds. The increase in flow rate
corresponded to 1 Volt increments in the power supply to the pump. The pump was
set to circulate steady flow.
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5.3.4 Initial results and Discussion
The profiles in Figure 5.5 were from the chamber with no IVUS channel in the base
but with the sample holder replaced. The gelatin based samples were used. Three
different flow rates are shown in Figure 5.5, 80, 90 and 100 ml min1. This was
within the limits of the IV-bag.
Again, although a profile could be seen in Figure 5.5 between -5 and -6.5 on the x-
axis, the edges were not well defined and it was difficult to determine the ends of the
profile. The edge of the chamber and the surface of the gelatin sample are indicated.
The profiles from the surface of the sample were used in order to obtain an estimate
of the wall shear stresses on the sample.
-A.5
Depth through flow from top of chamber (mm)
—•— 80 ml/min —90ml/min —*— 100ml/min
Figure 5.5: LDA data of velocities in the flow chamber with no IVUS channel and gelatin based
samples. There are three different flow rates, 80, 90 and 100 ml min"1.
The wall shear stresses calculated using Equation 2.3 for each profile are shown in
Table 5.1. Although there was not a broad range of flow rates, and the profiles
obtained were not well defined, the shear stress at the sample surface increased with
flow rate. The value of viscosity taken for the calculation was 1.002 mPa s, the
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viscosity of water at 20 °C (Weast et al 1988). The viscosity of the water with milk
was measured using a size 75 calibrated Cannon-Fenske viscometer tube (Sigma-
Aldrich) and was found to be comparable to that of water.




Table 5.1: Wall shear stresses calculated for each profile in Figure 5.5.
Profiles obtained when using the pump to administer flow to the chamber are shown
in Figure 5.6. The flow chamber set-up was without the IVUS channel and without
the samples and sample holder (i.e. smooth Perspex base). The profile was much
smoother than in Figure 5.5 but again the profde at the channel edges (between -7.5
and -8 and between -6.5 and -7 on the x-axis) are poorly defined. The profiles do not
go to zero at the edges of the channel. There is the start of a 'phantom' profile which
were thought to be caused by reflections in the Perspex base, this 'phantom' profile
was not seen when gelatine samples were used. The flow rates ranged from 100 ml
min"1 to 275 ml min"1. Each run was repeated three times and the error bars are the
standard deviation in each data set.
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Figure 5.6: LDA profiles at increased flow velocities. A pump system was used in the set-up. The
profiles are the mean of three sets of data and the error bars are the standard deviation.
Again, the shear rates at the chamber wall where the sample would be placed were
calculated by performing a linear regression at the edge of the profile. For each
dataset the last four points in the profile were used. The calculated wall shear stress
values are shown in Table 5.2. While the profiles within the flow channel were well
defined for each flow rate, at the edges of the flow channel the profiles were unclear
(between x=-7.5 and -8 and between x=-6.5 and -7). The calculation of the wall shear
rate and hence wall shear stress to which attached microbubbles would be subjected
were subject to the interpretation of the edge of the profile at the surface of the agar
sample.





Table 5.2: Wall shear stresses corresponding to the profiles in Figure 5.6.
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The value of wall shear stress for 100 ml rnin 1 in Table 5.2 is comparable to that for
the corresponding profile at 100 ml min"1 in Table 5.1. For the previous profile
(Figure 5.5) the wall shear stress at 100 ml min 1 was calculated to be 0.45 Pa where
as in Table 5.2 the wall shear stress at 100 ml min"1 was 0.45 Pa.
In-order to investigate if better profiles could be obtained if data with 45 pm
resolution was collected, the probe was incremented across the width of the flow
channel (from side to side at a constant distance from the agar sample, as opposed to
through the channel towards the agar sample) in 45 pm increments. This was to see if
the profile obtained was better defined with the higher resolution measurements than
the 200 pm profiles. If the profile was found to be more detailed and if the edges
were better defined, it would be worth investing in re-designing the flow chamber to
allow profiles with 45 pm resolution measurements to be made. The probe volume
was scanned in 45 pm increments across the width of the flow channel. The profile
obtained is shown in Figure 5.7. The profile is better defined at the edges of the flow
channel than previous measurements. The profiles can be seen to go to zero which
was not the case when incrementing the probe volume towards the agar samples. The
chamber was 6 mm wide and the IV-bag was used to provide flow in this set-up. The
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Distance across flow channel (mm)
Figure 5.7: LDA velocity profile across flow channel, (6 mm wide). The resolution of profile was
45 pm and the flow rate was 90 ml min"1.
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The better defined profile at the edges of the chamber was thought to be due to the
increased resolution of the measurements and to the orientation of the probe volume
in the flow. The probe volume was incremented sideways across the channel from
one edge to the other, so when close to the edge of the channel, the backscatter of the
laser light was not affected as it was previously when the probe was incremented
through the flow and into the Perspex base. As the probe became close to the edge of
the chamber, a fraction of it was out of the flow and positioned in the Perspex, hence,
reducing the accuracy of the measurements of the flow velocities. Using the
alternative orientation of the probe volume, the whole probe volume was in the flow
for a longer period of time and as it approached the edge of the channel, the
backscatter from the base of the chamber remained relatively constant, since the
depth of the probe volume in the flow was unchanged.
5.3.5 Discussion and further development
From Figure 5.5 and Figure 5.6 it was possible to broadly identify the flow profile
through the flow channel. However, the boundaries of the channel were difficult to
determine making it difficult to determine the shear stress at the surface of the
sample. Since better profiles at the edges of the channel seemed to be possible to
obtain when incrementing the probe volume in the 45 pm resolution direction, as
shown in Figure 5.7. It was thought that more reliable data for the shear stress on the
surface of the samples could be obtained.
As well as potentially obtaining better profiles, an improved flow chamber design
would give more confidence of the flow path and of the flow profiles within the
chamber. The initial channel design had tapered ends as shown in Figure 5.8a, which
meant that the actual flow path was unknown. There could have been some
meandering of the flow along the flow path due to the shape of the channel.
After discussion with Prof Bill Easson, a fluid dynamics expert from Mechanical
Engineering at The University of Edinburgh, a new chamber design was proposed.
The new channel shape is shown in Figure 5.8b. The new flow channel did not have
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tapered ends and was 70 mm longer than the previous channel. This allowed the flow
profile to develop as fluid travelled through the channel. The inlet and outlet
reservoirs stabilised the flow as it entered and left the channel. The IVUS channel
was behind the samples, not underneath, which permitted experimental work using
IVUS to be undertaken using the same flow chamber and flow channel for which
there would eventually be data on the wall shear stress. As with the previous version
of the flow chamber, a glass slide was incorporated to allow a window for the laser.
The cross-sectional flow area remained the same as that of the previous flow
chamber (6 mm x 1.5 mm). Due to the new channel design, there was more
confidence that the flow behaviour within the channel would be as predicted. The
agar samples could be placed in a different orientation with respect to the probe
volume which would allow measurements of 45 pm resolution from the surface of




Flow outlet and reservoir
Flow inlet and reservoir
0
Figure 5.8: Schematic diagram showing flow channel shape for flow chamber versions 1 and 2,
a) version 1 b) version 2.
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5.4 Final flow chamber design
The final chamber design is shown in Figure 5.9. The chamber was made from 3
layers of Perspex. The overall dimensions were 160 mm x 80 mm, with each layer
being 6 mm thick. The base layer was a plain Perspex rectangle. The centre layer had
a channel with 2 wells for agar samples of dimensions 10 x 1.5 x 6 mm. The flow
channel specification was 125 mm x 1.5 mm x 6 mm; at each end of the channel
were two reservoirs which stabilised the flow before entering the flow channel. Fully
developed flow at the sample surfaces was assumed. Luer fittings were attached to
each end of the channel to allow tubing to be connected securely. In the same layer,
behind the sample wells, was a channel for use with the high frequency IVUS
transducer. The IVUS catheter could then be used to scan through the agar samples
in the wells. The IVUS channel was 2 mm deep and 1.5 mm wide and was parallel to
the flow channel as shown in Figure 5.9. A luer fitting was used at the end of the
IVUS channel with a Y junction to secure the catheter in place. As with the previous
How chamber, a microscope slide was inserted into the centre of the top layer, with
the bottom of the slide flush with the bottom of the Perspex. This was glued in place
and made watertight. A second centre layer was also made without the IVUS channel
lest there were any adverse effects on the profiles due to the IVUS channel. There
were two 2 mm holes through each layer which were used with steel rods for
alignment of the layers. The chamber was sealed using silicon grease between the
sections and then clamped together. This provided a leak proof seal and was time
saving when assembling the chamber. G-clamps were used to hold the layers
together.
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Figure 5.9: Diagram of the sections of the flow chamber. Enlarged is the area of sample holder.
As before the chamber was mounted in the LDA system. The pump system was used
to administer steady flow. Flow rates of 110, 195, 300 and 385 ml min"1 were used.
Flow profiles from the surface of the sample were measured. The new orientation of
the probe volume in the flow channel is shown in Figure 5.10. The probe volume
was incremented in 45 pm intervals towards the surface of the agar sample. Initially
the probe volume was incremented through the channel from top to bottom in order
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to locate the peak flow position. The flow profile from the surface of the agar sample
was then found at this depth in the flow.
channel
Figure 5.10: Orientation of the probe volume in the flow channel with respect to the surface of
the sample.
5.5 Final results
Figure 5.11 shows the mean velocity profiles obtained using LDA, the error bars are
one standard deviation. As expected, as the flow rate was increased, the peak
velocity increased and hence the shear rate increased. The section of the profile
between 38.4 and 38.6 mm on the x-axis is the profile at the sample surface, the area
of the profile at about 37.4 mm is the profile at the edge of the chamber.
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—e— 110 ml/min -a— 195 ml/min -^—300 ml/min —385 ml/min
Figure 5.11: LDA velocity profiles from the surface of an agar sample in the flow chamber, for
flow rates of 110,195, 300 and 385 ml min"1. The error bars are one standard deviation. The x-
axis is the distance from the front edge of the flow chamber i.e. from z = 0.
To calculate the shear stress at the surface of the sample, a linear regression was
performed in Excel (Microsoft Excel 2000). The points of the profiles at the surface
of the samples were used. Figure 5.12 shows the profile close to the edge of the
channel at the surface of the sample for a flow rate of 300 ml min"1. The gradient of
this line was the wall shear rate and was used to calculate the wall shear stress, the
error bars are one standard deviation of the mean points as plotted in Figure 5.11.
Four data points were used for each linear regression. Using a linear fit to the data
close to the edge of the vessel of interest is a standard method of determining wall
shear rate. A study of shear rate calculations from FDA measurements for steady and
pulsatile flow (Fatemi and Rittgers 1994) found less than 10% error in wall shear
stress measurements for steady flow when linear fits were used. Since the profiles
shown in Figure 5.11 are not perfectly symmetrical it was thought that applying a
linear fit to the data close to the edge would give the most reliable wall shear rates.
To assess any variability in calculating the wall shear rate, the linear regression was
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repeated with the last 5 data points in the profile, but no significant difference in the
wall shear stress calculation was found, this was expected since the points were 45
pm apart. The wall shear stresses were calculated using Equation 2.3, where the
viscosity of the fluid was again taken to be that of water at 20 °C. The wall shear
rates and stresses calculated for each of the profiles in Figure 5.11 along with the
standard error in calculating the gradient are shown in Table 5.3. These values are
plotted in Figure 5.13 for each flow volume. There is a linear trend in the increase in







110 36.54 + 0.05 1.2 + 0.1
195 56.63 + 0.16 1.8 + 0.4
300 85.19+1.17 2.95 + 0.02
385 101.72 + 0.43 3.4 + 0.2
Tabic 5.3: Measured peak velocities using LDA and calculated wall shear stress for each flow
rate.
Distance from edge of flow chamber (cm)
♦ end of profile, flow 300 ml/min line of best fit, linear regression
Figure 5.12: Plot of the end of the profile at surface of the agar sample with linear regression to
find the line of best fit. Error bars are one standard deviation of the mean velocity.
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Figure 5.13: Wall shear stress as a function of flow volume in the flow chamber. The error was
calculated using the standard error in each gradient. (R2=0.9837).
The second laser beam pair measured the velocity component of off-axis flow in the
z-direction, horizontally perpendicular to those in Figure 5.11. These were found to
be approximately constant at zero in the flow region, examples of the distribution of
point velocities for flow rates of 110 ml minand 385 ml min"1 are shown in Figure
5.14.
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Distance from edge of flow chamber (mm)
■ 385 ml/min 110 ml/min
Figure 5.14: Plot of point velocities horizontally perpendicular to flow direction for flow at 110
ml min"1 and 385 ml min"1.
5.6 Discussion
This chapter has described how Laser Doppler Anemometry (LDA) was used to
determine flow profiles in a modified flow chamber which could be used for IVUS
imaging of microbubbles attached to agar. LDA is a well-established technique
allowing non-invasive, high resolution measurements of the velocities of liquids and
gases. It has recently been used to validate numerically predicted wall shear stresses
in arteries (Walsh et al 2003). Walsh et al used pulsatile flow in a model artery with
LDA and calculated time-averaged velocity profiles. These profiles were then
compared to profiles found using computational fluid dynamics (CFD). They
concluded that for pulsatile flow LDA should be used for point velocity validations
but large errors were found when experimentally determining the wall shear stress.
The calculation of the shear rate from LDA data was highly dependent on the curve-
fitting technique used. An earlier study of shear rate calculations from LDA
measurements for steady and pulsatile flow (Fatemi and Rittgers 1994) found less
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than 10% error in wall shear stress measurements for steady flow when linear fits
were used.
Since steady flow was used in the set-up described in this study, the errors in the
calculated wall shear stresses were small. The resolution of the data points was 45
pm, so the profile was detailed very close to the chamber wall. When the profile was
extrapolated back to the wall at both ends of the profile, the distance between the
profile edges was 1.38 + 0.04 mm. On measuring the chamber width with a
micrometer, at a position as close as possible to where the LDA measurements were
taken, the width was found to be 1.43 + 0.02 mm. The difference was due to errors in
both methods of calculating the distance, but the values are comparable.
Linear regressions on the end of the profile at the agar surface were used to calculate
the shear rate. When 5 data points were used instead of 4, there was no significant
difference in the wall shear stresses calculated. The mean difference in wall shear
stress value calculated using 5 data points was + 0.08 Pa. No more than 5 points were
used in the regression as the further from the wall the points were taken the less
linear the profile became.
The profiles in Figure 5.11 are parabolic and for the lower flow rates symmetrical.
As the flow rate increased, the profile in the channel became slightly asymmetrical.
Also, the off axis flow (Figure 5.14) perpendicular to that in Figure 5.11 is not
consistently at zero. This could have been due to the increased flow rate causing
turbulence in the channel. To find the likelihood of the flow being turbulent, the
Reynolds numbers for the minimum and maximum flow rates were calculated and
found to be 540 and 1515. The Reynolds numbers (Re) were calculated from,
„ pvhRe = -— (5.3)
F
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where, p is the fluid density, v is the fluid velocity, h is the characteristic distance
(height of flow channel) and p is the dynamic fluid viscosity. Both Reynolds
numbers are suitably low enough to suggest that the flow in the channel should have
been laminar. As the flow rate increased, fully developed flow would take longer to
occur, which could be the cause of the deviation from symmetrical parabolic shape at
increasing flow rates. The entrance length (Le) required for fully developed flow to
be achieved can be calculated from:
Le = 0.06 Re h (5.4)
Using the Reynolds numbers previously described the entrance lengths were
calculated to be 5 cm for the lowest flow rate and 14 cm for the highest flow rate.
The position within the flow chamber where the LDA measurements were made was
9.5 cm along the flow channel, hence as the flow rates were increased, fully
developed flow was not achieved. Although, fully developed flow was not achieved,
the shear rate for each flow rate was determined.
Current in-vitro work where the effect of wall shear stress on microbubbles is
investigated can use supplier quoted values for the shear stress in the commercial
flow chambers used. As introduced in Chapter 2, the wall shear stress within a
parallel plate flow channel can be calculated using Equation 2.4 by assuming that
throughout the region of interest the wall shear stress and volume flow rate are
related. In parallel plate flow chambers the wall shear stress has been shown to vary
across the chamber by as much as 80% (Chung et al 2003), so the exact shear stress
at specific points within a chamber can be difficult to calculate. The supplier quoted
values will not be applicable to the whole region of interest with in the flow
chambers.
The flow chamber described here allows high frequency IVUS imaging of samples
with microbubbles attached under flow conditions, the LDA data gives wall shear
stress values for different flow rates at the surface of the sample being investigated,
so the shear rate at the area of interest is known.
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When the shear rate is calculated using Equation 2.4 for the flow rates used in
Chapters 5, the values calculated are higher than those obtained from the LDA data.
Table 5.4 shows a comparison of wall shear stresses obtained from the LDA data and
those calculated using Equation 2.4. The calculated values are consistently higher
than experimental values for work completed with flow chamber version 1 and lower
for version 2.
Flow rate (ml min"1) Calculated (Pa) Measured (Pa) % Difference
Flow chamber 1, with IV-bag
80 0.59 0.29 51
90 0.67 0.35 48
100 0.74 0.45 39
Flow chamber 1, with pump
100 0.74 0.45 39
162 1.20 1.02 15
225 1.67 1.54 8
275 2.04 2.68 -31
Flow chamber 2
110 0.90 1.16 -29
195 1.59 1.76 -11
300 2.45 2.95 -20
385 3.14 3.37 -7
Table 5.4: Comparison of wall shear stress obtained from LDA data and calculated wall shear
stress from Equation 2.3.
As the flow rate through flow chamber 1 increased the difference between
experimental and theoretical wall shear stresses decreased. As mentioned before, the
flow path and profile within the first flow chamber was difficult to predict due to the
shape of the flow channel. The uncertainty in the flow profile and path meant the
LDA data was essential for determining the wall shear stress within the flow
chamber. Elowever, since the profiles determined in this flow chamber were not well
defined at the flow channel edges (Figure 5.6), the calculation of the wall shear stress
was subject to the method used to calculate the shear rate.
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The difference between calculated and measured wall shear stress in the second
version of the flow chamber did not seem to follow a trend. The measured wall shear
stress was consistently higher than the theoretical wall shear stress.
5.6.1 Reliability
To asses the reliability of the LDA data, the profiles in Figure 5.11 were used to
calculate the mean velocity through the chamber for each flow rate. This could be
compared to the estimated approximate mean flow velocity expected through a flow
area of 9 mm2 at each volume flow rate. The comparisons are shown in Table 5.5.
The estimated velocities are similar to the measured mean velocities, confirming that
the flow velocities obtained using LDA were comparable to the values which would











Table 5.5: Comparison of estimated and measured mean velocities through the flow chamber.
Three flow profiles for a flow rate of 195 ml min"1 are shown in Figure 5.15. The
profiles were measured over two days. There is little difference between the three
profiles. The slight difference between the red profile and the other two is due to a
small difference in the positioning of the probe volume. The mean velocity of each
profile between the edges of the flow channel is 0.39 m s"1.
It would have been beneficial to perform computational modelling of the flow
through the flow channel. Computational fluid dynamics (CFD) would allow wall
shear stress on the contrast agents to be determined and would potentially allow the
study of a variety of flow conditions and flow rates. Unfortunately CFD was not
performed for the flow chamber in this study.
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Distance from edge of flow chamber (mm) (flow rate
195 ml min"1)
Run 1 Run 2 Run 3
Figure 5.15: Flow profiles in the flow chamber with a flow rate of 295 ml min-1. Three profiles
taken at three different times.
5.6.2 Physiological Wall Shear Stresses
The work in this study has been completed with steady flow. When subjected to
pulsatile flow the attached microbubbles may respond in a different manner.
However, the aim of this study is to investigate whether or not the microbubbles
detach from the agar samples with increased wall shear stresses. When attached to
disrupted plaque the microbubbles will not always experience shear stresses as if
attached to an intact endothelial wall, since they may be contained within crevices or
fissures in the wall.
Physiological flow rates in the coronary arteries range from 80 - 130 ml min"1
(Lupotti 2002) with a peak centre velocity of approximately 36
cm s"1. The flow rates used in the present study were from 75 - 480 ml min"1 through
a flow area of 9 mm".
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The LDA data in Figure 5.11 shows that the peak velocities of flow to which the
microbubbles were subjected in the flow channel ranged from 36 - 84 cm s"1. At
these velocities wall shear stresses of 1.16 to 3.37 Pa were calculated from the
measured shear rates. Reported wall shear stresses experienced by artery walls are
highly dependent on the measurement technique used. However, normal main
arteries can experience wall shear stresses of up to 7.0 Pa with mean wall shear
stresses of less than 1.5 Pa as described in Chapter 2 (Malek et al 1999).
5.7 Chapter 5 summary
LDA was used to determine the flow profdes within the flow chamber at different
flow rates. The profdes were used to calculate the shear stress on the surface of agar
samples. This was the shear stress to which microbubbles attached to the samples
would be subjected. It is of use to know the wall shear stress under which
microbubbles remain attached, so the potential for in vivo usage can be determined.
It is also beneficial to know the shear rates under which the microbubbles will bind
to surfaces. This is discussed further in Chapter 7. While the shear stresses
experienced at the walls of the flow channel were known, the specific forces acting
on the attached bubbles were not known. This is discussed briefly in Appendix 2.
The values of wall shear stress determined in the flow chamber can be used to
determine the wall shear stresses under which the microbubbles remain attached to
the agar. Chapter 6 describes how the flow chamber was used with IVUS to image
microbubbles attached to agar samples when subjected to increasing wall shear
stresses. LDA has the potential to benefit contrast microbubble research by allowing
the study of targeted microbubbles with: different binding agents, different contrast
agents, and different flow conditions.
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Chapter 6
Imaging attached bubbles under controlled shear
stresses
6.1 Introduction
In Chapter 3 it was shown that the in-house contrast agent could be attached to agar
and imaged under flow conditions. Chapter 5 described in detail one method of
determining the velocity flow profiles in a flow chamber. The chamber could also be
used for IVUS imaging of contrast agent attached to agar samples. While in Chapter
3 it was shown that the contrast agent remained attached to the agar at flow rates of
up to 135 ml min" , the wall shear stresses to which the attached microbubbles were
subjected was unknown. The flow chamber used in Chapter 3 (flow chamber version
1) was redesigned for use with LDA. In order to assess how well the microbubbles
were attached to the agar, the same flow chamber described in Chapter 5 (flow
chamber version 2) was employed with IVUS and microbubbles attached to agar.
This was to investigate the flow rates, and hence wall shear stresses, the
microbubbles could be subjected while remaining echogenic and without detaching
from the samples. As described in Chapter 2, part 2.2.4.1 the avidin-biotin interaction
is strong with a dissociation constant of 10"15 M compared to antibody-antigen
dissociation constants of KT7-10"n, however, it is not known how strength of the
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avidin-biotin bond relates to the wall shear stress within the flow chamber. Therefore
it is not known how well the in-house microbubbles will be attached and for what
flow rates they will remain attached.
6.2 Methods
Agar containing no scatterers was manufactured as described in Chapter 3. Samples
were then cut to 1.5 + 0.2 mm thick. The microbubbles were attached to the agar
using streptavidin in an identical manner to that described in Chapter 3. Samples
with and without microbubbles attached were prepared. The samples were carefully
placed in the sample wells in the new flow chamber described in Chapter 5.
In the version 1 of the flow chamber, samples with and without microbubbles
attached could be placed in the sample wells of the flow chamber and imaged under
the same conditions thus allowing comparisons between agar samples in the flow
chamber. In the new chamber, when two blank samples were placed in the two
sample wells, different echoes were seen. An example of this is shown in Figure 6.1;
the echo from the surface of the samples with no microbubbles attached is different
in each well. A possible reason for the difference in the images is that as the IVUS
catheter is inserted into the IVUS channel, there is a bend close to the first sample
well. As the catheter is moved through the channel, the imaging angle between the
transducer and the agar surface may change, accounting for the difference in received
echo. At the agar sample in well 1 the transducer was at an angle of approximately 4°
whereas at well 2, the transducer was at approximately 2°. While two samples in the
chamber at the same time could not be compared, comparisons of samples placed in
the same wells could be made.
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Figure 6.1:1VUS images at 40 MHz of agar samples with no microbubbles attached placed in
both sample wells of the flow chamber.
Initially samples without microbubbles were imaged at increasing flow rates,
following this samples with microbubbles attached were imaged. All samples were
placed in the flow chamber. The same pump system as described in Chapter 5 was
used. The samples were imaged at increasing flow rates from 75 ml min1 to 385 ml
min"1 (75, 110, 195, 300 and 385 ml min"1) the same flow rates for which LDA data
was collected were used. After each increase in flow rate the sample was left exposed
to flow for at least 30 seconds before images were obtained, allowing the flow to
stabilise at the increased flow rates and to ensure the agar surface was subjected to
each flow rate for a considerable length of time. The images were captured using the
image capture card and software described in Chapter 3. Later, the RF data for each
sample was also captured using the method and data capture card described in
Chapter 3. An air-water interface was used as the perfect reflector as described
previously. However for the work described in this Chapter, the perfect reflector data
was collected at 2.5 mm depth since the surface of the agar sample was 2.5 mm from
the centre of the catheter when imaged with IVUS.
Samples with microbubbles attached were then placed in the flow chamber. Care was
taken when placing the samples in the chamber as an accidental slip could cause the
attached bubbles to be wiped off. As with the samples with no microbubbles
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samples were exposed to each flow rate for at least 30 seconds prior to image
capture. Again, RF data was later captured for samples with microbubbles attached.
While the work described so far was being undertaken, simultaneous work was being
undertaken on optimisation of the in-house microbubble (Moran et al 2003a, Moran
et al 2004). The bubble constituents and preparation technique were varied in order
to optimise the ultrasonic backscatter and to reduce mean bubble size.
On finding that increasing the amount of PE in the microbubble shell increased the
echogenicity, microbubbles containing an increased amount of PE were attached to
the agar samples as previously described. Samples were placed in the flow chamber
and imaged at increasing flow rates. Sonicating the contrast agent had been
previously found to reduce the mean microbubble size and increase the mean
backscattered power which is shown in Figure 6.2. There is a large difference in the
mean microbubble size between no sonication and 30 seconds sonication. Sonicating
for longer than 30 seconds did not have any increased effect. Sonicated bubbles with
increased PE in the shell were also attached to the agar samples and imaged in the
flow chamber at increasing flow rates. RF data from the attached microbubbles was





Figure 6.2: Variation in mean backscatter power and mean contrast agent size for sonicated and
unsonicated in-house microbubbles. (Courtesy of Dr C.M. Moran)
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6.2.1 RF data analysis
For the captured RF data, the mean backscatter power was calculated across the
microbubble line and/or surface of the sample, depending on the sample being
imaged. The software available for analysis of the data allowed specific areas to be
selected. This could be by either selecting the required line of data and position on
the line, or by selecting an area on the image via the mouse. Both methods were
attempted. While using the line number and position on the line was good for
repeatability, i.e. for choosing the depth in the image at the surface of the sample,
each reconstructed image had a different orientation, so the line number was different
each time. The line number for a particular area was roughly known, but to get the
exact area, it was necessary to repeat the step until the correct part of the image was
selected. When using the alternative method of selecting the required area, the mouse
could be used to position the cursor on the region of interest. This made the process
less time consuming.
Three regions of interest were chosen for each sample. These were taken across the
surface of the agar exposed to flow. An image showing three regions of interest is
shown in Figure 6.3. Each ROI contained 9 lines of RF data with the mean of these 9
lines giving the data for each section. The mean backscatter power at each site was
then used to calculate the mean backscatter power for the surface of the sample. The
mean backscatter power for samples with and without microbubbles attached was
calculated. For the samples without microbubbles attached it was sometimes difficult
to determine the surface of the sample, the thickness of the sample was known so this
was used as a guide to find the surface. The position of the sample surface relative to
other features in the flow chamber was also known, so this was also used as a guide.
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Figure 6.3: Image of microbubbles attached to agar placed in flow chamber. Image is
reconstructed from the RF data collected from the IVUS scanner. The three positions where the
RF data was collected are shown and marked 1, 2 and 3, each region of interest was 9 lines of
RF data, the span of these lines are indicated by the blue, pink and green lines.
6.3 Results
6.3.1 IVUS Images
An example of an IVUS image from an agar sample with no microbubbles attached
is shown in Figure 6.4. The flow rate through the flow chamber was 195 ml min"1.
The surface of the agar sample exposed to flow is indicated.
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Figure 6.4: IVUS image of agar sample with no microbubbles attached in the flow chamber.
Flow rate of 195 ml min"1.
IVUS images of original recipe bubbles attached to agar in the flow chamber
subjected to flow rates of 110 ml min 1 and 385 ml min"1 are shown in Figure 6.5a
and b. There was no noticeable difference between the images suggesting that the
microbubbles were not detached with increasing flow rate.
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Figure 6.5: IVUS images of agar samples with original recipe microbubbles attached, a) flow
rate 110 ml min"1, b) flow rate 380 ml min"1.
Figure 6.6 shows microbubbles made containing increased PE attached to agar and
subjected to a flow rate of 195 ml min"1. The echo from the bubble line is brighter
than the echo in Figure 6.5. This suggests that the echo from the attached
microbubbles increases with increased PE concentration, as it does when the
microbubbles are in a suspension. This is also seen with the sonicated microbubbles
in Figure 6.7. The microbubbles were sonicated for 30 seconds prior to being
142
Chapter 6: Imaging attached bubbles under controlled shear stresses
attached to the agar. The echo from the bubble line was enhanced and there was
increased coverage across the agar sample.
Figure 6.6: IVUS images of microbubbles made with increased amounts of PE, attached to agar
samples placed in the flow chamber. Flow rate of 195 ml min"1.
Figure 6.7: IVUS images of microbubbles made with increased PE, sonicated for 30 seconds
attached to agar samples. Flow rate through flow chamber was 195 ml min"1.
For each of the above sets of attached microbubbles, images were recorded at
increasing flow rates. For each flow rate there was no visible difference in the image.
After increasing the flow rate to 385 ml min"1 and reducing it again to 110 ml min"1,
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the image did not appear different. This suggested that for each microbubble recipe
the microbubbles were firmly attached and were not removed at increasing flow
rates.
6.3.2 Mean Backscattered Power
In addition to the IVUS images and to investigate if the mean backscattered power
from the attached microbubbles varied with increasing flow rate, the RF data
collected at each flow rate was used to calculate the mean backscattered power at
three points across the surface of the agar sample as described previously. The mean
backscatter power from original recipe microbubbles attached to 0% scatterer agar,
across the surface of the sample (i.e. the mean backscatter power from position 1, 2
and 3), with increasing flow rate is shown in Figure 6.8. Mean backscatter powers
across agar samples without microbubbles attached are also shown. The mean
backscatter power from the agar with microbubbles attached was approximately 12
dB greater than from the sample with no bubbles attached.
After the flow rate was increased to 385 ml min"1, it was reduced to 110 ml min"1.
These points are represented by the filled data points in Figure 6.8. There was no
significant difference between the mean backscattered power at 110 ml min"1 before
and after the flow rate was increased.
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Flow rate (ml min ~1)
400 500
° original recipe bubbles 1 x no bubbles 1
a no bubbles 2 a Original recipe bubbles 2
Figure 6.8: Mean backscatter power across the surface of the agar sample with increasing flow
rate. The data is the mean backscatter power across the surface of the agar sample for each flow
rate in Figure 6.9. Mean backscatter power from original recipe microbubbles and samples
without microbubbles attached are shown.
The mean backscatter power at the three positions across the surface of the sample is
shown in Figure 6.9. The first position was at the centre of the sample and positions






























Position on sample surface
110min/min Dl95ml/min A300ml/min x385ml/min x110ml/min
Figure 6.9: Mean backscattered power for original recipe microbubbles attached to agar
samples. The x-axis is labelled 1, 2 and 3 which represents the positions across the surface of the
sample, with 1 being the centre and 2 and 3 being left and right of the centre. The mean
backscatter power at each point for each flow rate is shown.
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The microbubbles did not attach evenly over the whole agar surface meaning the
agar section chosen to be placed in the flow chamber was not necessarily covered
completely, this is shown in Figure 6.9 where the mean backscatter power at position
1 gave the greatest mean backscatter power at each flow rate. The mean backscatter
power reduced by approximately 10 dB at positions 2 and 3. The position of the
sample in the ultrasound field was also thought to contribute to the reduction in the
mean backscatter power at positions 2 and 3 and this is discussed further in section
6.4.
The mean backscatter power for microbubbles made with an increased amount of PE
and microbubbles with increased PE which were sonicated prior to attaching are
shown in Figure 6.10. Unattached microbubbles with increased PE have been shown
in-house to have increased mean backscatter power with sonicated microbubbles
having even greater backscatter. However, in Figure 6.10 there was no significant



























Flow rate (ml min'1)
400
o original recipe bubbles




Figure 6.10: Comparison of mean backscatter power across the surface of the agar sample for
normal microbubbles, microbubbles with increased PE and microbubbles with increased PE
which have been sonicated with increasing flow rate. Also displayed is the mean backscatter
power across the surface of the agar sample with no microbubbles attached.
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The mean backscatter power from each position across the surface (region of interest
1, 2 and 3) for the data in Figure 6.10 is shown in Figure 6.11. Again there was no
apparent trend in increased backscattered power with increased amounts of PE.
There was no significant difference in the mean backscatter from different bubble
types, however, the mean backscatter power for each bubble type is significantly























Position on sample surface
o no bubbles
a increased PE
□ original recipe bubbles
x sonicated increased PE
Figure 6.11: Mean backscatter power at each position across the sample surface. Data for
original recipe microbubbles, increased PE microbubbles, increased PE and sonicated
microbubbles and agar samples with no microbubbles attached. The error bars are one
standard deviation of the mean.
6.4 Discussion
From the images obtained with IVUS, it appeared that the microbubbles remained
attached to the agar samples when subjected to increasing flow rates. After
increasing the flow rate and reducing it again, there was no observable difference in
the IVUS images. This was confirmed when the mean backscattered power from the
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sample surface was considered. There was no significant difference between the
mean backscattered power before and after increasing the flow rate.
There was variation in the backscatter power at each position across the surface of
the agar sample. Figure 6.9 shows the mean backscatter power from original recipe
microbubbles at the three points across the surface for each flow rate. The highest
backscatter power was from the centre of the samples while for samples with no
microbubbles attached, the backscatter across the surfaces was more consistent. The
difference across the surfaces of the samples with bubbles attached was possibly due
to the distribution of contrast agent on the surface of the agar and the position of the
sample in the ultrasound field. The centre of the sample was closest to the transducer,
thus would experience maximum acoustic pressure.
There did not appear to be any trend with mean backscatter power and increasing
flow rate. For Figure 6.8 the mean backscatter across the surface of the sample was
taken to be the mean backscatter power. The mean backscatter power did not vary
significantly with increasing flow rate. After the flow rate had been increased to 385
ml min"1 and then reduced to 110 ml min"1, the mean backscatter power across the
surface of the sample did not reduce. This was in agreement with the IVUS images
which were not found to change with increasing flow rate.
From the data obtained previously, in Chapter 5, the shear stresses at the surface of
the agar sample for increasing flow rates were known. From the RF and IVUS
images, it was thought that the microbubbles remained attached to the agar at
increasing flow rates. The maximum measured wall shear stress the microbubbles
were subjected to was 3.4 Pa (34 dynes cm"2). Although the wall shear stress for flow
rates greater than 385 ml min"' were not determined due to the increased pressure
causing the flow chamber to leak, at flow rates above 385 ml min 1 the microbubbles
were thought to remain attached to the agar as the images obtained did not appear to
differ.
148
Chapter 6: Imaging attached bubbles under controlled shear stresses
As described in Chapter 2 values of wall shear stress measured in-vivo are highly
dependant on the measurement techniques used. In arteries the values of wall shear
stress is less than 1.5 Pa, but can reach up to 7.0 Pa (Malek et al 1999). The
microbubbles remained attached and echogenic when subjected to wall shear stresses
of up to 3.4 Pa. In-vivo, the wall shear stress to which a microbubble would be
subjected would be highly dependent on the site being investigated. The surface of a
plaque in an artery may not be smooth and can contain fissures and crevices. The
position of the microbubbles within the plaque would affect the wall shear stress
experienced.
From the ongoing optimisation of the microbubble, it was found that increased levels
of PE within the microbubble shell increased the mean backscattered power. When in
solution, the increase in mean backscatter power was significant at higher levels of
PE. An increase was not seen when the contrast agent with increased PE in the shell
was attached to the agar.
From the IVUS images, the enhancement of the agar surface was more apparent
when the microbubbles contained increased amounts of PE. However, when the RF
data was analysed to calculate the mean backscatter power, there was no obvious
trend between mean backscatter power and bubble composition as shown in Figure
6.10. The increased PE microbubbles which were sonicated prior to attachment while
not constantly having the largest backscatter power, did have better coverage across
the surface of the agar samples, this is shown in Figure 6.11 where the difference in
mean backscatter power between positions 1, 2 and 3 is less for the sonicated
contrast agent than it is for the unsonicated agents. The standard deviations of the
mean backscatter power across the agar surface are shown in Table 6.1, this confirms
that there was better coverage when the contrast agent was sonicated prior to
attachment.
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No Original Increased PE Sonicated
bubbles bubbles bubbles bubbles
Mean backscatter power -38.40 -26.02 -25.95 -26.33
Standard Deviation 0.24 3.09 4.98 0.48
Table 6.1: Mean and standard deviation in mean backscatter power across surface of agar
sample with no bubbles, original recipe bubbles, increased PE bubbles and sonicated bubbles
attached.
The standard deviation for the samples with no bubbles attached and with sonicated
bubbles attached are both less than those for original and increased PE bubbles.
While there was no difference in the mean backscatter power across the surface for
the agar samples with contrast agent attached contrast agent with original levels of
PE typically had enhanced sections across the surface, but not usually for the whole
surface, as shown in Figure 6.7. It was thought that sonicating the microbubbles
broke the shell of the outer microbubble which reformed and created smaller
microbubbles. It was not known where the biotin was located within the microbubble
shell. The breaking of the outer bubble shell potentially exposed more biotin from
the layers within the microbubble to the streptavidin coated agar causing an
increased number of microbubbles to bind and hence better coverage across the
surface. As with the original recipe microbubbles those manufactured with increased
amounts of PE in the shell remained attached at increased flow rates and wall shear
stresses up to 3.4 Pa.
Since the backscatter varied across the surface in Figure 6.11 the mean backscatter
power at each position across the surface of the agar samples was compared. Again
there was no significant difference in the backscatter for the different bubble types.
While the IVUS images and mean backscatter power data suggested that the
microbubbles remained attached to the agar samples at increasing flow rates, this was
not confirmed optically. It was attempted to get optical images of the microbubbles
attached to the agar samples but this was difficult due to the agar samples being
opaque.
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6.5 Chapter 6 summary
Microbubbles were attached to the agar samples. The samples were placed in the
flow chamber described in Chapter 5. The attached microbubbles were imaged with
IVUS at 40 MHz and subjected to the same flow rates for which flow profiles were
determined in Chapter 5. The images obtained from IVUS suggested that the
microbubbles remained attached at increasing flow rates. The mean backscatter
power across the surface of the agar samples was calculated, there was no significant
difference in the backscatter power at the low and high flow rates confirming that the
microbubbles remained attached to the agar at the increased flow rates. The wall
shear stresses obtained in Chapter 5 were applicable for the flow rates used in this
work, so the wall shear stresses under which the microbubbles remained attached
were known. The maximum shear rate to which the microbubbles were subjected
was 3.4 Pa (34 dynes cm" ). In-vivo the mean value of wall shear stress for pulsatile
flow is around 1.5 Pa (15 dynes cm"2). The wall shear stresses in the flow chamber
obtain using LDA suggest that the in-house contrast agent could potentially remain
attached in-vivo, once attachment has been achieved. However, attachment of
microbubbles under flow conditions is also an active area of important research
(Dayton et al 1999a, Rychak et al 2004, Takalkar et al 2004).
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Chapter 7
Attachment of targeted microbubbles under shear
stress
7.1 Introduction
It was shown in Chapters 3 and 6 that the in-house contrast agent could be attached
to agar, imaged with high frequency ultrasound and that the microbubble remained
attached under high shear rates. While it is important to know the forces which will
detach targeted microbubbles, it is also of great importance to know that the contrast
agent can be attached under flow conditions. Current work in the field of attaching
contrast agent was introduced in Chapter 2. At low flow rates, targeted microbubbles
have been able to attach in-vitro. This is suitable for low flow rates and for small
vessels. For larger blood vessels and areas of high flow rates, it is difficult to ensure
the microbubble comes into contact with the vessel wall which reduces the number
of microbubbles which will attach. The radiation force has been used to push the
microbubbles towards vessel walls increasing the number which make contact, hence
increasing the number which will attach (Dayton et al 1999a, Rychak et al 2004).
Previously the in-house microbubble had been attached to the 0% scatterer agar
plates as described in part 3.6.1 which involved placing the bubble solution on the
prepared plates and allowing them to attach over two hours. This chapter describes
preliminary work on attachment of the in-house contrast agent to 0% scatterer agar
under flow conditions to further determine in-vivo applicability.
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7.2 Methods
7.2.1 Timed Attachment
In order to determine the time for successful attachment of contrast agent to the 0%
scatterer agar, the agar samples were prepared with streptavidin in the standard way
described in Chapter 3. 0.5 ml of agent was added to a plate at half hour intervals.
These were then all washed with saline after 1.5 hours. As well as assessing binding
over hours, agar samples were also left with contrast agent on for 3, 5 and 12 minutes
to determine if attachment was possible for shorter time periods.
After the samples were washed, each one was imaged using the technique described
in Chapter 3, (part 3.6.1). The same block of agar with the wedge shape cut out
(Figure 3.14) was used to image the microbubbles attached to the 0% scatterer agar.
The IVUS catheter was placed in the cut out area and each agar sample placed over it
in turn. For each, the RF data and image was captured.
7.2.2 Flow Experiments
The flow chambers described previously throughout this thesis were used. Both
versions were utilised as there were benefits seen in using each chamber. For flow
chamber version 1 it was easier to image samples with no microbubbles attached and
samples with microbubbles attached during the same imaging session. Whereas for
flow chamber version 2 the flow channel design meant there was more confidence
that the flow profile obtained was parabolic.
It was not known if the microbubbles would attach to the samples under flow
conditions. 0% scatterer agar samples prepared with a coating of streptavidin as
described in Chapter 3 were placed in flow cell version 1. The same RF capture and
image capture facilities were used to collect data throughout the experimental work.
Prior to the circulation of the contrast agent, RF and image data for the coated agar
was saved. Initially 3 ml of microbubbles in saline was added to 300 ml saline and
circulated around version 2 of the flow chamber at a rate of 35 ml min '. The agent
was allowed to circulate continuously. The IVUS scanner was used to monitor the
echo from the surface of the samples. Images were saved and RF data captured after
153
Chapter 7: Attachment of targeted microbubbles under controlled shear stress
1, 2 and 2.5 hours. These times were initially chosen since the timed attachment
experiments suggested that the microbubble would bind to agar after at least 1.5
hours. Later attachment images were captured before agent was circulated and after
approximately 2 hours of circulation. The pump system was used with flow chamber
version 2 as there were practical difficulties using version 1 with the pump.
To allow achievement of flow rates slower than was possible with the pump system a
syringe pump was also used. The syringe pump held a 60 ml syringe and allowed a
maximum flow of 1.65 ml min"1. When the syringe was emptied it was refilled with
the same solution and the syringe pump restarted. 0.5 ml of bubbles in saline was
used in the syringe with 50 ml of saline. The low flow rate was necessary to prolong
the contact time of the bubbles with the agar surface, increasing the likelihood of
attachment. This set-up was used with flow chamber version 1.
The above work was repeated with streptavidin coated agar samples with saline and
with streptavidin coated agar samples with unbiotinylated in-house contrast agent as
controls.
During each experimental run, the IVUS catheter was marked on the covering sheath
at the point where it corresponded with the entry to the flow chamber. This was so
measurements at the same position within the flow chamber could be taken before
and after circulation of the contrast agent. As well as marking the catheter, the
outsides of the flow chambers where the transducer could be seen through the
Perspex were marked at the position of the transducer (see Figure 7.1). Initially it
was found that there was difficulty in imaging the same area once the IVUS catheter
had been moved. Each sample was imaged and data captured prior to circulation of
contrast agent, the catheter was then left in position to image one sample
continuously. The other samples were then imaged in the same place that the first
measurements had been made (using the markers on the IVUS catheter and the flow
chamber) after the contrast had been allowed to circulate for at least 2 hours.
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Figure 7.2: Mean backscatter power as a function of time of contact between biotinylated
contrast agent and streptavidin coated agar. Under no-flow conditions.
Figure 7.2 shows how attachment of microbubbles under static conditions had
increased significantly after the bubbles were left for at least 1 hour 30 minutes so
when the contrast agent was circulating around the flow chamber, it was left for at
least 2 hours to allow attachment.
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7.3.2 Flow experiments
Agar surfaceAgar surface
Figure 7.3: Streptavidin coated agar sample in flow chamber a) initial image, before saline is
circulated, b) image after saline has been circulated for 2 hours (flow chamber version 1).
I. .. I'lWi
Agar surface Agar surface
Figure 7.4: Streptavidin coated agar samples in flow chamber, a) initial image before circulation
of unbiotinylated contrast agent, b) after saline with unbiotinylated contrast agent has been





Figure 7.5: Streptavidin coated agar samples in flow chamber a) initial image before
biotinylated contrast is circulated, b) after biotinylated contrast has been circulated for 2 x/i
hours (flow chamber version 1).
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a 1% biotin-bubbles syr V1











Before and after circulation of contrast agent
o saline only V2
x 1% biotin-bubbles pump V2
□ 0% biotin-bubbles V2
Figure 7.6: Mean backscatter power for streptavidin coated agar samples before and after being
subjected to flow containing biotinylated in-house contrast agent, non-biotinylated in-house
contrast agent, and saline only a) Flow chamber version 1 (VI), b) flow chamber version 2 (V2)
error bars are one standard deviation.
Both chambers showed no enhancement of the agar surface when saline and non-
biotinylated bubbles were circulated (Figure 7.3, Figure 7.4). The IVUS images
shown in Figure 7.5 shows enhancement of the agar surface after biotinylated
contrast agent had been circulated around flow chamber version 1. However, the
mean backscatter power across the agar surface before and after circulation of
contrast agent did not show a significant increase in the mean backscatter power in
either flow chamber as shown in Figure 7.6.
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7.4 Further Attachment Experiments
In order to determine if the microbubbles containing more biotin in the shell attached
more readily than the original recipe contrast agent of 1% biotin, contrast agents
containing 3% and 5% biotin in the shell were circulated through the flow chambers
as described previously in section 7.2.2.
7.4.1 Results
Figure 7.7: IVUS images showing microbubbles containing 3 and 5% biotin after circulating for
2 Vi hours, a) before contrast, b) after 3% biotin-bubbles are circulated, c) before contrast, d)
after 5% biotin-bubbles are circulated.
Figure 7.7 shows enhancement of the agar surface after circulation of contrast agent
containing both 3% and 5% biotin. Figure 7.7b and d show the line of attached
contrast agent where Figure 7.7b shows 3% biotin contrast agent and Figure 7.7d
shows 5% biotin contrast agent.
The mean backscattered powers shown in Figure 7.8 shows that in version 1 of the
chamber there was some enhancement of the agar surface after circulation of the
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contrast agent, with the mean increase in mean backscatter power over both
chambers being 2 + 2 dB. This value becomes a mean of 3 + 2 dB when the value for
the 3% biotin-bubble in chamber version 2 is not included. The omission of the mean
value for 3% biotin for flow chamber version 2 was due to the significant difference
between the mean backscatter power for the 3% biotin bubbles in chamber version 2
and the other mean backscatter powers after circulation of the 3% and 5% biotin
bubbles shown in Figure 7.8. The reason for the difference was unknown but may
have been due to an error in the experimental set-up for the 3% microbubbles. The
3% biotin bubbles used in both versions of the chamber were from the same batch so
discrepancies between bubble batches are unlikely. By not including the mean
backscatter power from the 3% biotin bubble in flow chamber version 2, the mean
increase in mean backscatter power does not change significantly. The mean
backscatter powers shown in Figure 7.8 are below those for bubbles attached under

























Before and after circulation of contrast agent
X3% biotin-bubble V1
a 5% biotin-bubble V1
o 3% biotin-bubble V2
□ 5% biotin-bubble V2
Figure 7.8: Mean backscatter power for 3% and 5% biotin microbubbles before and after
circulation of microbubbles, error bars are one standard deviation.
7.5 Discussion
From the data presented here, biotinylated contrast agent attached to the streptavidin
coated agar when circulated over time. There was enhancement of the agar boundary
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after the contrast agent had been circulated for 2 hours as shown in Figure 7.5 and
Figure 7.7. However, with the 1% biotin contrast agent, the mean backscatter power
across the surface was not as high as seen when the contrast agent was attached
under static conditions. Although unlike the mean backscatter powers shown in
Figure 7.6, Figure 7.8 shows an increase in the mean backscatter power for the 3%
and 5% biotin microbubbles.
Both versions of the flow chamber were used for the attachment experiments.
Greater enhancement of the agar boundary was seen in version 1 of the chamber. It
was thought that this was due to a number of factors. The syringe pump was used
with version 1 of the flow chamber, this provided a flow rate of 1.65 ml min" , which
was slower than the flow rate through version 2 of the flow chamber. A slower flow
rate meant that potentially the microbubbles remained in contact with the agar for a
longer period of time. In version 1 of the flow chamber, a larger area of the agar
surface was imaged, this was due to the location of the IVUS channel with respect to
the sample. The position of the IVUS catheter within the flow chambers is
represented diagrammatically in Figure 7.9. The larger surface area being imaged in
version 1 meant there was a greater chance that a section with bubbles attached
would be imaged. However, the sample area over which the mean backscatter power
was calculated was the same for both flow chambers, so the mean backscatter powers
obtained were for the same amount of data in all cases.
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Flow channel
Version 1 Version 2
Figure 7.9: Diagram showing area of agar sample being imaged in flow chamber version 1 and
version 2. A larger proportion of the sample surface was imaged in version one of the chambers.
As a comparison; images (with no microbubbles attached) from version 1 and 2 of
the flow chambers are shown in Figure 7.10. The area over which the surface of the
agar sample was imaged in flow chamber version 1 was approximately 5 mm
whereas in version 2 it was approximately 3 mm.
Figure 7.10: IVUS images from a) version 1 and b) version 2 of the flow chamber.
On varying the proportion of biotin in the contrast agent shell, it was thought that the
number of attachment events may increase, as there would be a greater probability of
biotin making contact with the streptavidin. From the images shown in Figure 7.7,
Surface of agar
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there was attachment of the contrast agent containing 3% and 5% biotin. The mean
backscatter power was not significantly different between the 1%, 3% and 5% biotin
bubbles. However, the IVUS images in Figure 7.7 show a brighter line of attached
bubbles for the contrast agent containing 3% and 5% biotin than for the 1% biotin
bubbles shown in Figure 7.5 suggesting that more binding events occurred when
more biotin was incorporated into the microbubble shell.
Current research on attaching targeted microbubbles under flow conditions suggests
that the radiation force could be used as a mechanism to push the microbubbles
towards the vessel wall, increasing the numbers which make contact, hence,
increasing the number of microbubbles which bind (Dayton et al 1999a). This is
especially relevant in larger vessels of high flow rates as few microbubbles will make
contact with the vessel wall. Dayton et al (1999a) have demonstrated the use of the
radiation force to displace contrast microbubbles towards a vessel wall, in this
instance, vessels of 200 pm and 50 pm were used. More recently the acoustic
radiation force has been used to enhance adhesion of lipid shelled microbubbles
which were targeted to P-selectin (a cell adhesion molecule) (Rychak et al 2004).
Attachment studies of contrast agents have been completed under controlled shear
rates (Takalkar et al 2004). Takalkar (2004) assessed the binding and detachment of
lipid based contrast agent targeted to P-selectin where the targeted microbubbles
were drawn through a P-selectin coated flow chamber which was 2.5 mm wide with
a gasket thickness of 0.254 mm. Attachment and detachment at increasing shear rates
were studied. The maximum number of microbubbles was found to attach to the
chamber wall at a wall shear stress of 0.06 Pa and 50% of the bubbles had detached
by the time the wall shear stress was increased to 3.4 Pa.
In this chapter the flow rates through both flow chambers were very low. Attachment
at the increased flow rates was not attempted as when the microbubbles were
circulated, they would need to remain in the flow channel above the agar samples
long enough to make contact and bind. At the increased flow rates, the contrast agent
was less likely to make contact with the flow chamber wall. Using Equation 2.4,
described in Chapter 2 for determining the shear stress between parallel plates, the
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wall shear stress for fully developed flow in both chambers was calculated and is













Table 7.1: Calculated wall shear stresses for flow chambers version 1 and 2 for the flow rates
used during attachment experiments.
The theoretical wall shear stress calculated using equation 2.4 for flow chamber
version 1 and version 2 was 0.01 Pa and 0.30 Pa respectively. While these were not
expected to be the exact wall shear stresses in the flow chamber, previously in
Chapter 5 the theoretical and experimental wall shear stresses were shown to be in
good agreement.
7.5.1 Methods of improving attachment
Methods of attaching contrast agents need to be improved. In the case described in
this chapter, the radiation force could potentially be utilised to increase the number
of microbubbles which make contact with the agar surface. The in-house
microbubbles are currently being developed for the targeting of vulnerable plaque
and are to be imaged with intravascular ultrasound. The ultrasound catheter itself
could provide a mechanism for enhancing attachment of the targeted contrast agent
as the microbubbles can be introduced to the flow system via the catheter. A diagram
of an IVUS catheter is shown in Figure 7.11. If the contrast agent is introduced via
the catheter, the microbubbles will go direct to the area of interest and are,
potentially, more likely to bind to the area of interest, however, this method will only
deliver the contrast agent to the appropriate area, it does not prolong the length of
time the contrast agent will remain in contact with the area of interest. This technique
was not feasible with the current flow chamber design as the IVUS catheter imaged
the agar surface through the samples; the catheter was not positioned at the surface of
the agar coated with streptavidin.
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Figure 7.11: Cross-section through an IVUS catheter, showing potential use for delivery of
targeted contrast agents.
Attachment work completed so far has been for steady flow. When pulsatile flow is
considered, there may be a greater chance of the microbubbles binding during
diastole when the flow rate reduces, thus increasing the length of time the
microbubbles are in a certain position.
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Figure 7.12: Malvern Mastersizer size distribution of in-house agent before and after being
pumped for 30 minutes (green line: before being circulated red line: after being circulated).
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In order to determine if the pump had an influence on the microbubbles being
circulated, a sample of bubbles was sized using the Malvern Mastersizer 2000 before
being pumped. The sample was then re-sized after being circulated through the pump
for 30 minutes. Figure 7.12 shows the size distribution before and after the agent was
circulated through the pump.
The d(0.5) value before the contrast agent was circulated (green line) was 1.132 pm
and after being circulated was 1.283 pm meaning that the size of the microbubbles
increased slightly after being pumped. This could be due to some smaller bubbles
being destroyed, or the contrast agent could have reformed to make larger bubbles;
the size distribution for the contrast agent which had been pumped was broader than
the distribution for the un-pumped sample. While there were some affects of the
pump on the microbubbles, the distribution remained largely unchanged so the pump
system was not thought to affect the microbubbles significantly.
7.6 Chapter 7 summary
Preliminary attachment studies of the in-house agent were performed. Both versions
of the flow chamber were used as they were both thought to have advantages and
disadvantages. The contrast agent was circulated around the flow chambers for 2-2.5
hours. For flow rates of 1.65 ml min"1 in the first version of the flow chamber, the in
house agent was found to attach to streptavidin coated agar. However, the mean
backscatter power across the agar surface did not show significant enhancement of
the agar surface. Microbubbles containing 1%, 3% and 5% biotin were used. The 3%
and 5% biotin microbubbles appeared to give better coverage in the IVUS images;
however, there was no significant difference in the mean backscatter power between
the different bubble compositions. The attachment experiments performed in the
second version of the flow chamber did not consistently show attachment of
microbubbles when being circulated at a rate of 35 ml min"1. Differences between
the flow chambers and the flow channels were thought to account for the difference
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in attachment success. The flow rate through each flow chamber was also thought to
have an effect.
Attachment of the microbubbles under flow conditions is necessary for in-vivo
applications. Small vessels and regions of low flow rates are more likely to allow
contact between the vessel wall and the contrast agent; in larger vessels other
techniques such as utilising the radiation force may be necessary. It is known that the
microbubbles remain attached when subjected to flow, so optimising the attachment
process is now necessary.
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The work presented throughout this thesis describes an in-house ultrasonic contrast
agent which has been developed and continues to be developed to enable imaging of
vulnerable plaque with intravascular ultrasound. The microbubble has been tested
during initial development stages and continuously throughout development.
An advance in ultrasonic contrast imaging is the targeting of contrast agents to attach
to specific markers expressed on cells at certain sites within the body. In order to
develop techniques for imaging of attached contrast agents it is necessary to attach
the agents in vitro. However, development of commercially available contrast agents
for the purpose of targeting is difficult due to commercial sensitivity. Manufacturers
of contrast agents are reluctant to divulge the contents of their microbubbles or the
best method ofmodifying them, hence the need to develop a bubble in Edinburgh for
targeting. The new in-house contrast agent has a lipid shell and has been found to be
echogenic at intravascular frequencies of 30 and 40 MHz. The contrast agent is
capable of being targeted to attach to specific sites of interest by modifying the shell
constituents.
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Of interest at the current time are cardiovascular applications for targeting vulnerable
(unstable) plaque in arteries. Areas of inflammation are associated with areas of
vulnerable plaque and are known to express specific markers; the microbubble can
be modified to target these areas. As well as targeting vulnerable plaque, the in-house
agent has the potential to be targeted to any site of interest if the relevant antibodies
are utilised.
The in house contrast agent was biotinylated and attached to streptavidin coated agar.
The attached contrast agent was imaged with high frequency intravascular- and
transcutaneous transducers and subjected to different peak acoustic pressures. When
attached to agar containing no additional scatterers, the contrast agent could be
imaged with high frequency ultrasound.
A new flow chamber was developed for imaging attached contrast agent under flow
conditions. Attached microbubbles have been imaged at increasing flow rates and the
microbubbles have been found to remain attached to agar at wall shear stresses
comparable to those found in-vivo.
The flow chamber was modified for use with laser Doppler anemometry (LDA).
LDA is a high resolution technique for the measurement of the velocities of fluids
and gases. The flow profile in the new flow channel was found using LDA and used
to calculate the shear stress on the surface of the agar samples. The microbubbles
were found to remain attached under wall shear stresses of 3.4 Pa, mean arterial wall
shear stress is 1.5 Pa. The technique of using LDA with the flow chamber has
potential to be used for future contrast studies, different contrast agents, different
binding mechanisms and flow conditions can be studied.
Initial work was completed on attachment of the contrast agent under flow
conditions. Under slow flow rates contrast agents were found to attach to streptavidin
coated agar. This is a continuing field of research with groups investigating methods
of attaching contrast agent in-vivo when the vessels being studied can be large and
the flow rates high.
168
Chapter 8: Summary and Conclusions
8.2 Future Work
The in-house contrast agent is currently being further optimised and characterised for
use with high frequency ultrasound. For use with IVUS, as described in this thesis, it
is necessary to produce smaller microbubbles which will resonate at the higher
acoustic frequencies (Moran et al 2006). The work described in this thesis has
involved imaging the in-house agent in-vitro, more recent work has involved
imaging the in-house agent and commercial contrast agent in excised sheep aorta as
shown in Figure 8.1. It is possible to target the agent to target specific markers within
the artery. Currently markers expressed at areas of unstable plaque are of interest,
although the agent can be targeted for a variety of applications such as angiogenesis
(Ellegala et al 2003, Leong-Poi et al 2003). In future development of the in-house
agent applications other than targeting vulnerable plaque may be considered.
Figure 8.1: IVUS image
C.M Moran.)
Microbubble agents are also being developed for applications other than increasing
contrast in ultrasound images and have great potential for the future developments
(Unger et al 2004). In addition to diagnostic applications, the in-house agent can be
developed further to allow drug delivery, the microbubble can be loaded with a drug,
targeted to a specific site of interest and used to deliver the drug immediately to the
affected area. The mechanism of drug delivery from microbubbles to cells is one
which needs further work to understand and optimise the technique. As well as drug
delivery, delivery of genetic material with the aid of ultrasound is also a feasible
development (Newman et al 2001). The study of the transfer of material from
contrast agents is on-going and current work in the department is investigating the
transfer of materials from attached contrast agents as is the application of
sonoporation to microbubbles and cells.
of the Definity circulating in ex-vivo sheep aorta. (Image courtesy of Dr
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The behaviour of individual contrast agents when suspended in a solution has been
previously studied (Sboros et al 2003), however, the behaviour of individual
microbubbles when attached to a surface is unknown. It is of interest to know the
behaviour when considering targeting applications of contrast agents.
The method used to manufacture the agent described in this thesis is solvent based
which is time consuming and results in small quantities of agent. A non-solvent
method ofmanufacturing the agent is currently being developed and this method will
allow large quantities of the agent to be made. The new method is heat based and
results it a solution containing fewer un-dissolved lipid crystals. Current work
involves investigation of the size distribution and echogenicity of the agent and will
determine if the new method produces smaller microbubbles which can be used with
40 MHz ultrasound.
Small animal imaging is a continually expanding field of interest. High frequency
ultrasound can be used to obtain high resolution images. A consequence of the small
size of a mouse (a few centimetres wide), a large depth of penetration is not required
to image organs or vessels of interest so higher frequencies and hence higher
resolution imaging can be used. A contrast agent which is echogenic at higher
frequencies would allow contrast imaging and targeted imaging in small animals to
be studied.
The flow chamber has been characterised for certain flow rates and LDA can be used
to further characterise the wall shear stress for lower and higher flow rates. This will
have use in future attachment and detachment studies where different microbubble
compositions, and the effectiveness of different binding mechanisms under flow
conditions can now be studied.
Harmonic imaging of the in-house agent when attached to agar could improve
detection of the agent. Currently it is not possible to perform harmonic imaging using
the available IVUS scanner however, a prototype IVUS catheter for performing
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harmonic imaging is being developed elsewhere (Goertz et al 2005b). There are also
alternative set-ups available which allow harmonic imaging. Work has begun on
imaging the in-house agent using harmonic imaging at lower frequencies, an
example image of sheep aorta imaged using a Diasus scanner transmitting with a L8-
16 probe and receiving using LI0-22 probe is shown in Figure 8.2, where the aorta
before and after the addition of contrast agent is shown. Other methods of
distinguishing the microbubble echoes from tissue echoes by using techniques such
as pulse inversion have yet to be investigated with IVUS and could potentially
enhance the images obtained from attached contrast agents.
Figure 8.2:Sheep aorta mounted on slab of tissue mimicking material. Both images obtained
scanner transmitting with a L8-16 probe and receiving using L10-22 probe, a) vessel prior to
injection of contrast, b) vessel post injection of 1ml of in-house contrast agent (Image courtesy of
Dr C.M Moran.)
The attachment of the agent under flow conditions is crucial for in vivo usage. A
reliable method of attaching the bubbles under flow conditions, especially in areas of
high flow is needed. The binding mechanism could be modified so as to use a
mechanism which binds on contact. This combined with utilising the radiation force
as a method for pushing the bubbles in flow towards the vessel wall would enhance
the attachment of microbubbles to the area of interest. The radiation force has been
shown to be a feasible technique for pushing bubbles towards vessel walls and will
be most applicable in large vessels with high flow rates (Rychak et al 2005).
The field of ultrasound contrast agents is a very active area of current research and is
continually expanding.
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Appendix 1
Development of in-house contrast agent
Ap1.1 Introduction
Chapter 3 describes the development of in in-house contrast agent suitable for
imaging with 40 MHz intravascular ultrasound and which was to be developed for
targeted imaging of vulnerable plaque. This appendix provides a concise overview of
the development and optimisation of the in-house agent.
Section 3.4.1 describes the general protocol for the manufacture of the in-house
agent. The lipid constituents of the microbubbles: Phosphatidyl Choline (PC),
Cholesterol, Phosphatidylethanolamine (PE) and Phosphatidyl Glycerol (PG) (Sigma
Aldrich Company Ltd, Dorset, UK), were dissolved in chloroform, this allow the
mixing of the constituents. Nitrogen gas was used to evaporate the chloroform off the
mixture leaving a lipid residue in the container. The residue was re-dissolved in
cyclohexane and placed in dry ice in preparation for freezing. The mixture was left to
freeze dry overnight. The resulting white powder of the combined lipids could then
be mixed with saline to form the contrast agent. When dissolved in saline the natural
form the lipids take is in the form of multi-layer microbubbles, gas was then bubbled
through the solution to incorporate the gas into the agent. The process is described
more fully in (Moran et al 2004) and (Moran et al 2006)
The tests completed during initial optimisation of the in-house agent are described in
Table Apl.l. These tests are described in Chapter 3. The aim of agent optimisation
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was to develop an agent which was echogenic at intravascular frequencies and which
could be targeted to specific sites. Ideally the agent would be reduced in size to
approach the bubble size which would be resonant at 40 MHz. Further work on
optimisation of the in-house agent was completed in parallel to the work described in
this thesis, various methods for reducing the size of the agent and increasing the
mean backscatter power were tested and are described in Table Apl.2. Table Apl.3
describes the different agent compositions used for attachment in Chapters 6 and 7.
The initial studies found that the amount of biotin in the agent shell was important
for the attachment of the agent.
Variation tested Method of testing Result summary
Cholesterol content
in agent shell
Agent containing 30-70% cholesterol
was made. Each agent was imaged
with IVUS and the images studied to
determine any change in backscatter.
No significant change in
mean backscatter power
was found with change in
cholesterol concentration.
Amount of mixture
dissolved in saline to
make up agent
Solutions from 5 mg agent per ml of
saline to 100 mg per ml were imaged
with IVUS to determine the optimum
concentration of agent in saline.
25 mg per ml of saline




Helium and Nitrogen were bubbled
through the agent solution (gas tube
placed in bottom of the container and
bubbled through) or bubbled on top
of the solution (gas tube placed by
top surface of solution and bubbled
on top, agitating the solution). The
resulting agent was image with IVUS.
From the images obtained
from IVUS it was thought
that Nitrogen gas bubbled
on top of the solution gas
the most echogenic
bubbles.
To determine if the
mean backscatter
power from the agent
varied with the gas
used for bubbling on
the solution.
Nitrogen and Helium were bubbled
on top of the solutions. Each was
imaged with IVUS and the mean
backscatter power for each
compared. Agent made with no extra





Helium and no extra gas.
Lifetime of agent The agent was imaged with IVUS
and the mean backscatter power
determined for the same samples
over 48 hours.
There was no significant
decrease in mean
backscatter from the
agent after 48 hours.
Targeting of agent Biotin was incorporated into the
agent shell. Streptavidin coated
surfaces were used to determine if
the agent could be attached
successfully.
The agent containing
biotin in the shell attached
to streptavidin coated
surfaces.
Table Apl.l: Summary of tests completed on agent described in Chapter 3.
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Variation tested Method of testing Result summary
Concentration of PE in the
agent shell
The proportion of PE in the
agent shell was varied from
10% to 90% and the mean
backscatter power and mean
agent size determined for
each.
The mean backscatter power
increased with increasing PE
concentration.
Sonication of the agent The agent, after being
reconstituted in saline, was
sonicated for increasing
lengths of time from 30
seconds to 300 seconds and
the change in mean
backscatter power and agent
size determined.
The mean backscatter power
from the agent increased
after being sonicated for 30
seconds. There was no
change in mean backscatter
power for increased lengths
of sonication.
Table Apl.2: Summary of tests completed on agent in parallel to work competed in this thesis.
The work described in this table was performed by Dr C M Moran.
Variation tested Method of testing Result summary
Amount of biotin in shell In attachment under flow
conditions described in
Chapter 8, agent containing





Sonication of agent The agent was sonicated for
30 seconds prior to being
placed on the agar for
attachment.
The was a increase in
attachment when the agent
was sonicated.
Variation of PE in shell The agent was made with
34% more PE in the shell





Table Apl.3: Description of bubble types used for targeting.
Currently the method of bubble manufacture is being modified with a new non-
solvent method being used. This method allows the manufacture of larger quantities
of agent. The new method has initially produced batches of contrast agent which
contain fewer lipid crystals than the solvent method. Further investigation of the size
distribution and echogenicity of the agent will determine if the new manufacture
method produces smaller microbubbles. This work is currently ongoing.
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Appendix 2
Hydrodynamic forces to which attached
microbubbles are subjected
Ap2.1 Forces on bubbles at surfaces
While the experimental techniques and results presented in this thesis allowed the
ultrasonic imaging of attached microbubbles under flow conditions and the
determination of the wall shear stress to which the attached bubbles were subjected.
The specific forces acting on the attached bubbles were not known. It is instructive to
consider the forces present to increase understanding of the situation to avoid making
any fundamentally flawed assumptions.
The forces on the bubble against the wall due to flow would comprise of drag, lift
and torque forces shown in Figure Ap2.1. It is of interest to know the strength of the
forces on the attached bubbles due to the flow to understand how the bubble may be
affect by the flow.
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Figure Ap2.1 Forces on an attached bubble under flow conditions.
The hydrodynamic force (Fh) (drag) for a spherical particle in contact with a plane
wall has been shown to be(0'Neil 1968),
Fh = 1.7009 x 67rnrpv[rp) (Ap2.1)
where, p is the dynamic viscosity of the fluid, rp is the radius of the particle and v(rp)
is the velocity of the fluid at a distance of rp from the surface. The value 1.7009 is the
dimensionless coefficient of force acting on the sphere. The fluid is assumed to be
incompressible with a constant density and viscosity and the flow is assumed to be
steady and laminar with low Reynolds numbers.
The torque acting on a spherical particle at a surface exposed to a shear flow has
been calculated by (Hubbe 1984),
TH=1.38xFHrp (AP2.2)
where Th is the hydrodynamic torque and can be used to calculate the adhesive force
between the particle and surface since,
TH=Fada0 (AP2.3)
where Fati is the adhesive force and 2ao is the area of contact between the particle and
surface. These equations have been previously used to study particle-membrane
interactions under flow conditions (Elzo et al 1996).
Equation Ap2.1 can be used with the data obtained in Chapter 6 where the viscosity
of the water was 1 mPa.s and the radius of the bubble was 1pm, the flow velocity at
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lpm from the edge is taken to be 1 cm s"1. The torque acting on the attached bubble
can then be calculated using Equation Apl.2, which can in turn be used to calculate
the adhesive force between the bubble and agar surface by Equation Ap2.3.
Substituting the above values into equations Ap2.1, 2.2 and 2.3, the following values
were obtained, Fh=3.2x10"10 N, Th=4.4x10~16 N and Fad 2.2x10 9 N.
The above equations are applicable for rigid spheres whereas contrast microbubbles
are compressible, however, these calculations provide the basis for the calculation of
the forces on the contrast agent due to the flow.
The calculated forces on the bubbles show that the adhesive force is orders of
magnitude greater than the lift force and one order of magnitude greater than the drag
force, this is dependent on the assumption for the value of at area of contact (0.2pm
in this case). This however does not take account of the binding force between the
avidin and biotin used to attach the bubbles.
Cells when attached to surfaces do not always form perfect spheres, thus varying in
the area of contact at the surface. Cells when subjected to flow align and elongate in
the direction of the flow, thus leading to non-spherical particles at the surface. Work
has considered the effect of cell smoothing and cell surface on the forces experienced
by the particles (Brooks and Tozeren 1996). The forces on cells subjected to flow
were calculated. As a spherical cell aligned in the direction of the flow, the forces
acting on the cell were found to decrease by 25%. When the cell modelled was given
a rough surface, the forces on the cell were slightly smaller than for a smooth cell.
The attached contrast agents when subjected to flow may experience forces similar to
those of rigid spheres, however, during insonation, the agents will experience forces
due to the ultrasound which may also affect the net force experienced by the attached
bubbles.
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Initial Simulations
Initial 2D simulations studying the forces on attached bubbles were run by Dr Paul
Stansell, Department of Physics, University of Edinburgh. Microbubbles were
modelled as cylinders, against a surface. The drag, lift and torque forces experienced
by single and multiple cylinders was considered. Figure Ap2.2 shows normalised
drag, lift and torque forces against separation of the cylinders for a row of 10
cylinders. As the separation increases, the forces expressed on each of the cylinders
tends towards that of a single cylinder. For smaller spacing between cylinders, the
first experiences larger forces than the following cylinders. Figure Ap2.3 shows the
forces experienced on each cylinder. For each force, the first cylinder in the row
experiences a greater force than the following cylinders. For small spacing between
cylinders, the last cylinder in the row experiences an increased drag and torque force
but a decreased lift force. These initial simulations can be further developed for
different flow conditions and for spheres to enhance the understanding of the forces
experience by attached microbubbles.
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He-Cl2S, v-0.1, g-6.00025, a-18, UE-122Q, i.y-203 Ha-e.25, v-0.1, g-0. 80825, 8-10, UK—1220. Ly-SOO
gapa
30-0.25, v-0,1, g^-,Q'M2S, a-10, IJ»1220,Ly«200
gajya
Figure Ap2.2Forces experiences as the separation between cylinders increases, drag, lift and
torque forces. Printed by permission, Dr Paul Stansell
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Pm&M. ix*m&
Figure Ap2.3 Forces on each cylinder as the separation increases, drag, lift and torque forces.
Printed by permission, Dr Paul Stansell
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LASER DOPPLER ANEMOMETRY MEASUREMENTS OF THE SHEAR
STRESSES ON ULTRASONIC CONTRAST AGENT MICROBUBBLES
ATTACHED TO AGAR
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Abstract—Ultrasonic contrast agents are currently being developed to target and hind to specific areas of interest
such as atheromous plaque. A microbubble has been developed in-house which can be targeted to attach to
specific cell-lines. To assess the feasibility of using the microbubble in vivo, the shear stresses which the bound
microbubbles can withstand need to be known. A flow chamber was developed for use with intravascular
ultrasound (IVUS) and laser Doppler anemometry (LDA). Biotin was incorporated into the microbuhble shells
and streptavidin was used to attach them to agar. IVUS at 40 MHz was then used to image the attached
microbubbles under steady flow at a range of flow rates from 75 to 480 mL min-1 through a flow area of 9 mm2.
LDA was employed to find high resolution velocity profiles of the flow in the chamber at a selection of these flow-
rates and the shear stresses on the bubbles were calculated. The bubbles were found to remain attached to the
agar for shear stresses of up to 3.4 Pa. This compares with mean physiological arterial shear stresses of less than
1.5 Pa for pulsatile flow. (E-mail: M.Butler@ed.ac.uk) © 2005 World Federation for Ultrasound in Medicine
& Biology.
Key Words: Ultrasound. Contrast agents, Microbubbles, Targeted, Shear stress, Laser Doppler Anemometry.
INTRODUCTION
Ultrasonic contrast agents are gas-filled microbubbles
approximately 5 /u,m in diameter. They are currently used
diagnostically to enhance the backscattcr of ultrasound in
areas such as the liver and heart (Campani et al. 1998;
Kaul 2001; Miller and Nanda 2004). Therapeutic appli¬
cations are presently being developed to target and attach
microbubbles to specific sites of interest within the body
(Klibanov et al. 1997; Klibanov et al. 1999; Lanza 1996;
Lindner 2004; Villanueva et al. 1998). This application
has potential for gene and drug delivery, as well as
detection of tumours (Ellegala et al. 2003) and vascular
thrombus (Unger et al. 2002).
Angiograms are used to visualize blood flow in the
cardiovascular system. However, it is not possible to say
whether a narrowing in an artery is due to a stable or
unstable (vulnerable) plaque. Intravascular ultrasound
(IVUS) is used to image plaque and different types have
been broadly distinguished using spectral analysis (Spen-
Address correspondence to: Mairead Butler, Medical Physics and
Medical Engineering, University of Edinburgh, The Chancellor's
Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK. E-
mail: M.Butler@ed.ac.uk
cer et al. 1997; Watson et al. 2000; Nair et al. 2001).
IVUS elastography is a technique also being investigated
as a method of assessing plaques (de Korte et al. 1998).
However, an accurate diagnosis of unstable plaque is still
not possible. There is a real clinical need for optimising
the diagnosis and hence treatment of vulnerable plaques.
With a view, to this a targeted lipid-based microbubble
has been developed in-house (Moran et al. 2003a, Moran et
al. 2004a). It is echogenic at intravascular frequencies. The
microbubble has the potential to attach to markers ex¬
pressed on the surface of plaques and hence to identify
vulnerable plaques using IVUS. To assess the feasibility of
using the microbubbles in vivo, it is necessary to know the
shear stresses that they can withstand without detachment
and how they behave at different flow rates.
Attached microbubbles under flow conditions have
been imaged in vitro (Klibanov et al. 1999; Villanueva et
al. 1998) and, more recently, they have been studied
under controlled shear rates (Takalkar et al. 2004).
Takalkar et al. (2004) assessed the binding and detach¬
ment of a contrast agent targeted to P-selectin. A flow
chamber was coated with P-selectin and the targeted
microbubbles were drawn through the chamber. Attach¬
ment and detachment studies at increasing shear stresses
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were completed. The maximum number of microbubbles
was found to attach to the chamber surface at a shear
stress of 0.06 Pa and 50% of the bubbles had detached by
the time the shear stress was increased to 3.4 Pa. The
density of antibody on the microbubble shell and wall
shear rate have been found to be critical parameters for
bubble adhesion (Weller et al. 2002).
A flow chamber has been designed which can be
used for IVUS imaging of microbubbles attached to agar
using avidin and biotin. The attached microbubbles can
be imaged under a range of flow rates. In order to know
the shear stress to which the attached microbubbles are
subjected, a detailed profile of the flow is required. While
it is important to know the shear stresses under which the
microbubbles can attach to surfaces, it is also necessary
to determine the shear stress which attached micro-
bubbles can withstand.
Shear stress
Shear stress is calculated from Nichols and
O'Rourke (1990),
/ du\
Shear stress = ju.1 — I (1)
where p, is the viscosity of the fluid, u is the velocity of
the fluid and x is the distance from the surface, perpen¬
dicular to the flow. These variables are represented dia-
grammatically in Fig.l. A high-resolution flow profile
near the surface of the wall is needed to calculate the
shear stress on attached microbubbles.
Laser Doppler Anemometry
Laser Doppler Anemometry (LDA) is a well-estab¬
lished technique allowing noninvasive, high-resolution
measurement of the velocities of liquids and gases
(Durrani and Greated 1977). In LDA, the Doppler shift
of laser light scattered by seeding particles in the flow is
measured and the corresponding velocities in one, two or
three dimensions are determined. This study describes
how this technique has been used to determine the flow
profile in the flow chamber.
flow of viscosity
p. with velocity u
flow/
profile
Fig. 1. Shear stress variables: x is the distance from the wall. p is
the viscosity of the fluid and v is the flow velocity of the fluid.
MATERIALS AND METHODS
Flow chamber
A flow chamber was developed to enable ultrasonic
imaging of contrast agents attached to surfaces. The design
was modified to allow LDA measurements. After initial
experimental work with LDA (Butler et al. 2004), the
design was modified to allow higher resolution velocity
measurements to be made. The position of the samples in
the flow was changed from the base of the chamber to the
side, so the probe volume could be moved in 45 /am
increments. A schematic diagram of the final version of the
chamber is shown in Fig. 2. The chamber was made from
three layers of perspex. The overall dimensions of the flow
chamber were 160 X 80 mm; each layer was 6 mm thick.
The base layer was a plain perspex rectangle. The center
layer had a channel with two wells for agar samples, of
dimensions 10 X 1.5 X 6 mm. The flow channel specifi¬
cation was 125 X 1.5 X 6 mm; at each end of the channel
were two reservoirs. Luer fittings were connected to each
end of the channel, to allow tubing to be attached se¬
curely. In the same layer, behind the sample wells, was a
channel for use with a high frequency IVUS transducer.
The IVUS catheter could then be used to scan through
the agar samples in the wells. This channel was 2 mm
deep and 1.5 mm wide and was parallel to the flow
channel, as shown in Fig. 2. A luer fitting was used at the
end of the IVUS channel, with a Y-junction to secure the
catheter in place. The top layer had a microscope slide
inserted into the center with the bottom of the slide flush
with the bottom of the perspex. This was glued in place
and made watertight. The microscope slide allowed a
clear scratch-free window for the laser and was placed so
that, when the chamber was assembled, it was positioned
over the area of the sample wells. There were two 2 mm
holes through each layer, which were used with steel
rods for alignment of the layers.
The agar samples used for all of the work described
here were made following a standard tissue-mimic recipe
(Teirlinck et al. 1998) but without the addition of the
scatterers. This reduced the backscatter from the water-
sample interface, enabling the detection of microbubbles
with IVUS. The speed of sound through the agar was
determined using a scanning acoustic microscope; the
acoustic impedance was then calculated and found to be
1.57 MRayl. Water was circulated through the flow
chamber at a constant flow rate using a voltage con¬
trolled pump. The chamber was sealed using silicone
grease between the sections and then clamped together.
This provided a leak-proof seal and was time-saving
when assembling the chamber.
Attaching the microbubbles
The lipid-based biotinylated bubbles were made
in-house (Moran et al. 2003a; Moran et al. 2003b). Agar
samples were coated with 1 mL of streptavidin in buffer
Shear stress on attached microbubbles • M.B. Butler et al. 547
Fig. 2. Diagram of the sections of the flow chamber: (a) Sections of the chamber, (b) Enlargement of sample area and
(c) View of How area from above.
(0.5 mL streptavidin per 6 mL buffer) and left for 20 to
24 h. They were then washed with saline and 1 mL of
blocking buffer (saline and 1% BSA) was added and left
for 2 h. The samples were washed again with saline and
200 /xL of the in-house microbubble was added and left
for a further 2 h. Finally, the samples were washed with
saline again to remove any excess microbubbles.
IVUS
A Boston Scientific ClearView Ultra IVUS scanner
was used with a rotating Atlantis 40 MHz transducer
(Boston Scientific, Natick, USA). The samples with and
without bubbles attached were placed in the wells in the
flow chamber. The chamber was sealed, the IVUS cath¬
eter was placed in the IVUS channel and both samples
were imaged. The voltage controlling the speed of the
pump was increased from 2 V to 15 V in 1 V increments;
this corresponded to flow rates of 75 mL min-1 to 480
mL min-1. Images of the sample with microbubbles
attached were recorded at each flow rate after approxi¬
mately 60 s; this was repeated for the sample with no
bubbles attached. The images were recorded as single
frames using Matrox Intellicam software (Matrox VITE
Limited, Sefton Park, Buckinghamshire, UK).
To quantify any change in backscatter with increas¬
ing flow rate, a PC with a digitising card (Gage-Applied
Technologies Inc, Lachine, Canada (CS8500 digitising
card)) was used to capture the RF IVUS signal. For flow
velocities of 110, 195, 300, 385 mL min-1 and again at
110 mL min-1, one frame was acquired. Each RF frame
consisted of 256 image lines and was digitized to 8 bits
at rate of 250 Megasamples per second. Using prewritten
analysis software in IDL, a region-of-interest (ROI) of
128 data points and nine ultrasonic lines was chosen at
the point of the exposed surface of the agar. The ROI at
a distance of 2.5 mm from the transducer was calculated
to be 0.31 mm3. For each flow rate, the same depth of
ROI was chosen, although different depths were neces¬
sary for different samples due to slight differences in
sample thickness. The mean backscattered power for
three points across the surface of the sample was calcu¬
lated. Consecutive lines of ultrasound were chosen. The
data were normalized to an echo from an air-water in¬
terface with the depth between the probe and the water
being the same as the depth between the probe and the
sample surface in the flow chamber. Mean backscattered
power from samples with and without bubbles attached
for each flow rate was calculated.
LDA
A DANTEC LDA system based in Mechanical En¬
gineering, University of Edinburgh, was used to measure
the velocity profile in the chamber. The laser used was a
5 W argon ion laser with a wavelength of 488 nm. The
beam was split and one probe housed the two pairs of
beams used to measure 2D velocity data. A front lens
with 160 mm focal depth was purchased for this work;
this lens created a probe volume of 45 X 45 X 200 ju,m.
The laser probe was mounted on a traverse system,
which allowed fine mechanical movement of the probe in
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x, y and z directions. The samples were cut to size and
placed in the flow chamber. The flow chamber was
mounted on a tripod and positioned perpendicular to the
laser probe.
The laser was run at 0.2 W. Initially, the focal point
was positioned at the surface of the flow chamber on the
bottom left-hand corner. This was taken to be position
(0, 0, 0) as shown in Fig. 2. The flow chamber inlet was
connected to the pump and flow was started. At first, 6
mL milk per 2000 mL water was used to seed the flow.
This proved to be an effective and economic method of
getting the set-up running smoothly. Later, a fine pow¬
der, titanium dioxide (S. Black Ltd, Hertford, UK) suit¬
able for LDA work, which had a size distribution of 3 to
10 /am, was used to seed the flow. Once flow was
established, the LDA measurements were taken. The
flow rates used were 110. 195, 300 and 385 mL min-1.
Before determining the flow profile from the surface
of the agar samples, the profile through the flow channel
(from top to bottom) was found. This allowed the posi¬
tion of the peak velocity to be determined; the profile
from the sample surface was taken at this point. The
probe volume was then incremented in 45 /am intervals
toward the surface of the agar sample. Flow velocities
along the channel and across the channel width were
determined simultaneously by 2D LDA. At each point,
up to 10,000 velocity measurements were made. The
maximum time for each set was 15 s. Between each
increment, the traverse system was allowed to pause for
8 s, to allow vibrations in the system to disperse before
velocity data were collected. The data were collected and
processed using DANTEC LDA BSA software. Velocity
measurements for each flow rate were made three times
and the mean profile was calculated.
RESULTS
Figure 3 shows the mean velocity profiles obtained
using LDA; the error bars are one standard deviation of
the mean of three runs. As expected, as the flow rate is
increased, the peak velocity increases and, hence, the
shear rate increases. The right-hand side of the profile is
the profile at the sample surface and the left-hand side is
the profile at the edge of the chamber.
To calculate the shear stress at the surface of the
sample, a linear regression was performed in Excel (Mi¬
crosoft Excel 2000). The points of the profiles at the
surface of the samples (between 38.5 and 38.7 on the
x-axis in Fig. 3) were used. Figure 4 shows the profile
close to the edge of the flow channel for a flow rate of
300 mL min-1; the gradient of this line was the shear rate
and was used to calculate the shear stress; the error bars
are one standard deviation of the mean point of the three
data sets. Four data points were used for each linear
regression. Including an extra point in the linear regres¬
sion found no significant difference in the shear stress
—110 ml/min -e— 195 ml/min —a— 300 ml/min -®— 385 ml/min
Fig. 3. LDA velocity profiles from the surface of an agar
sample in the flow chamber, for flow rates of 110, 195 and 300
and 385 mL min1. The error bars are one standard deviation
of the mean of the three runs. The x-axis is the distance from
the front edge of the flow chamber. The region of the profile
between 38.5 and 38.7 on the x-axis is the profile at the sample
surface; the region of the profile between 37.3 and 37.5 on the
x-axis is the profile at the edge of the flow channel.
calculated. The shear stresses were calculated using eqn
1, where the viscosity of the fluid was taken to be that of
water at 20°C, i.e., 1.002 Pa s (Weast et al. 1988). The
shear rates and stresses calculated for each of the profiles
in Fig. 3, along with the standard error in calculating the
gradient, are shown in Table 1. These values are plotted
in Fig. 5 for each flow volume. There is a linear trend in
the increase in shear stress with flow rate in the chamber
(R2 = 0.98).
The second laser beam pair measured the velocity
components of off-axis flow, horizontally perpendicular to
those in Fig. 3. These were found to be approximately
constant at zero in the flow region; examples of the distri¬
bution of point velocities for flow rates of 110 and 385 mL
min "1 are shown in Figure 6.
60
0 . , . , 1 , , . , 1 . . . , 1 , . , .
3.84 3.845 3.85 3.855 3.86
distance from edge of flow chamber (cm)
♦ end of profile, flow 300 ml/min line of best fit, linear regression
Fig. 4. Plot of the end of the profile at surface of the agar
sample, with linear regression to find the line of best fit. Error
bars are one standard deviation of the mean velocity from the
three runs.
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Table 1. Measured peak velocity and calculated sheer rates
and shear stresses for varying flow rates
Flow rate Peak velocity Shear rate Shear stress
(ml min~') (cm s~') (s-1) (Pa)
110 36.54 ± 0.05 1162 ± 128 1.2 ± 0.1
195 56.64 ± 0.16 1756 ± 366 1.8 ± 0.4
300 85.00 ± 1.17 2947 ± 22 3.0 ± 0.02
385 101.72 ± 0.43 3373 ± 169 3.4 ± 0.2
IVUS images of microbubbles attached to the agar
samples in the flow cell are shown in Fig. 7. Figure 7a
shows a sample with no bubbles attached and Fig. 7b shows
a sample with microbubbles attached. Images grabbed at
increasing flow rates are shown in Fig. 8. As the flow rate
increases, the IVUS images do not change. This suggests
that the microbubbles remain bound to the agar samples
under increasing flow rales. The RF data shown in Fig. 9
confirmed this. Figure 9a shows a plot of the mean back-
scattered power for agar samples with and without micro-
bubbles attached at each position across the surface of the
agar sample. The first position was at the center of the
sample; the second and third points are on the left and right
of the center. The data are the mean for two different
samples, with the error bars being the standard deviation of
the mean backscatter power. Figure 9b shows the mean
backscatter power across the surface of the agar sample at
increasing flow rates. After increasing the flow to 385 mL
min-1, it was reduced again to 110 mL min-1 and the
backscatter data were collected again. The data collected
after reducing the flow rate to 110 mL min 1 are also
shown in Fig. 9b represented by filled-in data points. After
the flow rate was increased to 385 mL min 1 and reduced
0 100 200 300 400
flow volume (ml min'1)
Fig. 5. Shear stress as a function of flow volume in the flow
chamber. The error bars are the standard error which was
calculated by Excel during the linear regression. The units of
distance have been converted to cm for the shear rate calcula¬
tion. (R2 = 0.9837.)
distance from edge of flow chamber (mm)
Fig. 6. Plot of point velocities horizontally perpendicular to
flow direction, for flows at 110 mL min _1 and 385 mL min '.
to 110 mL min-1, there was no obvious difference in the
mean backscattered power from each section across the
sample, suggesting that the microbubbles were not dis¬
lodged with increasing flow rates.
DISCUSSION
The data described here have shown that the in-
house microbubbles remained attached to agar samples
when subjected to increasing flow rates. The shear stress
experienced by the attached microbubbles was deter¬
mined using LDA. The use of LDA with the flow cham¬
ber enabled the shear stress at the point in the flow
channel where the agar samples were positioned to be
determined.
The flow rates used in the present study were from
75 to 480 mL min-1 through a flow area of 9 mm2, with
shear stresses in the flow channel being determined for
110, 195, 300 and 385 mL min-1.
The LDA data in Fig. 3 show that the range of peak
flow velocities to which the microbubbles were subjected
was from 36 to 84 cm s . These velocities corresponded
to shear stresses of 1.2 to 3.4 Pa . Reported shear stresses
experienced by artery walls are highly dependent on the
measurement technique used. However, normal main
arteries experience mean wall shear stresses of less than
1.5 Pa (Hoeks et al. 1995).
Laser Doppler anemometry (LDA) is a well-estab¬
lished technique allowing noninvasive high-resolution
measurements of the velocities of liquids and gases. It
has recently been used to validate numerically-predicted
wall shear stresses in arteries (Walsh et al. 2003). In this
study, pulsatile flow in a model artery was used with
LDA and time-averaged velocity profiles were calcu¬
lated. These profiles were then compared with profiles
found using computational fluid dynamics (CFD). They
concluded that, for pulsatile flow, LDA should be used
for point velocity validations, but large errors were found
when experimentally determining the wall shear stress.
The calculation of the shear rate from LDA data were






Top and bottom of agar sample
(no microbubbles attached)
Bottom of agar sample
(with bubbles attached)
Fig. 7. (a) IVUS image from flow chamber with agar-based sample without microbubble attached, (b) IVUS image from
flow chamber with agar based sample with microbubbles attached.
highly dependent on the curve-fitting technique used. An
earlier study of shear rale calculations from LDA mea¬
surements for steady and pulsatile flow (Fatemi and
Rittgers 1994) found less than 10% error in wall shear
stress measurements for steady flow when linear fits
were used.
Since steady flow was used in the set-up described
in this study, the errors in the calculated shear stresses
were small. The resolution of the data points was 45 /am,
so the profile was detailed very close to the chamber
wall. When the profile was extrapolated back to the wall at
both sections of the profile at the edges of the flow channel,
the distance between the edges was 1.38 ± 0.04 mm. On
measuring the channel width with a micrometer, at a
position as close as possible to where the LDA measure¬
ments were taken, the width was found to be 1.43 ± 0.02
mm. The difference was due to errors in both methods of
calculating the distance, but the values are comparable.
Linear regressions on the section of the profile at the
edge of the channel were used to calculate the shear rate
at the surface of the samples. When five data points were
used instead of four, there was no significant difference
in the shear stresses calculated. The mean difference in
shear stress value calculated using five data points was
±0.08 Pa.
The profiles in Fig. 3 are parabolic and, for the
lower flow rates, symmetrical. As the flow rate increased,
the profile in the channel became slightly unsymmetrical.
Also, the off-axis flow (Fig. 6) perpendicular to that in
Fig. 3 was not consistently at zero. This could have been
due to the increased flow rate causing turbulence in the
channel. To find the likelihood of the flow being turbu¬
lent, the Reynolds numbers for the minimum and maxi¬
mum flow rates were calculated and found to be 600 and
1500, respectively. These both suggest that the flow in
the channel should have been laminar. As the flow rate
increased, fully-developed flow would take longer to
occur; this could also be the cause of the deviation from
symmetrical parabolic shape at increasing flow rates.
Current in-vitro work, where the effect of shear
stress on microbubbles is investigated, use supplier
quoted values for the shear stress in the commercial flow
chambers used. In flow chambers, the shear rate can vary
across the chamber (Chung et al. 2003), so the exact
shear stress at specific points in a chamber can be diffi¬
cult to calculate. The flow chamber described in this
paper allows high frequency IVUS imaging of samples
with microbubbles attached under flow conditions; the
LDA data give shear stress values for different flow
rates, so there is a potential to use any shear rate required.
The flow profile at different points in the chamber de¬
scribed here can be assessed so the shear stress through¬
out the chamber can be known.
The work in this study has been completed with
steady flow. When subjected to pulsatile flow, the at¬
tached microbubbles may respond in a different manner.
However, the aim of this study was to investigate
whether or not the microbubbles detached from the agar
samples with increased wall shear stresses. When at¬
tached to disrupted plaque, the microbubbles will not
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c) flow rate:
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experience shear stresses as if attached to an intact en¬
dothelial wall, as they will be contained within crevices
or fissures in the wall.
The microbubbles could be imaged with IVUS and
remained attached and echogenic under increased ilow
rates. This was confirmed with the calculated mean back-
scatter power at the surface of the sample. Figure 9b
shows that there was very little difference in the mean
backscatter power after the flow rate had been increased.
CONCLUSIONS
A flow chamber has been designed for ultrasonic
imaging of microbubbles attached to agar. Intravascular
ultrasound was used to image attached microbubbles
under steady flow conditions. The chamber was also used
with laser Doppler anemometry to allow detailed profiles
of the flow in the chamber to be found. These profiles
were used to calculate the shear rate at the wall of the
chamber and, hence, the shear stress to which the micro-
bubbles were subjected. The microbubbles were found to
remain attached and echogenic under flow rates higher
than physiological rates and to withstand shear stresses
of up to 3.4 Pa.
The shear stresses experienced at the surface of sam¬
ples for different flow rates are known for the flow cham¬
ber. These values can be used when the microbubbles are
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Fig. 9. (a) Mean backscatter power for each position across the
surface of agar samples with and without microbubbles attached.
Error bars are one standard deviation, (b) Backscattered power
against flow rate for agar-based samples with and without micro-
bubbles attached. The filled-in data points represent the mean
backscattered power after the llow rate had been increased to 385
mL min 1 and decreased back to 100 mL min-1.
attached to different samples or attached using different
binding methods when other detachment studies are under¬
taken. The in-house microbubbles have been found to re¬
main attached to agar samples under flow rates comparable
with physiological rates; this information has the potential
to be used in future characterization of the microbubble.
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